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Oligonucleotide delivery – Aims of this thesis 
1. Introduction 
Antisense technology reflects a naturally occurring physiological event since 
endogenously expressed antisense molecules exist which are able to regulate endogenous 
gene expression and to defend both prokaryotes and eukaryotes against viral invasion [1;2]. 
Antisense technology has a wide perspective of potential applications. At present, most of 
these applications are in fundamental research where inhibition of gene expression provides 
insight into the function and regulation of the genes studied. Despite the recent withdrawal of 
a first generation antisense candidate in a phase 3 clinical trial [3], a growing interest remains 
in developing drugs based upon the antisense mechanism, mainly aimed at interfering with 
viral infections and cancer. In August 1998, the first antisense molecule 
(Fomivirsen®, Vitravene) to treat cytomegalovirus infection was approved by the FDA [4]. 
Over 20 (first generation) antisense candidates are currently in various stages of clinical 
development, whereas oligonucleotides (ONs) of the second and third generation promise 
lower toxicity and increased stability against enzymatic degradation [5]. Replacing the sugar-
phosphate backbone by a synthetic peptide backbone has resulted in a nucleic acid analogue 
called PNA (peptide nucleic acids), combining the sequence specific action of antisense and 
chemical/hydrolytic (enzymatic) stability [6].  
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Figure 1. Structure of single stranded DNA, RNA and PNA 
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The ability of antisense molecules to bind to complementary mRNA through Watson-
Crick base pairing may sound simple. However, where and how antisense reaches its target(s) 
is still largely obscure. It is generally believed that antisense either sterically blocks mRNA’s 
function (Figure 2B) or promotes enzyme-mediated mRNA degradation (Figure 2C). RNase 
H is an endonuclease that recognizes RNA-DNA duplexes and selectively cleaves the mRNA 
strand. The mechanism is catalytic: once a mRNA molecule is cleaved, the antisense 
dissociates from the mRNA chain and is able to bind to a second mRNA. However, chemical 
modifications and/or changes in the backbone can reduce or eliminate RNase H recognition of 
the ONs/RNA duplex [7;8]: phosphodiester and phosphorothioate ONs can activate RNase H, 
whereas PNA’s are unable to activate RNase H. Further, any RNase which recognizes double 
stranded RNA’s or RNA/DNA duplexes could play a role in the action of antisense ONs. 
Regardless of the mechanism of action, the expression level of the targeted protein will only 
become noticeably reduced after significant turnover of the pre-existing endogenous protein 
pool. 
 
Figure 2. Schematic representation of the biochemical working mechanism of ONs. The translation of 
mRNA (green) into proteins is accomplished by ribosomes, which travel along the mRNA transcripts 
(A).  Binding of an antisense oligonucleotide (orange) can inhibit the translation (B): it can prevent the 
ribosomes from beginning or completing their journey.  Also RNase H can be activated. RNase H cuts 
the mRNA at the site where the ON has bound (C). 
 
With respect to antisense delivery, it is important to take into account that the 
antisense molecules can be active in both cytoplasm and nucleus. In the cytoplasm, the 
antisense can sterically block polypeptide elongation (translational arrest) and/or induce 
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RNase H mediated mRNA degradation. In the nucleus, the antisense can sterically inhibit 
splicing of pre-mRNA and/or induce enzymatic pre-mRNA destabilization [9].  
More recently, double stranded RNA (siRNA) was found to initiate sequence-specific 
gene silencing also in mammalian cells [10]. Consequently, there is growing interest in its 
therapeutic possibilities. siRNA consists of about 22 nucleotides in length and is homologous 
to the gene that is being suppressed. The 22-nucleotide sequences serve as a guide sequence 
that instructs a multicomponent nuclease, RNA-induced silencing complex (RISC) to destroy 
specific mRNA’s [11]. 
 
2. Biological barriers for the delivery of antisense oligonucleotides 
The biological efficacy of administered antisense ONs is restrained as they must 
overcome several obstacles before they reach their intracellular target (in the cytoplasm and/or 
the nucleus). The cellular uptake of antisense oligonucleotides is poor due to their large size, 
hydrophilicity, and negatively charged backbone. In addition, they are very susceptible to 
degradation by nucleases in the extracellular matrix and inside the cell. Consequently, 
therapeutic ONs as well as RNA are strongly dependent on carriers to cross cellular 
membranes, to escape from endosomes and to maintain their physicochemical properties in 
extra- and intracellular matrices. Several laboratories have been encouraged to look for 
appropriate pharmaceutical carrier systems for ONs. Different types of cationic lipids and 
cationic polymers are under investigation as non-viral carriers for antisense ONs [12;13]. 
Cationic lipids as well as cationic polymers spontaneously form interpolyelectrolyte 
complexes with negatively charged nucleic acids, called respectively lipoplexes and 
polyplexes [14]. The physicochemical features that govern the biological activity of lipo- and 
polyplexes are however not well understood, partly due to the complexity of the association 
and dissociation behavior of such complexes. Indeed, a critical step in the delivery of ONs is 
the dissociation of the ONs from the complexes at the right place; i.e. in the cytoplasm of the 
target cell [15]. If the affinity between the ONs and the cationic carriers is too low, the 
complex will dissociate prematurely, e.g. when it is still in the blood stream or in the 
extracellular environment, while a strong affinity might prevent the release of the ONs 
intracellularly. A critical balance between 'being associated extracellularly' and 'being 
dissociated intracellularly' needs to be maintained.  
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Figure 3. Schematic representation of the biological barriers for ON delivery: The carrier/ONs 
complex must be stable in the extracellular matrix (A). The carrier/ONs complex has to overcome the 
cellular membrane (B) and must escape from the endosomes (C) before the latter fuse with the 
lysosomes (D). Once the ONs are released from their carrier in the cytoplasm (E), the ONs must be 
resistant to nuclease activity (F). In case the nucleus is the biological target for the ONs, nuclear 
import is obligatory (G). 
 
To obtain real breakthroughs in understanding the complex matter of intracellular 
dissociation of DNA/carrier complexes there is an urgent need for tools which allow studying 
the dissociation of DNA/carrier complexes in cells. As overviewed below, several advanced 
light microscopy techniques show potential for this purpose.  
 
3. Fluorescence imaging and FRET to study DNA release in cells 
In many studies DNA complexes inside cells are visualized using fluorescently labeled 
DNA. In other reports both the DNA and its carrier are labeled with spectrally different 
fluorophores and dual color microscopy is used to observe simultaneously the DNA and its 
carrier in the cell [16-18]. The colocalization of the fluorescent markers may indicate that the 
DNA and its carrier are associated, a lack of colocalization may indicate that the DNA is 
released from its carrier. However, due to the resolution limit of a microscope it remains 
possible that the fluorescent-labeled molecules are observed colocalized without being 
associated. Fluorescence resonance energy transfer (FRET) between a donor fluorophore on 
the DNA and an acceptor fluorophore on the carrier (or vice versa) could be a better 
alternative to study the complexation. Indeed, FRET only occurs when the donor and acceptor 
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fluorophores are in close proximity, in other words when the DNA is associated to its carrier. 
However, FRET needs a proper positioning of the donor and acceptor molecules, which is 
hard to obtain in DNA/carrier complexes as they arise through (spontaneous) self assembling 
of the DNA and the carrier molecules. To our knowledge, FRET between fluorophores on 
cationic liposomes and (intercalating) dyes on pDNA have only been reported using a 
conventional fluorimeter [19-22]. Intracellular FRET studies by means of fluorescence 
microscopes on DNA/carrier-complexes did not appear in literature so far. However, rather 
recently the Kataoka group reported on intracellular FRET measurements on DNA/carrier 
complexes where both the donor and the acceptor label were attached to the plasmid DNA 
[23]. FRET was reported to occur when the ‘double labeled’ pDNA was complexed to the 
cationic polymers or cationic lipids: upon complexation the pDNA molecule condenses which 
brings the donor and acceptor fluorophore in each others proximity [24]. The intracellular 
release of the pDNA could be observed as the FRET signal disappeared upon dissociation of 
the pDNA from its carrier whereby the DNA molecule is decondensed. The FRET approach 
of the Kataoka group clearly offers an advantage, as one does not need to label each cationic 
carrier when different cationic carriers are investigated. Meanwhile, one also avoids changes 
in the physicochemical properties of the carrier due to the label.  
 
4. Fluorescence fluctuation techniques 
In conventional imaging, average intensities of fluorescence are directly measured as a 
function of space to monitor the distribution of the labeled components throughout the cells. 
In techniques like fluorescence recovery after photobleaching (FRAP), fluorescence 
polarization and fluorescence lifetime imaging (FLIM), intensities of fluorescence are 
monitored as a function of time. The fluctuations of the intensities are however not of direct 
interest. 
Modern fluorescence fluctuation techniques are capable to determine the absolute 
fluorophore concentration as well as molecular brightness and/or diffusional characteristics of 
individual molecular species within one sample mixture. Therefore, fluorescence fluctuation 
spectroscopy (FFS) requires a confocal detection volume and low fluorophore concentrations. 
As illustrated in Figure 4, the detector monitors the fluorescence fluctuations caused by the 
diffusion of fluorescent molecules through the focal volume of a microscope. The 
experimental fluorescence fluctuation profile can be further processed using: 
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- autocorrelation analysis to distinguish between different species based on their 
temporal behavior: Fluorescence Correlation Spectroscopy (FCS) and Image 
Correlation Spectroscopy (ICS). 
- fluorescence intensity analysis to distinguish between different species based on their 
difference in fluorescence: Photon Counting Histogram analysis (PCH), Fluorescence 
Intensity Distribution Analysis (FIDA), or a heuristic statistical analysis of the 
fluorescence fluctuation data as described by Van Craenenbroeck et al. [25;26]. 
 
 
Figure 4. (A) Schematic setup of a dual color FFS instrument. The excitation light from the laser is 
reflected by a triple chroic mirror into the back aperture of the objective lens. The light emitted by the 
fluorescent molecules in the excitation volume passes through the objective lens and the triple chroic 
mirror, to be split by the subsequent dichroic mirror into a red and a green component. Both green and 
red detector monitor the fluorescence intensity as a function of time. (B) Schematic view of 
fluorescently labeled ONs, freely migrating through the excitation volume. Inside the excitation 
volume the fluorophores are excited and emit light (filled circles), outside the excitation volume the 
fluorophores remain in a dark ground state (open circle).  
 
When only one of the interacting components is fluorescently labeled, changes in 
diffusion behavior or molecular brightness of the label are an indication for association. FCS 
can resolve different species on the basis of different translational diffusion coefficients 
[27;28]. However, a change in the molecular weight by a factor of eight is required to detect a 
change in the correlation time by a factor of two. [29]. FIDA/PCH discriminate different 
fluorescent species according to their specific molecular brightness. Hereby, size information 
given by the diffusion time of the molecule is no longer needed [30-32].  
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Both FCS and FIDA have also been extended to variants with two detectors 
monitoring different polarization components or spectral emission bands of fluorescence in 
the same focal volume, respectively called two dimensional FIDA (2D-FIDA) and 
Fluorescence Cross Correlation Spectroscopy (FCCS) [33;34]. Combining FCS and FIDA 
into FIMDA allows simultaneous determination of diffusion coefficients and molecular 
brightness values from a single measurement [35]. The combination of FIDA with 
fluorescence lifetime analysis distinguishes fluorescence species on the basis of both their 
specific molecular brightness and the lifetime of the excited state [36]. 
For large molecules (like DNA-complexes), slow diffusion becomes a limiting factor 
for detection using FCS [27;37]. In contrast to conventional FCS, the size information given 
by the diffusion time of the molecule is no longer needed when using intensity analysis or 
cross correlation analysis, allowing the sample to be moved relative to the focus. 
Development of scanning fluorescence correlations spectroscopy wherein the intensity 
fluctuations are measured as a function of position rather than time provides a means to study 
aggregation in systems like biological cell membranes but provides no information about the 
dynamics. Using the scanning FCS technique a study of the distribution of antibodies specific 
for the epidermal growth factor was carried out on A431 cells [38]. Because the latter 
measurements are slow and usually require fixed preparations, image correlation spectroscopy 
was introduced [39;40]. Image correlation spectroscopy relies on the spatial intensity 
fluctuations in images collected with a confocal laser scanning microscope. To obtain 
dynamic information, analysis of many temporally spaced images is needed. Spatial 
autocorrelation analysis of the images yielded information on the molecular concentration and 
aggregation state. Collecting a time series of images from a sample followed by correlation 
analysis between different images in the time series as well as spatial autocorrelation in the 
individual images provides information on molecular dynamics. Additionally, a two color 
image cross correlation spectroscopy variant has been used to demonstrate colocalization of 
two different molecules on the surface of cells. The introduction of video rate system enabled 
to measure diffusion coefficients that are three orders of magnitude larger than those 
measurable with ICS on slower CLSM systems [41]. 
FFS is sensitive in changes in the aggregation state of the fluorophore, as the 
autocorrelation function is influenced by the square of the specific brightness of each 
component. However, whenever highly intense fluorescence peaks appear in the fluctuations 
profiles, auto- and cross-correlation analysis are no longer feasible. In both single and dual 
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color FFS, these highly intense fluorescence peaks have been reported for several 
polymer/oligonucleotide complexes [42-44] as well as for liposome/oligonucleotide 
complexes [45]. As a consequence one cannot study the complexation of oligonucleotides 
based upon a change in their mobility (as correlation analysis is necessary to obtain the 
diffusion coefficient from the fluctuations) [42;44]. As an alternative approach, the 
fluorescence fluctuations could be analysed by photon histogram analysis (PCH) as this 
allows to distinguish between free and complexed molecules based on their difference in 
molecular brightness. However, previous work in our group has shown that the highly intense 
fluorescence peaks also did not allow to apply PCH analysis on the fluorescence fluctuations 
of DNA/carrier complexes mainly due to the ‘heterogenity’ of the highly intense fluorescence 
peaks appearing in the fluorescence fluctuation profiles [43]. In conclusion, searching for the 
presence or absence of highly intense fluorescence peaks in the fluorescence fluctuation 
profiles seems to be the only way of analysis one can use to know whether oligonucleotides 
are complexed to/or dissociated from their carriers. However, highly intense fluorescence 
peaks may also be due to aggregation of free ONs with cellular components, which could be 
misinterpreted as being original carrier/ONs-complexes. Therefore, the fluorescent labeling of 
both the carrier and the ONs should improve the signal specificity. In dual color FFS, both 
interacting components are labeled with spectrally different fluorophores (e.g. red and green) 
and their emission light is detected separately by two detectors monitoring the same focal 
volume. When dissociated, the components are only detected in one detector, as they carry a 
red or a green fluorophore. However, when associated, the complex is detected in both 
detectors simultaneously as it bears both red and green fluorophores.  
 
5. Some critical remarks 
Since both single- and dual color FFS detect fluorescent molecules at the single 
molecule level, also fluorescent contaminants present at low concentration will be detected. 
As a result, the used fluorescent molecules should be extensively purified to remove any free 
dye. It should be noted that a certain degree of contamination can be tolerated if properly 
corrected for in the data analysis. Also the type of fluorescent dyes has to be carefully 
selected. In general they should be highly fluorescent (i.e. they should generate high counts 
per molecule), preferentially at low laser excitation power, and show little photobleaching. 
Fluorescence enhancement or quenching of the fluorophores may occur in the reaction under 
investigation. However, changes in molecular brightness can only be corrected for to a limited 
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extend in autocorrelation analysis [25] and fluorescence intensity distribution analysis might 
be more suitable.  
When dual color FFS is considered, the experimental setup is also critical since two 
laser beams have to be focused in the same spot, and the detection volumes have to be brought 
to a perfect overlap. Autofluorescence of the cells and photobleaching can further complicate 
the data analysis. Autofluorescence excited at 532 nm was reported to depend on the 
incubation conditions of the cells. FFS revealed that the changes in autofluorescence were due 
to changes in molecular brightness of the autofluorescent particles as the average number of 
particles detected in the focal volume did not change [46]. Also, at high laser excitation 
power, cell photodamaging can be observed. Some of these problems which arise 
intracellularly can be addressed by using two photon excitation (2PE) [47-49]. In 2PE, the 
simultaneous absorption of two photons of approximately half the energy is required for 
transition to the excited state. Only the focal plane receives sufficient photon flux for this 
simultaneous absorption to occur. In one photon excitation, the out-of-focus fluorescence is 
rejected due to the insertion of pinholes, but illumination still occurs all along the cone-like 
profile of the focused laser beam. Therefore out of focus photobleaching and photodamaging 
effects will be more severe when 1PE is used. Using 2PE, photobleaching and photodamaging 
only occur in the focal plane. 
 
6. Aims and outline of this thesis  
To overcome the problems in antisense delivery, many groups are currently screening 
a high number of pharmaceutical carriers for ONs delivery. However, while much effort is 
oriented towards the synthesis of new carriers, the optimization of the physicochemical and 
pharmaceutical features of the complexes is frequently neglected. We believe that rational 
design of improved vectors requires a better knowledge of the multistage process by which 
pharmaceutical vectors deliver ONs into cells. In this optimization process we should pay 
attention to all the critical steps involved in the delivery of ONs by pharmaceutical carriers: 
(1) the preparation of the carrier/ONs-complexes, (2) the stability of the complexes in 
biological fluids, (3) the transport of the complexes from the extracellular space to the 
intracellular environment and (4) the cellular behavior of the complexes. An important step, 
which has to occur once the complexes arrive in the cells, is the release of the ONs from their 
carrier. 
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Although the association and dissociation of pharmaceutical carrier/ONs complexes 
have been studied extensively in vitro (i.e. in buffer), information on the complexation in 
biological media, and especially in the cellular environment is limited. Therefore, very 
challenging is the development of innovative methods to study the behavior of pharmaceutical 
carrier/ONs complexes in the cytoplasm and nucleus of cells. With this scope in mind, this 
thesis deals with dual color fluorescence fluctuation spectroscopy. The main aim of this thesis 
is to evaluate the potential of this method to study the complexation between ONs and their 
carriers in buffer and in the living cells. 
 
In this chapter (Chapter 1) the basic principles of antisense therapy and the obstacles 
in non viral antisense delivery were briefly summarized. A literature overview on advanced 
fluorescence microscopy techniques that allow studying intracellular processes was made. 
Advanced microscopy techniques clearly show potential to help to a better understanding of 
the mechanisms which process macromolecular therapeutics or nanoscopic drug vectors in 
biological environments. The experimental results in Chapter 2 will illustrate the need for 
advanced microscopy techniques to understand why some carrier/ONs combinations show 
biological activity, whereas other combinations fail. Therefore, we wish to evaluate the use of 
dual color FFS to study the dissociation/association of ONs from/to their carrier in buffer and 
in living cells. In Chapter 3 we will elucidate the complexation behavior between 
oligonucleotides and the cationic polymer poly-L-Lysine (pLL) by single and dual color FFS. 
Poly-L-Lysine is a well-studied cationic polymer and is used in this study as a model for 
cationic homopolymers used as pharmaceutical carrier. In Chapter 4 we will evaluate to what 
extent dual color FFS is able to study the model pLL/ONs complexes in living cells. In the 
following chapters, two alternative types of carrier/ONs-complexes will be studied by dual 
color FFS in buffer: pegylated polymer/ONs complexes in Chapter 5 and liposome/ONs 
complexes in Chapter 6. Using liposome/ONs complexes as a model, we will also prove that 
dual color FFS is an excellent technique to study the stability of carrier/ONs-complexes in cell 
lysate and in living cells. 
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Chapter 2 
 
   
 
On the biological activity of anti-ICAM-1 
oligonucleotides complexed to non-viral carriers. 
 
Parts of this chapter have been published in Journal of Controlled Release 96: 207-219 (2004). 
 
1. Introduction 
Today, most studies on the cellular behavior of DNA carriers deal with the delivery of 
plasmid DNA. The cellular behavior of ONs packed in pharmaceutical carriers has been 
investigated less systematically [1]. This may be partially explained by the fact that the 
cellular delivery of plasmids can be evaluated rather easily by measuring the cellular 
expression of the corresponding protein. However, the biological evaluation of antisense ONs 
effects is more difficult because of the “high background”: antisense ONs have to decrease a 
pre-existing high level of target RNA or translated protein. Modified assays are recently 
developed to counter this problem [2;3].  
In the first part of this chapter, we studied the biological efficiency of anti-ICAM-1 
ONs packed in several types of pharmaceutical carriers. We used a well-studied antisense 
assay in which the ability of the ONs to downregulate the expression of the intercellular 
adhesion molecule-1 (ICAM-1, a 90-110 kDa membrane glycoprotein) is evaluated. The 
ICAM-1 gene plays an important role in inflammatory diseases like rheumatoid arthritis, 
ulcerative colitis, Crohn’s disease, … [4;5]. Published data describe antisense-specific and 
effective inhibition of ICAM-1 by antisense oligonucleotides in tissue culture [6;7], in rodents 
[8;9] and in humans [10]. 
As related projects of our group are focusing on pulmonary gene delivery through 
inhalation [11], the human lung epithelial cell line A549 was used to determine the biological 
efficiency of the ONs. ICAM-1 is normally expressed at low levels on the surface of these 
cells. In response to tumor necrosis factor-alfa (TNF-alfa), an increased expression 
(“upregulation”) of ICAM-1 has been demonstrated [12]. When targeted to human ICAM-1 
mRNA, antisense ONs can inhibit the upregulated expression in A549 cells by different 
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mechanisms. The oligonucleotide “ISIS 1939”, which targets specific sequences in the 3’-
untranslated region of the mRNA, is biologically active by RNase H mediated degradation of 
the targeted mRNA. The oligonucleotide “ISIS 1570” targets the AUG translation initiation 
codon. In the latter case, the protein level is reduced but not the ICAM-1-mRNA level [6].  
Antisense ONs can bind to mRNA both in the cytoplasm and in the nucleus, therefore 
reaching the nucleus should not be a requisite for biological activity. However, as RNase H is 
more abundant in the nucleus [13], the nuclear accumulation of the ONs might result in higher 
efficiency in case of “ISIS 1939” ONs. In general, it is observed that microinjection of free 
ONs in the cytoplasm leads to an accumulation of the ONs in the nucleus within minutes. This 
is attributed to simple diffusion, with subsequent trapping of the oligonucleotides [14-16]. 
Recently, PS-ONs are reported to continuously shuttle between the nucleus and the 
cytoplasm, in an active transport, carrier-mediated and nuclear pore complex mediated way 
[17]. In contrast to previous reports, phosphodiester oligodeoxynucleotides have been found 
to be actively imported into the nucleus [18]. 
A biological assay answers the question whether a certain pharmaceutical carrier 
successfully delivers ONs or not. However, it does not give an answer on the important 
question why one carrier is successful while another one fails. In the second part of this work, 
we tried to find out why some carrier/ONs combinations showed biological activity and why 
others did not. We were especially interested in knowing how cellular methods like flow 
cytometry and confocal laser scanning microscopy (CLSM) could provide us with additional 
information on the cellular delivery of the carrier/ONs combinations studied. 
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2. Materials and methods 
 
2.1. Cell culture 
Human lung carcinoma cells (A549 cells, ATCC number: CCL-185) (DSMZ, 
Braunschweig, Germany) were cultured in Dulbecco’s modified Eagle’s medium (DMEM; 
without phenol red) (Gibco, Merelbeke, Belgium) containing 2 mM glutamine, 10% heat 
inactivated fetal bovine serum (FBS), 1% penicilline-streptomycine. Cells were grown at 
37°C in a humidified atmosphere containing 5% CO2. Cells were prophylactically treated 
against mycoplasma with Plasmocin (Invivogen, Cayla, France). Hoechst 33258 
(bisbenzimidazole) (ICN Biochemicals, Inc. Aurora, Ohio) was used to prove that cells were 
free of mycoplasma. 
 
2.2. Oligonucleotides 
The 20-mer ICAM-1 antisense ONs (5’-CCC CCA CCA CTT CCC CTC TC-3’) 
employed in the present study target the 3’ non-coding region of ICAM-1 mRNA. This 20-
mer antisense ON corresponds to ISIS 1939. They were supplied by Eurogentec (Seraing, 
Belgium) as phosphorothioate ONs (PS-ONs) and phosphodiester ONs (PO-ONs). Also the 5’ 
rhodamine green (RhGr) labeled ONs were supplied by Eurogentec. 
 
2.3. Cationic carriers 
Lipofectin (DOTMA:DOPE (weight ratio 1:1)) was purchased from Life Technologies 
(Gaithersburg, MD). Lipofectin is a combination of a cationic lipid (N-(1-(2,3-
dioleoyloxy)propyl)-N,N,N-trimethylammonium chloride (DOTMA), Figure 1A) and a 
neutral lipid (dioleoylphosphatidylethanolamine (DOPE), Figure 1B). 
 
Poly(ethylene glycol)-poly-ethylene-imine (pEG-pEI, Figure 1C) was a kind gift of the 
University of Nebraska. The weight average molecular weight (MW), as determined from 
static light scattering, was 12,4 kg/mol. The total content of nitrogen was 3.75 µmol/mg 
polymer. 
 
PEI (25 kg/mol) was obtained by Sigma-Aldrich (Bornem, Belgium). 
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Pegylated poly (2-dimethylamino) ethylmethacrylate-co-aminoethylmethacrylate 
(pEG-pDMAEMA-co-AEMA, MW 1700000 g/mol, 8 mol % AEMA, Figure 1D; abbreviated 
as graft-pDMAEMA) was a generous gift of the University of Utrecht. Part of AEMA (max 
25 %) was conjugated with pEG 5000, using a versatile method to synthesize pDMAEMA-
conjugates as described elsewhere [19].  
Alexa647-succinimidylester (Amersham Pharmacia, Piscataway, NJ) was used to label 
part of the non-pegylated AEMA. The non-conjugated label was removed by means of 
dialysis (molecular weight cutoff 12 kD, Medicell International Ltd.). It could be calculated 
that each polymer chain bore on the average 12 fluorescent labels. 
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Figure 1. Structure of the cationic lipid DOTMA (A), the neutral helper lipid DOPE (B), the cationic 
block-copolymer pEG-pEI (C) and the cationic copolymer graft-pDMAEMA (D). 
 
2.4. Preparation of the lipoplexes and polyplexes for cellular experiments 
In case of Lipofectin, 100 µL DMEM containing 20 µg/mL Lipofectin was added to 
each well, followed by 50 µL of the ONs solution in DMEM.  
Where graft-pDMAEMA/ONs or pEG-pEI/ONs polyplexes were used, 150 µL of the 
polyplex dispersion was added to each well. We emphasize that, contrary to the complexation 
with Lipofectin, the complexation took place before the polyplexes were applied on the cells. 
Polyplexes of a polymer/ONs weight ratio of 4 (w/w = 4) were prepared by mixing (in one 
step) polymer and ONs stock solutions (in DMEM), followed by vortexing the dispersion 
during 10 seconds. To obtain the desired final ONs concentration, the dispersions were further 
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diluted with DMEM. The polyplexes were allowed to equilibrate for 30 minutes at room 
temperature prior to use. 
 
2.5. Inhibition of ICAM-1 expression in A549 cells 
A549 cells were plated onto 96-well microtiter plates (104 cells/well). On day 3 (at 
90% confluency) the cells were washed three times with phosphate buffered saline (PBS) 
(Gibco, Merelbeke, Belgium) and free or complexed ONs were added to the cells, followed 
by four hours of incubation. Subsequently, the free or complexed ONs were removed. After 
washing the cells three times with PBS, 100 µL culture medium supplemented with 10 ng/mL 
TNF-alfa was added to induce overexpression of ICAM-1. After 18 hours, the cells were 
washed, fixed for 15 min at room temperature in PBS containing 20 mg/mL 
paraformaldehyde and blocked with 2% normal goat serum (NGS) in a 1% BSA/PBS 
solution. The expression of ICAM-1 was measured as follows. Cells were washed and 
incubated for 90 min at 37°C with mouse anti-human ICAM-1 antibody (ImmunoSource, 
Zoersel, Belgium) (0.5 µg/mL). After removal of the mouse anti-human ICAM-1 antibody, 
the cells were washed and incubated for 1 h at 37°C with sheep anti-mouse antibody-
horseradish peroxidase conjugate (1:1000). After 3 washes, the peroxidase activity was 
assessed using 100 µL of o-phenylenediamine dihydrochloride (OPD; Sigma, Bornem, 
Belgium). After 15 min incubation at 37°C, the reaction was stopped by adding 100 µL 2 M 
H2SO4 and the absorbance was read on an ELISA plate reader at 490 nm. A0 is the absorption 
of the cells without TNF-alfa induction (“basal expression”). ATNF is the absorption of the 
cells upon induction with TNF-alfa but in the absence of ONs. AONsTNF is the absorption of the 
cells upon induction with TNF-alfa and after treating the cells with (free or complexed) ONs. 
 
2.6. Agarose gel electrophoresis experiments 
The polyplex dispersions (pEI/ONs: w/w 1.6 and graft-pDMAEMA/ONs: w/w = 4) 
used in the gel electrophoresis experiments contained 26.7 µg/mL RhGr labeled PO-ONs or 
RhGr labeled PS-ONs. Thirty minutes after the preparation of the polyplex dispersions, 
DNase I (Roche, Belgium) or unlabeled ONs (PS or PO) were added to the dispersions. 
Another 30 minutes later, 30 µL of these dispersions was mixed with 5 µL of a 50% sucrose 
solution in distilled water and placed in the wells of a 1.1 % agarose gel. A TBE buffer was 
used containing 10.8 g/L Tris base, 5.5 g/L boric acid and 0.58 g/L EDTA. A potential of 100 
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V was applied for 60 min. The oligonucleotides in the gel were detected based upon the 
fluorescence of their RhGr-label. 
 
2.7. Cellular uptake of ONs measured by flow cytometry 
A549 cells were harvested using trypsin and 3 x 105 cells were incubated at 37 °C 
during 4 hours in DMEM containing RhGr-ONs (0.5 µM) either in the absence or presence of 
a cationic carrier (Lipofectin (13 µg/mL), graft-pDMAEMA (w/w = 4) or pEG-pEI (w/w = 
4)). After incubation, the cells were centrifuged 3 times (200 g for 5 min); after each 
centrifugation step the pellet was washed with PBS. Consequently, the cells were resuspended 
in DMEM. The fluorescence intensity of the cells was recorded at 520 nm using a flow 
cytometer (Becton Dickinson, Erembodegem, Belgium) at an excitation wavelength of 488 
nm. Cell viability was simultaneously evaluated by adding propidium iodide (detection at 700 
nm, excitation at 488 nm). 5000 cells were analyzed. 
 
2.8. Confocal laser scanning microscopy 
The cells were seeded onto sterile 8-well Nunc chambers (Nalge Nunc Int., Naperville, 
Il) and allowed to adhere for 1 day. 150 µL of RhGr-ONs (0.5 µM in DMEM) in the absence 
or presence of a cationic carrier (Lipofectin (13 µg/mL), graft-pDMAEMA (w/w = 4) or pEG-
pEI (w/w = 4)) were added to the cells and incubated for 3 hours at 37°C. The cells were 
washed three times with PBS before investigating them by confocal laser scanning 
microscopy (Bio-Rad MRC 1024; Hemel Hempstadt, UK). Confocal sections were taken 
every 0.5 µm. Cell viability was simultaneously evaluated by adding propidium iodide. We 
used a 60x water immersion objective and a krypton/argon laser (488 nm) for the excitation of 
the RhGr. 
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3. Results and discussion 
 
3.1. Biological activity of ICAM-1 antisense ONs in the presence or absence of 
cationic carriers 
To evaluate the biological activity of ONs bound to different carriers we used the 
ICAM-1 assay. In this assay we determined the inhibition of the ICAM-1 protein expression 
on the surface of A549 cells induced by TNF-alfa. ISIS 1939 PS-ONs and its phosphodiester 
analog (PO-ONs) were chosen because they are more active than ISIS 1570 [6].  
 
It was important to assure that ICAM-1 experiments were done on mycoplasma-free 
cells. Indeed, we observed that in mycoplasma infected cells the basal ICAM-1 expression 
(A0) was increased to the same level as the induced ICAM-1 expression (ATNF) (data not 
shown). We observed that the treatment of the cells with Plasmocin successfully eliminated 
the mycoplasma: extranuclear Hoechst 33258 fluorescence was absent while the basal ICAM-
1 expression returned to a normal level. These observations agreed with the study of Fabisiak 
et al. who reported that cytokine levels (as measured by ELISA) in mycoplasma infected cells 
were 50-fold higher than in the non-infected lines. They also observed that treatment of these 
cells with mycoplasma removal agents eliminated extranuclear Hoechst fluorescence and 
significantly reduced the cytokine levels [20].  
 
Maus et al. reported that cationic liposomes themselves inhibit the TNF-alfa induced 
ICAM-1 expression in human endothelial cells [21]. To verify whether the cationic carriers 
used in this study influence the ICAM-1 expression, we determined the ICAM-1 expression of 
the A549 cells in the presence and absence of the (free) carriers. As Figure 2 shows, 
Lipofectin did not influence the ICAM-1 expression, in the concentrations used in this study. 
Also graft-pDMAEMA, and pEG-pEI did not influence the ICAM-1 expression (data not 
shown). 
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Figure 2. Basal (empty bar) and TNF-α induced (shaded bar) ICAM-1 expression of A549 cells in the 
presence (bar 3 and 4) and absence (bar 1 and 2) of Lipofectin (n = 6). 
 
In the absence of a carrier, the PS-ONs and PO-ONs failed to inhibit TNF-alfa induced 
ICAM-1 expression even at concentrations of up to 1 µM (data not shown). Probably, this can 
be explained by the inability of naked ONs to diffuse passively through the cellular membrane 
as they are large (5-10 kDa), negatively charged, hydrophilic molecules.  
 
Figure 3A shows that after treatment with Lipofectin/PO-ONs no significant decrease 
in the level of induced ICAM-1 protein expression was observed for different concentrations 
of PO-ONs (0.25-1.2 µM). Other groups already showed that cationic lipids were not able to 
confer antisense activity on PO-ONs [6;22]. Although, as shown in Figure 3B, Lipofectin/PS-
ONs complexes were able to significantly decrease the ICAM-1 expression.  
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Figure 3. Inhibition of ICAM-1 expression in A549 cells by PO-ONs (A) and PS-ONs (B) in the 
presence of Lipofectin. A549 cells were treated with serum-free medium containing Lipofectin (13.3 
µg/mL) and the indicated concentration of ONs (3: 100 nM, 4: 250 nM, 5: 500 nM, 6: 750 nM, 7: 1 
µM, 8: 1,2 µM). Bar 1 and 2 show respectively the basal and the induced ICAM-1 expression. The 
ICAM-1 expression of TNF-alfa-treated cells was set to 100 %. All the data are expressed as mean 
values of 4 measurements (n = 4). 
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Figure 4 shows that, in contrast to Lipofectin, graft-pDMAEMA efficiently delivered 
both PO-ONs as well as PS-ONs to ICAM-1 mRNA. Especially, a very efficient inhibition of 
the ICAM-1 expression was obtained when graft-pDMAEMA/PS-ONs complexes were used, 
even at very low PS-ONs concentrations.  
We further observed that the ICAM-1 expression was not inhibited using pEG-pEI as a 
carrier for the PS-ONs and the PO-ONs (data not shown). 
0
20
40
60
80
100
120
1 2 3 4 5
O
D
42
0
B
0
20
40
60
80
100
120
1 2 3 4 5
O
D
42
0
A
O
D
42
0
O
D
42
0
 
Figure 4. Inhibition of ICAM-1 expression in A549 cells by PO-ONs (A) and PS-ONs (B) in the 
presence of graft-pDMAEMA. A549 cells were treated with graft-pDMAEMA/ONs complexes (w/w 
= 4) in serum-free medium at the indicated concentration of ONs (3: 100 nM, 4: 500 nM, 5: 1 µM). 
Bar 1 and 2 show respectively the basal and the induced ICAM-1 expression. The ICAM-1 expression 
of TNF-alfa-treated cells was set to 100 %. All the data are expressed as mean values of 4 
measurements (n = 4). 
 
Three major questions were revealed from Figures 3 and 4:   
(a) How to explain why PS-ONs complexed to Lipofectin were biologically active while 
PO-ONs complexed to Lipofectin did not show antisense activity? (Figure 3B versus 
Figure 3A)  
(b) Why is there a discrepancy between Lipofectin and graft-pDMAEMA in the delivery 
of PO-ONs? (Figure 3A versus Figure 4A)   
(c) Why do PS-ONs complexed to graft-pDMAEMA show a better biological effect than 
PO-ONs complexed to graft-pDMAEMA? (Figure 4B versus Figure 4A) 
 
One hypothesis to explain the first question is that the oligonucleotides dissociate from 
the cationic lipid already during the endosomal escape. Marcusson et al. suggested from 
CLSM measurements that the lipid indeed stays in the endosomal compartment while the 
oligonucleotides travel through the cell [23]. Consequently, free PO-ONs and PS-ONs are 
delivered in the cytoplasm. As PS-ONs are more resistant to intracellular nucleases, this may 
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explain why PS-ONs complexed to Lipofectin were biologically active while PO-ONs 
complexed to Lipofectin did not show antisense activity. 
 
One hypothesis to explain the second question is that graft-pDMAEMA may stay 
associated with the ONs in the cytoplasm for a longer time and, consequently, may protect the 
ONs from nuclease degradation. Though our CLSM-observations show similar distributions 
for ONs complexed to graft-pDMAEMA or complexed to Lipofectin (see 3.3.), 
gelelectrophoresis shows that Lipofectin/ONs complexes are easily destabilized in a buffer 
solution containing the extracellular DNase I (Figure 5A), whereas graft-pDMAEMA/ONs 
complexes remain very stable (Figure 5B), even over a few days.  
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Figure 5. (A) Gel electrophoresis on free RhGr-PO-ONs (lane 1 and 2) and Lipofectin/RhGr-PO-ONs 
complexes (lane 3 and 4). Lane 2 and 4 show the effect of incubating the sample with DNase I for over 
24 h. The RhGr-PO-ONs concentration in all the dispersions was 20 µg/mL, the DNase I concentration 
was 14 µg/mL. (B) Gel electrophoresis on free RhGr-PO-ONs (lane 1 and 2) and graft-
pDMAEMA/RhGr-PO-ONs complexes (lane 3 and 4). Lane 2 and 4 show the effect of incubating the 
sample with DNase I for over 24 h. The RhGr-PO-ONs concentration in all the dispersions was 20 
µg/mL, the DNase I concentration was 14 µg/mL. 
 
Besides the protective characteristics of the polymer (see question b) and the nuclease 
resistance of the PS-ONs (see question a), other phenomena might explain why graft-
pDMAEMA/PS-ONs showed a better activity than graft-pDMAEMA/PO-ONs (question c). 
We wondered whether the chemical modification of PO-ONs into PS-ONs influences the 
interaction of the oligonucleotides with their carriers, which may, on its turn, influence their 
biological effect. Therefore, RhGr-PO-ONs/carrier and RhGr-PS-ONs/carrier complexes were 
exposed to increasing concentrations of respectively (unlabeled) PS-ONs and PO-ONs 
followed by gel electrophoresis analysis. Figure 6A shows the results of graft-
pDMAEMA/RhGr-PO-ONs complexes exposed to unlabeled PS-ONs; Figure 6B shows the 
results of graft-pDMAEMA/RhGr-PS-ONs complexes exposed to unlabeled PO-ONs. The 
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“competition experiment” in Figure 6 shows that graft-pDMAEMA formed more stable 
complexes with RhGr-PS-ONs (Figure 6B) than with RhGr-PO-ONs (Figure 6A): while PS-
ONs were able to displace RhGr-PO-ONs from graft-pDMAEMA, PO-ONs could not 
displace the RhGr-PS-ONs from their carrier.  
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Figure 6. (A) Gel electrophoresis on graft-pDMAEMA/RhGr-PO-ONs complexes (w/w = 4) exposed 
to increasing concentration of unlabeled PS-ONs. The RhGr-PO-ONs concentration in all the 
dispersions is 26.7 µg/mL. Lane 1 contains RhGr-PO-ONs alone. Lane 2 contains graft-
pDMAEMA/RhGr-PO-ONs complexes. In lanes 3-9 unlabeled PS-ONs were added to the graft-
pDMAEMA/RhGr-PO-ONs complexes in 0.5; 1; 1.5; 3; 4; 5 and 6-fold to the RhGr-PO-ONs 
concentration. (B) Gel electrophoresis on graft-pDMAEMA/RhGr-PS-ONs complexes (w/w = 4) 
exposed to increasing concentrations of unlabeled PO-ONs. The RhGr-PS-ONs concentration in all the 
dispersions is 26.7 µg/mL. Lane 1 contains RhGr-PS-ONs alone. Lane 2 contains graft-
pDMAEMA/RhGr-PS-ONs complex. In lanes 3-9 unlabeled PO-ONs were added to the 
pDMAEMA/RhGr-PS-ONs in 0.5; 1; 1.5; 3; 4; 5 and 10-fold to the RhGr-PS-ONs concentration. 
 
Similar results were obtained when using the polymer pEI (Figure 7): PS-ONs were 
able to displace RhGr-PO-ONs from pEI while PO-ONs could not displace RhGr-PS-ONs 
from pEI. Dheur et al. used this result to explain why in their experiment the pEI/PO-ONs 
complexes exerted antisense activity while the pEI/PS-ONs complexes did not. They argued 
that the pEI/PS-ONs complexes were too stable to release the PS-ONs from the carrier [24]. 
However, following this argumentation and considering our results in Figure 6, one would 
expect no antisense activity for the graft-pDMAEMA/PS-ONs complexes, while Figure 4B 
clearly shows a biological effect. It illustrates that it is hard to correlate the outcome of 
measurements like e.g. gel electrophoresis with the cellular behavior of DNA complexes. 
Therefore, techniques which could measure the intracellular dissociation behavior of DNA-
complexes are highly recommended as they would yield more biologically relevant 
information. 
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Figure 7. (A) Gel electrophoresis on pEI/RhGr-PO-ONs complexes (w/w = 1.6). The RhGr-PO-ONs 
concentration in all the dispersions is 26.7 µg/mL. Lane 1 contains RhGr-PO-ONs alone. Lane 2 
contains pEI/RhGr-PO-ONs complexes. For lanes 3-9 unlabeled PS-ONs were added to the pEI/RhGr-
PO-ONs complexes in 0.5; 1; 1.5; 3; 4; 5 and 6-fold to the RhGr-PO-ONs concentration. (B) Gel 
electrophoresis on pEI/RhGr-PS-ONs complexes (w/w = 1.6). The RhGr-PS-ONs concentration in all 
the dispersions is 26.7 µg/mL. Lane 1 contains RhGr-PS-ONs alone. Lane 2 contains pEI/RhGr-PS-
ONs complexes. For lanes 3-9 unlabeled PO-ONs were added to the pEI/RhGr-PS-ONs complexes in 
0.5; 1; 1.5; 3; 4; 5 and 6-fold to the RhGr-PS-ONs concentration. 
 
3.2. Cellular uptake experiments by flow cytometry 
The cellular uptake of the rhodamine green labeled ONs (both PO-ONs and PS-ONs) 
was evaluated by flow cytometry. A major advantage of flow cytometry is that in a short time 
a huge population of cells can be evaluated for the absence or presence of fluorescent ONs. A 
disadvantage of the method is that we cannot obtain information on the intracellular 
localization and the integrity of the ONs. However, some groups did distinguish between 
endosomal or cytoplasmatic localization of ONs from flow cytometric studies. Therefore, they 
labeled the ONs with the pH sensitive dye fluorescein isothiocyanate (FITC) [25]. 
 
Upon exposure of the A549 cells to RhGr-labeled PO-ONs, no enhancement of cell-
associated fluorescence compared to the blanco cells could be observed. Figure 8A shows that 
all data were located in the upper left side of the graph. It indicates that the cells did not take 
up free RhGr labeled PO-ONs. This explains why free PO-ONs did not show any biological 
effect in the ICAM-1 assay (see 3.1). In case of RhGr-labeled PS-ONs, all cells showed a 
higher fluorescence as compared to the blanco cells, also after a washing step with acid 
glycine buffer (pH 2.0) (data not shown). However, we suggest that the increase in 
fluorescence of the cells was attributed to surface bound RhGr-PS-ONs and not to internalized 
RhGr-PS-ONs, as could be confirmed by CLSM measurements (see 3.3.).  
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Figure 8B shows that the complexation of RhGr-PO-ONs with Lipofectin resulted in 
an increased fluorescence in 90% of the cells. Figure 3A showed that the Lipofectin/PO-ONs 
complexes did not suppress the ICAM-1 expression. Combining the results from the flow 
cytometric measurements and the ICAM-1 assay indicates that the absence of antisense 
activity of Lipofectin/PO-ONs complexes was not attributed to an inefficient entrance of the 
complexes in the cells. 
 
As Lipofectin/PS-ONs complexes were biologically active, it was expected that flow 
cytometry would reveal the cellular uptake of ONs. Indeed, Figure 8C shows that in case of 
complexation of RhGr-PS-ONs with Lipofectin almost all the cells showed increased 
fluorescence compared to the blanco cells. Even very bright cells could be detected. 
 
A B
C
 
Figure 8. Cellular uptake of RhGr-ONs as studied by flow cytometry. A549 cells were treated for 4 
hours with 0.5 µM free PO-ONs (A) and ONs in combination with Lipofectin (13 µg/mL): 0.5 µM 
PO-ONs (B) and 0.5 µM PS-ONs (C). The threshold of the upper left part is calculated after measuring 
the fluorescence of blanco cells. The x-axis is a measure of the fluorescence intensity of the cells. The 
y-axis shows the forward scattering (FSC) and is a measure of cell size. 
 
Complexation of RhGr-PO-ONs with graft-pDMAEMA resulted in an enhanced cell-
associated fluorescence for 73% of the cells (data not shown). Also, graft-pDMAEMA/RhGr-
PS-ONs complexes were efficiently taken up by the cells (data not shown). 
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When labeled ONs were complexed with pEG-pEI no enhancement of cell-associated 
fluorescence could be observed (data not shown), even with RhGr-ONs concentrations of 1 
µM. Probably the absence of antisense activity in the ICAM-1 assay by the pEG-pEI based 
complexes (see 3.1.) can be explained by the inability of these complexes to enter the cells or 
by extracellular dissociation of the complexes. 
 
3.3. Intracellular localization experiments by CLSM 
In contrast to flow cytometry, CLSM can be used to study the intracellular distribution 
of the labeled ONs. In this study, the intracellular localization experiments were done on 
unfixed cells as non-viable cells have the property of internalizing significantly more ONs 
than viable ones (data not shown). CLSM experiments showed that A549 cells did not take up 
free RhGr-PO-ONs and RhGr-PS-ONs (data not shown). In case of RhGr-PS-ONs a faint 
staining of the cell surface could be detected, whereas in case of RhGr-PO-ONs no 
fluorescence at all was observed. These results agreed with those of the flow cytometric 
experiments and confirmed that the absence of biological activity in the ICAM-1 assay was 
due to the inability of free ONs to enter the cell. 
 
Figure 9 shows that, in the case of complexation with Lipofectin, a part of the RhGr-
PO-ONs was in the nuclei, as they stained green, while another part of the RhGr-PO-ONs was 
in the endosomes as revealed from the punctate regions in the cytoplasm. Similar CLSM 
results were observed for Lipofectin/RhGr-PS-ONs. The CLSM experiments showed that 
Lipofectin was able to deliver both types of ONs in the cellular environment, which agreed 
with the flow cytometric observations. However, only the Lipofectin/PS-ONs complexes 
showed antisense activity.  
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Figure 9. Transmission picture (gray), merged with a CLSM picture (green) of A549 cells transfected 
with RhGr-PS-ONs (A) and RhGr-PO-ONs (B) complexed with Lipofectin. A circle is drawn around 
the nuclei with green fluorescence, indicating nuclear accumulation of the RhGr-ONs. A scale bar is 
indicated in µm. 
 
Where graft-pDMAEMA is concerned, for both types of ONs, again similar CLSM 
images were obtained as with Lipofectin. Punctate green regions could be observed in the 
cytoplasm, indicating that part of the RhGr-ONs were undissociated from their carrier and/or 
still in the endosomes. Part of the cells showed green stained nuclei, corresponding with 
nuclear accumulation of the RhGr-ONs and therefore an indication for the successful 
dissociation of the ONs from their carrier. These observations were expected as both graft-
pDMAEMA/PS-ONs as graft-pDMAEMA/PO-ONs showed biological activity (see 3.1.). The 
intracellular dissociation of ONs from graft-pDMAEMA was confirmed by dual color 
experiments. Cells transfected with Alexa647-graft-pDMAEMA/RhGr-ONs complexes 
(Figure 10) showed that the polymer is unable to enter the nucleus (as expected for a polymer 
of very large molecular weight), whereas part of the oligonucleotides accumulated in the 
nucleus, proving they have been able to dissociate from their carrier in the cytoplasm. 
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Figure 10. Transmission image (gray), merged with both red and green CLSM images of A549 cells 
transfected with RhGr-PO-ONs complexed with Alexa647-graft-pDMAEMA. A circle is drawn 
around the nuclei with green fluorescence, indicating nuclear accumulation of the RhGr-ONs. A scale 
bar is indicated in µm. 
 
Complexation of ONs with pEG-pEI did not result in a significant staining of the 
cytoplasm or nuclei of the A549 cells. Consequently, the absence of the antisense effect, as 
observed in the ICAM-1 assay, could be explained by a low cellular uptake or by the 
dissociation of the complex in the culture medium. 
 -30-
CHAPTER 2 
4. Summary and conclusion 
In this study we showed that free PO-ONs and PS-ONs failed to decrease the ICAM-1 
protein level. Using CLSM and flow cytometric measurements we showed that this is due to 
the inability of naked ONs to diffuse passively through the cellular membrane, as they are 
large, negatively charged hydrophilic molecules.  
 
Although flow cytometric and CLSM experiments clearly showed cellular uptake for 
PS-ONs and PO-ONs complexed with Lipofectin, Lipofectin/PO-ONs did not show a 
decrease in the ICAM-1 protein level while Lipofectin/PS-ONs showed a biological effect 
(Figure 3). We therefore suggested that the absence of antisense activity of Lipofectin/PO-
ONs complexes is not attributed to an inefficient entrance of the complexes in the cells but 
rather to enzymatic degradation of the PO-ONs. Due to the backbone modification, PS-ONs 
are more stable in cells than PO-ONs [26], which may explain why they showed biological 
activity. 
 
Contrary to Lipofectin, graft-pDMAEMA efficiently increased the antisense activity of 
both types of ONs (Figure 4). Noticeably, graft-pDMAEMA/PS-ONs showed a very efficient 
inhibition of the ICAM-1 expression. As expected, flow cytometric and (dual color) CLSM 
experiments showed indeed cellular uptake and intracellular dissociation of both graft-
pDMAEMA/PS-ONs and graft-pDMAEMA/PO-ONs complexes. 
 
The gel electrophoresis competition experiments showed that graft-pDMAEMA forms 
more stable complexes with PS-ONs than with PO-ONs. However, as the graft-
pDMAEMA/PS-ONs complexes were more biologically active than the graft-
pDMAEMA/PO-ONs, it would be wrong to conclude from the gel electrophoresis 
experiments that the graft-pDMAEMA/PS-ONs complexes are too stable to dissociate 
intracellularly. Although in literature results from non-cellular experiments like gel 
electrophoresis are often used to predict the intracellular dissociation behavior of DNA 
complexes, our results clearly show that measuring the dissociation behavior of DNA-
complexes intracellularly is highly recommended. 
 
Although flow cytometry and CLSM are useful to understand the cellular uptake and 
intracellular localization of ONs, our experiments show that the outcome of CLSM and flow 
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cytometry measurements cannot explain why PO-ONs are active when complexed to graft-
pDMAEMA while they are unactive when complexed to Lipofectin. Similarly, one cannot 
explain from CLSM and flow cytometry why PS-ONs complexed to graft-pDMAEMA better 
decrease the ICAM-1 protein expression than PO-ONs complexed to graft-pDMAEMA. As 
PO-ONs become susceptible to degradation by cytoplasmic DNase as soon as they are 
released from their carrier, one could argue that a better understanding of the time and 
(intracellular) place at which dissociation of the complexes occurs is crucial to explain these 
observations. 
 
Compared with the spatial analysis of the DNA and the carrier (as in dual color 
microscopy), the temporal analysis of the movement of the DNA and the carrier could be 
more robust to conclude whether the fluorescently labeled species are interacting. While dual 
color microscopy answers the question “are the DNA and the carrier located together”, dual 
color FFS may answer the question whether they really move together. Because FFS can be 
applied on a cellular scale, we were interested to explore whether it will also allow studying 
the dissociation of carrier/ONs complexes intracellularly. Therefore, in Chapter 3 the 
complexation behavior between oligonucleotides and the cationic polymer poly-L-Lysine will 
first be studied in buffer by both single and dual color FFS.  
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Chapter 3 
 
   
 
Dual Color FFS to study the complexation 
between poly-L-Lysine and oligonucleotides 
 
Parts of this chapter have been published in Macromolecules 35: 8152-8160 (2002). 
 
1. Introduction 
Currently, the stability of DNA complexes is usually assessed using polyanion-
disruption assays [1;2]. Katayose and Kataoka have studied the dissociation of poly(ethylene 
glycol)-poly-L-Lysine/DNA complexes through the addition of poly(L-aspartic acid) [3]. 
However, to obtain real breakthroughs in the design and the understanding of the dissociation 
of DNA complexes in cells, there is an urgent need for advanced physicochemical methods, 
which allow characterizing this critical step in cells. Fluorescence fluctuation spectroscopy 
(FFS), which can be applied on a cellular scale [4], shows potential for that purpose. FFS 
monitors the fluorescence fluctuations caused by the diffusion of fluorescent molecules 
through the excitation volume of a microscope. From the fluctuation profile (Figure 1A) an 
autocorrelation curve can be derived (Figure 1B) which allows calculating the diffusion 
coefficient of the fluorescent molecules. Expecting that the diffusion of the DNA will change 
upon release from its cationic carrier, one could extract information on the association and 
dissociation of interpolyelectrolyte complexes based upon their diffusion coefficient. With 
this idea in mind, our group has recently introduced single color FFS in studying interactions 
between fluorescently labeled DNA and (non-labeled) cationic polymers like poly(2-
dimethylamino)ethyl methacrylate (pDMAEMA), poly(ethylenimine) (pEI), poly(ethylene 
glycol)-poly(ethylenimine) (pEG-pEI) and diaminobutane-dendrimer-(NH2)64 (DAB64) [5-
7]. We have shown, however, that autocorrelation analysis of the fluorescence fluctuation 
profiles of DNA/cationic polymer complexes is not feasible due to the presence of ‘highly 
intense fluorescence peaks’ in the fluctuation profile (Figure 1C). The highly intense 
fluorescence peaks are explained by the migration through the excitation volume of 
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‘multimolecular’ DNA/cationic polymer complexes, which are highly fluorescent as they 
carry a large number of fluorescently labeled ONs. We have concluded in this work that, in 
contrast to autocorrelation analysis, analyzing the fluorescence fluctuations by a method that 
distinguishes between species based upon their difference in fluorescence may allow the 
detection of associated and dissociated DNA.  
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Figure 1. Fluorescence intensity profile (A) and corresponding autocorrelation function (B) of a 
solution of free fluorescent molecules, together with the fluorescence intensity profile of a mixture of 
free fluorescent molecules and bright complexes (C). 
 
However, as mentioned in Chapter 1, the highly intense fluorescence peaks also do not 
allow to apply PCH analysis on the fluorescence fluctuations of DNA complexes mainly due 
to the ‘heterogenity’ of the highly intense fluorescence peaks appearing in the fluorescence 
fluctuation profiles [6]. In conclusion, searching for the presence or absence of highly intense 
fluorescence peaks in the fluorescence fluctuation profiles seems to be the only way of 
analysis one can use to know whether oligonucleotides are complexed to or dissociated from 
their carriers.  
In the more complex cellular environment, highly intense fluorescence peaks may also 
be due to aggregation of free ONs with cellular components, which would be misinterpreted 
as being original ONs-complexes. Therefore, the fluorescent labeling of both the carrier and 
the ONs should improve the signal specificity. In dual color FFS, both interacting components 
are labeled with spectrally different fluorophores (e.g. red and green) and their emission light 
is detected separately by two detectors monitoring the same focal volume. When dissociated, 
the components are only detected in one detector, as they carry a red or a green fluorophore. 
However, when associated, the complex is detected in both detectors simultaneously as it 
bears both red and green fluorophores.  
This chapter aims to evaluate (1) whether the complexation between cationic polymers 
and ONs can be investigated by dual color FFS, (2) whether the results revealed by dual color 
FFS are consistent with the results obtained from single color FFS. As a model, the in vitro 
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complexation between a 20-mer ON and the polycation poly-L-Lysine, which is intensively 
investigated as a pharmaceutical carrier for ONs [8], is considered. 
 
 
2. Materials and methods 
 
2.1. Oligonucleotides 
The 20-mer phosphodiester ONs (5’-CCC-CCA-CCA-CTT-CCC-CTC-TC-3’) (molar 
mass 5830 g/mol) and labeled analogues (using respectively rhodamine green and Cy5 as 
fluorescent marker) were synthesized by Eurogentec (Seraing, Belgium). The fluorescent 
labeling occurred at the 5’ end of the ONs; each oligonucleotide contained one label (RhGr or 
Cy5). The concentration of the ONs stock solutions (in Tris-buffer at pH 8) was determined 
by absorption measurements at 260 nm (1 OD260 = 33 µg ONs/mL). The contribution to the 
absorption at 260 nm by the label was taken into account in the determination of the 
concentration of the labeled ONs. The ONs stock solutions were further diluted with Hepes 
buffer (20 mM Hepes at pH 7.4). 
 
2.2. Cationic polymers 
Poly-L-Lysine was purchased from Sigma (St. Louis, USA). The molar mass, as 
determined from viscosimetric measurements, equaled 30 300 g/mol and was provided by the 
supplier. pLL stock solutions were prepared in Hepes buffer. 
To prepare rhodamine green poly-L-Lysine (RhGr-pLL), rhodamine green X-
succinimidyl ester (RhGr-SE) was purchased from Molecular Probes (Eugene, OR). Poly-L-
Lysine was dissolved in “labeling buffer” (0.1 M NaHCO3 at pH 8.8) at 1 mg/mL. To 1 mL of 
this pLL solution, 50 µL of DMSO containing 0.13 mg RhGr-SE was added drop by drop. 
After incubation for 1 hour in the dark at ambient temperature, RhGr-pLL was purified on a 
G25-Sephadex column (10 x 100 mm), which was previously equilibrated with Hepes buffer. 
The fractions containing fluorescent pLL were collected. Finding the amine concentration 
using the method of Snyder and Sobocinski [9] and measurement of the absorbance of the 
label allowed the determination of the average number of labels attached to the pLL. It could 
be calculated that, on the average, the pLL chains bore one RhGr-label. 
Cy5-poly-L-Lysine (Cy5-pLL) was prepared adding 1 ml of pLL solution (1mg/mL in 
0.1 M NaHCO3 at pH 9.3) to a vial of FluoroLinkTMCy5 monofunctional dye (Amersham 
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Pharmacia, Piscataway, NJ). After incubation for 1 hour in the dark at ambient temperature, 
Cy5-pLL was purified as described above. The degree of labeling was determined to be, on 
the average, one Cy5-label per pLL strand. 
Dextran sulfate (DS) was purchased from Sigma (St Louis, USA). The molar mass and 
sulfur content, provided by the supplier, equalled respectively 500 kDa and 2.3 sulfate groups 
per glucosyl residue. Stock solutions were prepared in Hepes buffer. 
 
2.3. Preparation of polyplexes 
The pLL/ONs complexes (varying in +/- charge ratio, see below) were prepared by 
adding (in one step) different volumes of the pLL stock solution to a fixed volume of the ONs 
stock solution. After addition of the polymer solution, the sample was vortexed for 10 
seconds. To obtain the final ONs concentration of 10 µg/mL (1.7µM), the samples were 
further diluted with Hepes buffer. The polyplexes were allowed to equilibrate for 30 min at 
room temperature prior to use.  
For FFS measurements on the pLL/ONs complexes, 500 µL of the sample was 
prepared as described above, however, the final ONs concentration equalled 0.2 µg/mL (34 
nM). The +/- charge ratio of the pLL/ONs complexes investigated by FFS equalled 20. After 
preparation, 200 µL of the sample was immediately transferred into the Nunc cuvettes (see 
below) to begin the FFS measurement.  
The +/- charge ratio, i.e. the ratio of the number of positive charges on the pLL chains 
to the number of negative charges on the ONs, was calculated assuming that 1 µg of 20-mer 
ONs contained 3.43 nmol negative charges and that 1 µg of pLL contained 7.81 nmol positive 
charges, as calculated from the molecular weight of Lysine monomer, the pKa of Lysine and 
the pH of the solutions. 
 
2.4. Particle size measurements 
Dynamic light scattering measurements (DLS) on the pLL/ONs polyplexes were 
carried out on a Malvern 4700 instrument (Malvern, Worcestershire, UK) at 25 °C and at an 
angle of 90 degrees. The incident beam was a HeNe laser beam (633 nm). The polyplexes 
were prepared as described above. To avoid dust particles, the polymer solutions were filtered 
before being added to the nucleotide solutions. Average pore size of the filter was 0.45 µm 
(Schleicher & Schuell, Dassel, Germany). The particle size was measured 30 min after the 
preparation of the complexes. For calculating the z-average hydrodynamic diameter from the 
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DLS data, the viscosity and refractive index of water at 25 °C (0.89 mPa.s and 1.333, 
respectively) were used. Polystyrene nanospheres (220 ± 6 nm; Duke Scientific Corp, Palo 
Alto, CA) were used to verify the performance of the instrument. The particle size of each 
sample was measured three times.  
 
2.5. Zeta potential measurements 
Zeta potential (ζ) measurements on the pLL/ONs polyplexes were performed at 25 °C 
on a Malvern Zetasizer 2000 (Malvern, Worcestershire, UK), which is based on 
electrophoretic light scattering. ζ was measured within 1 hour after the preparation of the 
complexes. Polystyrene nanospheres (-50 mV; Duke Scientific Corp, Palo Alto, CA) were 
used to verify the performance of the instrument. ζ of each sample was measured three times. 
 
2.6. Fluorescence fluctuation spectroscopy (FFS) 
As explained in the introduction, FFS basically monitors fluorescence intensity 
fluctuations in the excitation volume of a microscope. In dual color FFS, both interacting 
components are labeled with spectrally different fluorophores (e.g. red and green) and their 
emission light is detected separately by two detectors monitoring the same excitation volume. 
When dissociated, the components are only detected in one detector, as they carry a red or a 
green fluorophore. However, when associated, the complex is detected in both detectors 
simultaneously as it bears both red and green fluorophores. Autocorrelation analysis of the 
fluorescence fluctuations recorded in the green detector describes the diffusion behavior of all 
molecules emitting green light, regardless of whether they are free or associated to red-labeled 
components. On its turn, autocorrelation analysis of the red detector signal describes the 
diffusion of all red-labeled molecules. Cross-correlation analyses on the fluorescence 
fluctuations registered in the red and the green detector provides only information on the 
diffusion behavior of the dual labeled (i.e. interacting) molecules [10;11]. However, when the 
fluorescence quantum yield strongly increases upon binding or when several fluorescent 
labeled molecules associate, the fluorescence emitted by a complex becomes much higher 
than that of the free molecules. Highly intense fluorescence peaks appear in the fluctuation 
profiles (e.g. Figure 1C) and in more extreme cases auto- and cross-correlation analysis are no 
longer feasible. Therefore a statistical approach is considered to analyze the fluorescence 
fluctuation profiles when bursts of high fluorescence intensity occur. Here, a threshold level is 
calculated, above which all fluorescence values are identified as “highly intense fluorescence 
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peaks” [5;12]. In the absence of highly intense fluorescence peaks (i.e., when no threshold 
level could be calculated), the fluorescence fluctuations were analyzed by autocorrelation 
analysis and a diffusion coefficient could be calculated. In dual color FFS, the simultaneous 
appearance of a highly intense fluorescence peak in the red and green detector would indicate 
that a complex bearing both many red as well as many green labels is passing through the 
excitation volume. If the size of the migrating particle exceeds the dimensions of the detection 
volume, a peak of high fluorescence intensity is still observed on condition that the 
fluorescent dye is distributed throughout the particle (which is the case for homogeneously 
colored polystyrene beads and fluorescent-labeled carrier/ONs-complexes). 
In this study, dual color FFS experiments were performed on a dual color FFS setup 
installed on a MRC1024 Bio-Rad confocal laser-scanning microscope [13]. An inverted 
microscope (Eclipse TE300D, Nikon, Japan) was used, which was equipped with a water 
immersion objective lens (Plan Apo 60X, NA 1.2, collar rim correction, Nikon, Japan). The 
488 nm and 647 nm lines of the same krypton-argon laser (Biorad, Cheshire, UK) were used. 
The intensities of both excitation wavelengths were controlled independently from each other, 
using an acousto optic tunable filter. (Opto-Electronique, St. Rémy Les Chevreuse, France). 
To check whether the detectors adequately detected the fluorescence fluctuations in the 
excitation volumes (i.e. to verify whether the excitation volumes and the detection volumes 
optimally overlapped), the system was optimized as described by Schwille et al. [11]. The 
fluorescence fluctuations were processed by a hardware correlator and (if possible) the 
resulting autocorrelation curve was analyzed with specific software, yielding information on 
the concentration of the fluorescent molecules in the detection volume and the average 
diffusion time (τd) of the fluorescent molecules through the detection volume. The 
translational diffusion coefficient (D) is calculated using the measured diffusion time of a 
sample of free rhodamine dye with known diffusion coefficient (2.8 x 10-6 cm2/s) as internal 
standard. To perform the FFS measurements, the laser beam was focused at about 100 µm 
above the bottom of the glass-bottomed cuvettes (Nalge Nunc International, Naperville, IL), 
which contained the samples. Prior to use, the thickness of the bottom of the cuvette was 
measured using a micrometer and the collar rim correction was adjusted for 150 µm. 
Diffusion coefficients were calculated using the average diffusion time of at least 20 
measurements. Each pLL/ONs sample (both the single and the dual labeled) was 
independently prepared three times and each preparation was measured at least 10 times. The 
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fluorescence fluctuation profiles shown in Figure 3, Figure 4 and Figure 5 were representative 
for the measurements done on the respective pLL/ONs samples. 
The measurements on the homemade FFS apparatus were confirmed by conducting 
the same experiments on a commercial instrument (Confocor II, Zeiss-Evotec, Jena, 
Germany). 
 
 
3. Results & Discussion 
 
Figure 2 shows the average size and ζ of the pLL/ONs complexes. The dependence of 
the size and surface properties of the pLL/ONs complexes on the +/- charge ratio shows a 
typical profile as often observed for complexes formed between oppositely charged polyions 
[14]. At +/- charge ratio values between 1 and 3, large aggregates are formed. In this region, ζ 
equals approximately zero. Consequently, almost no electric repulsion occurs between the 
particles, which leads to a clustering of individual polyplexes. Upon further increasing the 
concentration of pLL, ζ reaches a plateau. The excess of cations in the complexes may explain 
the positive net charge of the polyplexes. This results in electric repulsion between the 
polyplexes, which prevents them from aggregating, and which explains the smaller size of the 
polyplexes at higher +/- charge ratio values in Figure 2. 
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Figure 2. The z-average hydrodynamic diameter (z) and zeta potential (▲) of pLL/ONs complexes, 
as a function of the charge ratio. Each sample was measured three times. 
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Figure 3 (A-data) shows the fluorescence fluctuation profile of free (i.e. non 
complexed) RhGr-ONs in buffer. These data result in an autocorrelation function from which 
a diffusion coefficient of 0.76 ± 0.07 • 10-6 cm²/s is calculated. This diffusion coefficient 
agrees with values reported in literature [5;15]. 
The B-data in Figure 3 show that the association of RhGr-ONs to pLL clearly 
influences the fluorescence fluctuation profile. Generally, the fluorescence intensity 
decreases. Moreover, highly intense fluorescence peaks also appear. The fluorescence 
intensity of the “baseline”, originating from the presence of free RhGr-ONs in the excitation 
volume, decreases as most of the RhGr-ONs become associated to the pLL. This lowers the 
average number of free RhGr-ONs in the excitation volume. It is assumed that the highly 
intense fluorescence peaks originate from the presence of pLL chains that bear a large number 
of RhGr-ONs. The distribution of the height of the peaks may be related to the polydispersity 
of the polyplexes with regard to the number of RhGr-ONs per polyplex. However, as the 
excitation profile in the confocal volume is not homogeneous and as single complexes do not 
necessarily always pass through the centre of the focus, the fluorescence of a complex partly 
depends on the place where it moves through the excitation volume. Also, differences in the 
degree of mutual quenching of the fluorophores depending on their spatial proximity may 
influence the height of the highly intense fluorescence peaks. The highly intense fluorescence 
peak-values disturb the calculation of an autocorrelation function from the fluorescence 
fluctuation profile.  
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Figure 3. Fluorescence fluctuation profile, as measured by single color FFS, of respectively a RhGr-
ONs solution (A), a pLL/RhGr-ONs sample (B, +/- = 20) and the same sample after addition of 
dextran sulfate (C, final concentration of dextran sulfate equaled 12 µg/mL). 
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Upon addition of dextran sulfate to the complexes (C-data in Figure 3), the 
fluorescence intensity of the “baseline” is almost completely restored, while the highly intense 
fluorescence peaks disappear. Dextran sulfate is an anionic polymer, which competes with the 
RhGr-ONs for binding to the pLL chains. From the fluorescence fluctuations obtained after 
adding dextran sulfate, an autocorrelation curve can be derived, which yields a diffusion 
coefficient of 0.77 ± 0.06 • 10-6 cm2/s. This value corresponds to the diffusion coefficient as 
measured for free RhGr-ONs. The incomplete recovery of the fluorescence intensity of the 
baseline may be attributed to the adsorption of pLL/RhGr-ONs complexes to the Eppendorf 
tubes. Especially since we have observed that the longer the incubation time of the polyplexes 
prior to addition of dextran sulfate, the lower the degree of recovery of the fluorescence 
intensity of the baseline after adding dextran sulfate (data not shown). 
 
In a second series of experiments, the fluorescence fluctuation profiles of RhGr-
pLL/ONs complexes have been measured (Figure 4). Contrary to the measurements in Figure 
3, the polymer chains, instead of the ONs, are fluorescently labeled with RhGr. The diffusion 
coefficient of RhGr-pLL, as calculated from the autocorrelation analysis of the A-data in 
Figure 4, equals 1.5 ± 0.2 • 10-6 cm2/s. The B-data in Figure 4 show that upon complexation of 
RhGr-pLL to ONs, highly intense fluorescence peaks appear and that the fluorescence 
intensity of the baseline significantly decreases, similar to the results in Figure 3. The highly 
intense fluorescence peaks in the B-data of Figure 4 clearly show that a RhGr-pLL/ONs 
complex consists of a number of RhGr-pLL chains. Combining the results of Figure 3 and 
Figure 4 suggests that the pLL/ONs complexes are “multimolecular” i.e. they consist of a 
number of ONs associated to a number of pLL-strands. However, these data cannot prove that 
all pLL/ONs complexes are multimolecular. 
Upon addition of dextran sulfate (C-data in Figure 4), the fluorescence intensity of the 
baseline is only slightly restored. Also, the highly intense fluorescence peaks do not always 
disappear, indicating that structures carrying many RhGr-pLL chains continue to exist. 
Autocorrelation analysis of the fluctuations of the baseline between highly intense 
fluorescence peaks yields a diffusion coefficient that is one order of magnitude lower than the 
value obtained for the free RhGr-pLL solution. However, a reproducible diffusion coefficient 
has not been obtained. These phenomena are probably attributed to the binding of the dextran 
sulfate polyanion to positively charged RhGr-pLL chains, resulting in complexes that are 
heterogeneous in size. We therefore suggest that the highly intense fluorescence peaks that 
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remain after adding dextran sulfate (C-data in Figure 4) are RhGr-pLL/dextran sulfate 
complexes. Adding dextran sulfate to a sample of free RhGr-pLL indeed has supported this 
hypothesis, as a diffusion coefficient of 0.10 ± 0.01 • 10-6 cm2/s, significantly lower than the 
diffusion coefficient of free RhGr-pLL (i.e. 1.5 ± 0.2 • 10-6 cm2/s), has been obtained. 
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Figure 4. Fluorescence fluctuation profile, as measured by single color FFS, of respectively a RhGr-
pLL solution (A), a RhGr-pLL/ONs sample (B, +/- = 20) and the same RhGr-pLL/ONs sample after 
addition of dextran sulfate (C, final concentration of dextran sulfate equaled 12 µg/mL). 
 
Figure 4 shows that due to the association of the pLL to the dextran sulfate, highly 
intense fluorescence peaks remain in the fluorescence fluctuation profiles, although Figure 3 
shows that the ONs are released from their cationic carrier. Similarly, upon dissociation of the 
polyplexes in the cell, the polymer and/or the ONs may unspecifically interact with different 
species which may result in highly intense fluorescence peaks when studied by single color 
FFS. Therefore, the fluorescent labeling of both the carrier and the ONs should improve the 
signal specificity. In this study we have evaluated whether dual color FFS allows studying the 
complexation between ONs and pLL. To minimize the detection of emission light from the 
green dye (i.e. RhGr) by the red detector, we have made use of RhGr and Cy5. It has been 
shown previously that the “cross-talk” between these fluorophores is limited, which makes 
them suitable for dual color FFS. In the dual color FFS experiments we have studied both 
RhGr-pLL/Cy5-ONs complexes (data not shown) as well as Cy5-pLL/RhGr-ONs complexes, 
which are discussed below.  
Figure 5 shows the fluorescence fluctuations measured at the same time by the red 
(upper panel) and green (lower panel) detector. The A-data (upper panel) represent the 
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fluorescence fluctuation profile of free Cy5-pLL, whereas the A’-data (lower panel) are the 
fluorescence fluctuations of free RhGr-ONs. 
As the B-data in Figure 5 show, the complexation of RhGr-ONs to Cy5-pLL decreases 
the fluorescence intensity of the baseline in both detectors. Moreover, highly intense 
fluorescence peaks also appear in both channels. It is especially clear that highly intense 
fluorescence peaks are registered by the two detectors at the same time. This means that at 
certain times a number of RhGr-ONs and a number of Cy5-pLL-strands simultaneously move 
through the excitation volume. This proves that the pLL/ONs complexes are indeed 
multimolecular as already suggested from the single color FFS results in Figure 3 and Figure 
4.  
Upon addition of dextran sulfate, highly intense fluorescence peaks are no longer 
detected by the green detector (C data in the lower panel of Figure 5). Also, the fluorescence 
intensity of the baseline almost completely returns to the value observed for free RhGr-ONs. 
The diffusion coefficient, as calculated from the autocorrelation function, equals the one 
obtained for free RhGr-ONs, proving that RhGr-ONs are released from the polyplexes upon 
addition of dextran sulfate. All these observations completely agree with the results from the 
single color FFS measurements on pLL/RhGr-ONs complexes (Figure 3). Moreover, upon 
addition of dextran sulfate, the fluorescence intensity of the baseline as registered by the red 
detector is only partly restored, and highly intense fluorescence peaks remain present (C data 
in the upper panel of Figure 5). This again agrees with the single color FFS observations on 
RhGr-pLL/ONs complexes in Figure 4. Also, the diffusion coefficient calculated by 
autocorrelating the baseline fluorescence fluctuations in between highly intense fluorescence 
peaks significantly differs from the diffusion coefficient of free Cy5-pLL. As suggested 
above, these phenomena are attributed to the binding of Cy5-pLL to dextran sulfate.  
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Figure 5. Fluorescence fluctuation profiles as simultaneously registered by the 'red detector' (upper 
panel) and 'green detector' (lower panel) of a Cy5-pLL/RhGr-ONs sample (+/- = 20) before (B) and 
after (C) addition of dextran sulfate. (A) and (A’) are the fluorescence fluctuations of respectively a 
2.0 µg/mL (free) Cy5-pLL and a 0.2 µg/mL (free) RhGr-ONs solution. 
 
The fluorescence intensity profiles from Figure 5 are further analyzed in a two-
dimensional scatter plot (Figure 6). Each data point in Figure 6 represents the green 
fluorescence (indicated by the x-value) and red fluorescence (indicated by the y-value) 
measured at a certain time in the excitation volume. First, the scatter plot shows the data 
obtained from the fluorescence fluctuation profiles measured in the red and green detector on 
free RhGr-ONs (◇) and on free Cy5-pLL () solutions. Second, the z-data are derived from 
the fluorescence fluctuation profiles, as measured by the red and green detector, on Cy5-
pLL/RhGr-ONs sample. Clearly, the z-data at high x- and y-values originate from the highly 
intense fluorescence peaks in the B-data of Figure 5 and correspond to the multimolecular 
Cy5-pLL/RhGr-ONs complexes. The z-data at lower x- and y-values originate from the 
baseline in Figure 5 (B-data) and correspond to structures bearing only one or a few Cy5-pLL 
strands and/or RhGr-ONs. To separate the multimolecular Cy5-pLL/RhGr-ONs complexes 
efficiently in the z-data, we propose calculating a “threshold value”. This threshold value, 
being the fluorescence intensity above which a fluorescence value is identified as a highly 
intense fluorescence peak, is determined for the fluorescence intensity profiles, registered by 
the green and red detector respectively, of the Cy5-pLL/RhGr-ONs sample (B-data in Figure 
5). The horizontal dotted line in Figure 6 shows the threshold value of the fluorescence 
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fluctuations measurement by the red detector; the vertical dotted line shows the one for the 
fluorescence fluctuations measured by the green detector. These lines divide the two-
dimensional scatter plot in four quadrants and allow a more detailed evaluation of the 
distribution of the z-data. The z-data in quadrant A originate from complexes that 
simultaneously show a high fluorescent signal both in the red and green detector; these data 
are attributed to complexes that consist of many Cy5-pLL and many RhGr-ONs molecules. 
The z-data in quadrant B are Cy5-pLL/RhGr-ONs complexes that contain numerous RhGr-
ONs but only one or a few Cy5-pLL molecules. The z-data in quadrant D are Cy5-
pLL/RhGr-ONs complexes that contain numerous Cy5-pLL chains but only one or a few 
RhGr-ONs. The z-data in quadrant C do not originate at all from multimolecular complexes. 
They probably originate from structures carrying too little Cy5-pLL and RhGr-ONs molecules 
to be identified as a peak of high fluorescence intensity. 
After adding dextran sulfate, the data points of the Cy5-pLL/RhGr-ONs sample (▲) 
approach the x-position of the data points of the original RhGr-ONs sample (♦) and only 
slight variations around the average x value of 530 kHz are observed. However, some of these 
data points have y values that differ significantly from the average y value around 70 kHz. 
This average y value of 70 kHz still is much lower than the 260 kHz of the original Cy5-pLL 
sample (). As only slight variations around the average x value are observed, the statistical 
algorithm is not able to identify any outliers in the set data points; hence, no threshold value 
can be calculated for the green detector. This means no peaks of high green fluorescence 
intensity are identified. For the red detection channel, a threshold line can be calculated for 
the Cy5-pLL/RhGr-ONs sample after adding dextran sulfate (horizontal dotted line (red) in 
Figure 6). Data points located above this threshold line are identified as peaks of high red 
fluorescence intensity and indicate that complexes bearing many Cy5-pLL strands still exist. 
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Figure 6. Scatter plot of the fluorescence fluctuations data, measured by dual color FFS as represented 
in Figure 5, of free RhGr-ONs (0.2 µg/mL, ♦), free Cy5-pLL (2.0 µg/mL, ) and Cy5-pLL/RhGr-
ONs polyplexes before (z) and after (▲) adding dextran sulfate. 
 
 
4.  Summary and conclusions 
 
This paper shows that dual color FFS is a straightforward method to detect the 
association and dissociation of pLL/ONs complexes. The FFS results on the dual labeled 
polymer/oligonucleotide complexes match the observations seen in the single color FFS 
measurements. Although we have not observed controversies between the single color and 
dual color FFS results on pLL/ONs complexes, a clear disadvantage of dual color FFS is that 
both interacting species have to be labeled, which enhances the risk of fluorophore induced 
artefacts. However, the very sensitive detectors used in FFS permit attaching only one 
fluorescent marker per polymer chain, which may not substantially modify the properties of 
the macromolecules. As explained above, a major advantage of dual color FFS over single 
color FFS in studying the complexation behavior of DNA complexes in cells is that it might 
yield a considerable improvement in signal specificity. In heterogeneous media like cells the 
DNA and the cationic polymers may interact not only with each other but also with many 
other different species. Furthermore, by two-dimensional scatter plot analysis of the dual color 
FFS data, we have obtained a more detailed view on the composition of the pLL/ONs 
complexes in the sample. Especially, dual color FFS proves that a substantial number of 
pLL/ONs complexes consist of numerous ONs bound to numerous pLL strands.  
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Chapter 4 
 
   
 
On the cellular dissociation of  
polymer-oligonucleotide complexes as studied 
by dual color FFS 
 
Parts of this chapter are submitted to Biochemistry. 
 
1. Introduction 
Although it is out of the scope of this chapter to review the results obtained in studies 
on the biophysical behavior of polymer/ONs complexes in cells, a brief glance through the 
literature reveals examples of polyplexes that dissociate in the cytoplasm [1-3], whereas 
others are believed to enter the nucleus prior to dissociation [4].  
Dual color microscopy has been used frequently to study the intracellular behavior of 
oligonucleotide/cationic carrier complexes, since it allows the simultaneous observation of the 
DNA and the cationic carrier in the cell. A lack of colocalization proves that the DNA is 
released from its carrier. Colocalization of the fluorescent markers may indicate that the DNA 
and its carrier are associated. In the latter case, however, it remains possible that the 
fluorescent labeled molecules are colocalized without being associated. Compared with the 
spatial analysis of fluorescent labeled molecules, the temporal analysis of the movement of 
these molecules could be more robust to conclude whether the fluorescent labeled species are 
migrating together, i.e. are still associated. Fluorescence fluctuation spectroscopy (FFS), 
which can be applied on a cellular scale [5], shows potential for that purpose. While dual 
color microscopy answers the question “are the carrier and the oligonucleotide located 
together”, dual color FFS may answer the question whether they really move together.  
In Chapter 3, we have proved that in buffer the association and dissociation of 
oligonucleotides to/from cationic polymers can be monitored by dual color FFS. When 
associating, the amount of detected free ONs decreases and highly fluorescent 
“multimolecular” polymer/ONs complexes appear (existing out of many ONs bound to many 
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polymer strands) which are clearly detected by FFS. When dissociating, the amount of free 
ONs increases and the multimolecular complexes disappear. Up to our knowledge, no reports 
in literature deal with FFS on polymer/ONs complexes in cells. In this study, we wish to 
explore (1) if dual color FFS is able to detect intact and dissociated polymer/ONs complexes 
in the cytoplasm and in the nucleus of living cells and (2) to what extent dual color FFS 
provides new information on the intracellular behavior of polymer/ONs complexes. 
 
 
2. Materials and methods 
 
2.1. Oligonucleotides  
RhGr-labeled 20-mer phosphodiester ONs as described in Chapter 3 were used. 
2.2. Polymers and polystyrene nanoparticles 
Cy5-labeled poly-L-Lysine (Cy5-pLL) as described in Chapter 3 was used. 
Cy5-labeled pegylated poly (2-dimethylamino) ethyl methacrylate – co – amino ethyl 
methacrylate (abbreviated as Cy5-graft-pDMAEMA) as described in Chapter 2 was used. 
Dextran sulfate (DS) as described in Chapter 3 was used. 
TetraspeckTM nanobeads (Molecular Probes, Eugene, OR) of 90 nm diameter and 500 nm 
diameter were used. TetraspeckTM nanobeads contain four different kinds of fluorophores with 
excitation/emission maxima of 365/430, 505/515, 560/580 and 660/680 nm respectively. Prior 
to use, the bead dispersions were sonified for 10 minutes. 
2.3. Preparation of polymer/ONs complexes 
The polymer/ON complexes were prepared by adding (in one step) equal volumes of 
the cationic polymer solution and the ONs solution, followed by vortexing during 10 seconds. 
To obtain the final ONs concentration of 10 µg/mL (1.7µM), the samples were further diluted 
with Hepes buffer. The polyplexes were allowed to equilibrate for 30 minutes at room 
temperature prior to use.  
The +/- charge ratio, i.e. the ratio of the number of positive charges on the polymer 
chains to the number of negative charges on the ONs, was calculated assuming that 1 µg of 
20-mer ONs contained 3.43 nmol negative charges, that 1 µg of pLL contained 7.81 nmol 
positive charges, as calculated from the molar mass of Lysine monomer, the pKa of Lysine 
and the pH of the solutions, and that 1 µg of graft-pDMAEMA contains 1.99 nmol positive 
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charges as calculated from the pH of the solution, the molecular weight and the pKa of the 
DMAEMA monomer and the degree of substitution.  
2.4. Cell culture  
Because of their clear morphology, Vero cells (ATCC nr.: CCL-81) were used for 
microinjection experiments. Vero cells  were cultured in Dulbecco’s modified Eagle’s 
medium (DMEM) without phenol red (Gibco, Merelbeke, Belgium) containing 2 mM 
glutamine, 10% heat deactivated fetal bovine serum (FBS) and 1% penicillin-streptomycin. 
Cells were grown to 70% confluency on glass-bottomed cover slips (Part No. PG-1.5-14-F, 
Glass bottom No. 1.5, MatTek Corporation) at 37 °C in a humidified atmosphere containing 
5% CO2. 
2.5. Fluorescence Fluctuation Spectroscopy 
In this study, FFS experiments were performed on a home made (dual color) FFS 
setup as described in Chapter 3. The measurements on the homemade FFS apparatus were 
confirmed by conducting the same experiments on a commercial instrument (Confocor II, 
Zeiss-Evotec, Jena, Germany). 
FFS measurements in buffer: 
Cy5-pLL/RhGr-ONs samples (prepared as described above) were further diluted with 
Hepes buffer until a final ONs concentration of 0.2 µg/mL (34 nM). After dilution, 50 µL of 
the sample was immediately transferred into a 96-well plate (Grainer Bio-one, Frickenhausen, 
Germany) to begin the FFS measurements. Diffusion coefficients were calculated using the 
average diffusion time of at least 20 measurements. Each Cy5-pLL/RhGr-ONs sample was 
independently prepared three times and each preparation was measured at least 10 times. The 
fluorescence fluctuation profiles shown in the figures were representative for the 
measurements done on the respective Cy5-pLL/RhGr-ONs samples. 
FFS measurements in cells: 
FFS measurements were done on Vero cells grown to 70% confluency on glass-
bottomed cover slips (Part No. PG-1.5-14-F, Glass bottom No. 1.5, MatTek Corporation).  
Microinjection experiments were performed on Vero cells in imaging medium (serum 
containing DMEM and 10 mM Hepes). A Femtojet® microinjector and an Injectman® NI 2 
micromanipulator (Eppendorf) were used. Injections were performed in the cytoplasm or the 
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nucleus of the cells. The Vero cells were injected with respectively free RhGr-ONs (10µM) or 
Cy5-pLL/RhGr-ONs (10µM RhGr-ONs, +/- charge ratio of 20) prepared in Hepes buffer. 
FFS measurements were done at randomly selected places in cytoplasm or nucleus. To 
ensure measurements in viable cells, only non-rounded cells without the appearance of 
cytoplasmic blebs were selected. Confocal sections in z-direction were taken every 0.5 µm to 
position the excitation volume in the cell. After the CLSM/FFS measurements, cell viability 
was evaluated using propidium iodide.  
 
 
3. Results & Discussion 
 
3.1. FFS on dual color labeled nanobeads in buffer and in cells 
As control experiment, dual color FFS measurements were first performed in the 
cytoplasm and nucleus of ‘blanc’ cells (i.e. cells which were not loaded with fluorescent 
molecules or fluorescent nanobeads). Generally, the fluorescence registered by the two 
detectors was very low while from time to time (very) small peaks appeared (the intensity of 
these peaks being maximally 3 kHz above the background noise).  
To validate the applicability of FFS for studying the association state of complicated 
nanosized polymer/ONs-complexes in complex media like the cytoplasm or nucleus of cells, 
we performed first FFS measurements on dual color nanobeads (respectively 90 nm and 500 
nm in diameter) injected in living cells. FFS measurements on a dispersion of these nanobeads 
in buffer revealed simultaneously occurring high fluorescence peaks of green and red 
fluorescence (Figure 1A). This clearly proves that the red and green detector are indeed able 
to simultaneously detect a highly fluorescent, dual color labeled particle that migrates through 
the excitation volume. 
We further performed FFS measurements on the nanobeads microinjected in Vero-
cells. Microinjecting 90 nm nanobeads in the nucleus (Figure 1B) or in the cytoplasm (Figure 
1C) resulted in the simultaneous appearance of Cy5- and RhGr-peaks in the detection volume 
(positioned at a different location than the site of injection). This proves that at least part of 
these beads is mobile in both cytoplasm and nucleus. Microinjected 500 nm nanobeads 
seemed quasi immobile in the cytoplasm as CLSM time-series experiments for 30 minutes did 
not reveal any diffusion of the beads (data not shown). Also, in FFS measurements, the 
microinjected 500 nm beads did not result into simultaneous RhGr-peaks and Cy5-peaks, 
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which we did see for these nanobeads in buffer (data not shown), confirming that they were 
physically entrapped in the cytoplasm. 
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Figure 1. Fluorescence fluctuation profiles, as simultaneously registered by the 'red’ and 'green’ 
detector, of a dispersion of dual color labeled nanobeads (90 nm) in buffer (A), in the nucleus of a 
Vero-cell after microinjecting the nucleus (B) and in the cytoplasm of a Vero-cell after microinjecting 
the cytoplasm (C). 
 
3.2. FFS on RhGr-ONs in cells 
Microinjection of free RhGr-ONs in the cytoplasm resulted in nuclear accumulation of 
the RhGr-ONs within minutes (CLSM images not shown). This rapid nuclear accumulation of 
ONs has also been reported in literature [6-9]. FFS measurements confirmed these 
observations as the RhGr-baseline fluorescence was significantly higher in the nucleus than in 
the cytoplasm of the same cell: it varied between 60 kHz to 200 kHz in the cytoplasm and 
between 150 kHz and 600 kHz in the nucleus (dependant on the amount of RhGr-ONs 
injected, as according to the manufacturer no reproducible volume can be microinjected). In 
the fluorescence fluctuation profiles as measured in the nucleus, RhGr-peaks were absent 
(Figure 2A upper profile) indicating that intensive clustering of the RhGr-ONs with nuclear 
components (which could result in highly green-fluorescent structures) probably does not 
occur. Autocorrelation analysis of the fluorescence fluctuations revealed a significant slow 
down of the RhGr-ONs (Figure 2B), which is in agreement with the recently demonstrated 
interaction between antisense ONs and their target mRNA in the nucleus [10]. In the 
cytoplasm, however, RhGr-peaks could be observed (Figure 2A lower profile), indicating that 
RhGr-ONs are clustered with cytoplasmatic components. Indeed, we recently observed that 
upon adding diluted cell lysate to labeled ONs, part of the ONs clusters, which is observed as 
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the appearance of high fluorescence peaks in the green fluorescence fluctuation profile (see 
Chapter 6). The latter observation points out the need for a dual color FFS approach to study 
the dissociation of polymer/ONs complexes in cells. Single color labeled aggregates could be 
due to non-dissociated polymer/ONs complexes (with the polymer or the ONs being labeled) 
but they could also be due to dissociated polymer/ONs complexes whereby the polymer or the 
ONs subsequently clusters with cellular components. In opposite, when dual color labeled 
aggregates are observed, they are for sure due to (non-dissociated) polymer/ONs complexes. 
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Figure 2. (A): fluorescence fluctuations in the cytoplasm (lower profile) and in the nucleus (upper 
profile) of a Vero-cell injected in the cytoplasm with RhGr-ONs. (B): autocorrelation curve of RhGr-
ONs in buffer (___) and in the nucleus of a Vero-cell (_x_). 
 
3.3. FFS on Cy5-polymer/RhGr-ONs complexes in cells 
Microinjection of the cationic copolymer Cy5-graft-pDMAEMA in the cytoplasm 
resulted in a homogeneous distribution of the labeled polymer throughout the cytoplasm (data 
not shown). Clearly, the polymer did not reach the nucleus. It is well known that only small 
structures can migrate passively through the nuclear pores [11]. Therefore, it could be well 
expected that Cy5-graft-pDMAEMA of a molar mass of 1700 kDa would not be able to cross 
the nuclear membrane. After transfecting Vero-cells with Cy5-graft-pDMAEMA/RhGr-ONs 
complexes for 3 hours, CLSM revealed that the polymer remained located in the cytoplasm 
whereas part of the oligonucleotides accumulated in the nucleus (and therefore must have 
been released from the polymer, Figure 3). Another part of the oligonucleotides remained 
present in the cytoplasm, predominantly colocalized with the polymer. This proves that Cy5-
graft-pDMAEMA/RhGr-ONs complexes are successfully taken up by the cells, they are 
subsequently released from the endosomes and they dissociate in the cytoplasm. This is in 
agreement with our previous results (in chapter 2) where graft-pDMAEMA proved to be an 
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efficient carrier for antisense ONs as biological activity could be observed when transfecting 
A549-cells with graft-pDMAEMA/ONs complexes [12].  
 
A B C
 
Figure 3.  Transmission image (A) and confocal fluorescence images (B: green; C: red) of a Vero-cell 
transfected for 3 hours with Cy5-graft-pDMAEMA/RhGr-ONs. A circle is drawn around the nucleus. 
 
Thus, in conclusion, CLSM experiments are sufficient to prove for certain that (part 
of) the Cy5-graft-pDMAEMA/RhGr-ONs complexes dissociate in the cytoplasm. When using 
a pharmaceutical carrier of lower molar mass, however, CLSM results may become 
insufficient to detect whether the complexes are associated or dissociated. Indeed, after 
incubating Vero-cells with Cy5-pLL/RhGr-ONs for 3 hours (the molar mass of pLL being 30 
kDa), colocalized green and red spots were present in both the cytoplasm and the nucleus 
(Figure 4). However, this occurrence of colocalized green and red fluorescence in the 
cytoplasm and nuclei does not necessarily imply that all RhGr-ONs are still associated to their 
Cy5-pLL carrier. They may just be localized together without being associated.  
 
A B C
 
Figure 4.  Transmission image (A) and confocal fluorescence images (B: green; C: red) of a Vero-cell 
transfected for 3 hours with Cy5-pLL/RhGr-ONs. An ellipse is drawn around the nucleus.  
 
Via CLSM it is thus not possible to elucidate whether intact complexes were 
transported from the cytoplasm into the nucleus or whether dissociation occurred in the 
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cytoplasm followed by nuclear accumulation of the free polymer and free ONs. Therefore, we 
thought that the temporal analysis of the movement of these molecules via FFS, instead of the 
spatial analysis of the fluorescent labeled molecules via CLSM, could be more robust to 
conclude whether the fluorescent labeled species are associated. Figure 5D shows that FFS is 
able to detect simultaneously occurring RhGr-peaks and Cy5-peaks in the cytoplasm of Vero-
cells already after 30 minutes of incubation of the cells with Cy5-pLL/RhGr-ONs complexes. 
This means that multimolecular Cy5-pLL/RhGr-ONs complexes are able to diffuse through 
the cytoplasm and pass through the excitation volume.  
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Figure 5.  Transmission image (A) and confocal fluorescence images (B: green; C: red) of a Vero-cell 
transfected for 30 minutes with Cy5-pLL/RhGr-ONs. An ellipse is drawn around the nucleus. The 
fluorescence fluctuation profile as registered by the green and red FFS detector when the excitation 
volume is positioned in the cell at location X (D). 
 
Upon longer incubation time, FFS was able to detect both Cy5-pLL and RhGr-ONs in 
the nucleus. However, simultaneously occurring Cy5- and RhGr-peaks were never observed 
in the nucleus (data not shown). This indicates that Cy5-pLL and RhGr-ONs migrate 
independently from each other in the nucleus. On the other hand, it remains possible that 
intact polyplexes were present in the nucleus, but that they were not detected by FFS as they 
did not migrate (or migrate too slowly) through the nuclear matrix and thus did not move 
through the excitation volume. To clear out this hypothesis, we microinjected Cy5-pLL/RhGr-
ONs complexes into the nucleus of Vero-cells. The simultaneous appearance of RhGr-peaks 
and Cy5-peaks in Figure 6A clearly indicates that Cy5-pLL/RhGr-ONs complexes migrate 
through the excitation volume, proving that FFS is able to detect intact Cy5-pLL/RhGr-ONs 
complexes in the nucleus. Therefore, from the absence of simultaneous peaks in the nuclei of 
the Cy5-pLL/RhGr-ONs transfected cells, it can be concluded that intact polyplexes did not 
reach the nucleus. This means that the Cy5-pLL/RhGr-ONs complexes first dissociate in the 
cytoplasm before the RhGr-ONs and the Cy5-pLL strands enter the nucleus. Such conclusion 
can not be made for certain based upon CLSM experiments. 
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Figure 6.  The fluorescence fluctuation profiles as registered by the green and red detector in the 
nucleus of a Vero-cell after microinjecting the nucleus with a Cy5-pLL/RhGr-ONs sample (A) and in 
the cytoplasm of a Vero-cell after microinjecting the cytoplasm with a Cy5-pLL/RhGr-ONs sample 
(B).  
 
Also other pharmaceutical carriers of low molar mass are reported to enter the nucleus 
after transfection [1;13;14]. We also observed in our experiments that microinjection of free 
Cy5-pLL resulted into nuclear accumulation. In a next step, we dissociated Cy5-pLL/RhGr-
ONs complexes with dextran sulfate prior to their microinjection in the cytoplasm of a Vero-
cell. Figure 7 clearly shows that the free RhGr-ONs accumulate in the nucleus, whereas the 
Cy5-pLL, bound to the high molar mass dextran sulfate is now unable to access the nucleus. 
Also, as expected, FFS measurements in the cytoplasm of this cell revealed Cy5-peaks, 
attributed to the Cy5-pLL/dextran-sulfate complexes migrating through the excitation volume 
(data not shown). 
 
A B C
 
Figure 7.  Transmission image (A) and confocal fluorescence images (B: green; C: red) of a Vero-cell 
15 minutes after injecting the cytoplasm with a sample which consists of Cy5-pLL/dextran-sulfate 
complexes and released RhGr-ONs. A circle is drawn around the nucleus. 
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4. Conclusion 
We have shown that cationic polymers of high molar mass, like graft-pDMAEMA of 
1700 kDa used in this study, cannot enter the nucleus upon microinjection in the cytoplasm. 
When such (red-labeled) polymers are used as a carrier for (green-labeled) ONs, CLSM 
experiments are sufficiently suited to prove whether the polymer/oligonucleotide complexes 
are able to dissociate in the cytoplasm or not: upon dissociation the released green-labeled 
ONs enter the nucleus while the red-labeled polymer chains remain in the cytoplasm, 
consequently the red and green labels do not colocalize in the nucleus. However, in opposite 
to the high molar mass cationic polymers, cationic polymers of lower molar mass, like pLL of 
30 kD used in this study, do enter the nucleus upon microinjection or transfection. 
Consequently, when such (red-labeled) polymers are used as carriers for (green-labeled) ONs, 
the nuclei might show both green and red fluorescence, regardless of whether the polyplexes 
are dissociated or not. Clearly, CLSM experiments cannot reveal whether the dual colored 
nuclei are due to intact Cy5-pLL/RhGr-ONs polyplexes or to dissociated Cy5-pLL and RhGr-
ONs chains. Our results show that dual color FFS, which monitors the movement of the 
fluorescent molecules, can solve this question. Upon cytoplasmic microinjection or upon 
transfection with Cy5-pLL/RhGr-ONs complexes, FFS was able to detect simultaneously red 
and green fluorescence peaks in the cytoplasm. In the nucleus, however, simultaneous peaks 
were never observed. From these results we could conclude that the Cy5-pLL and RhGr-ONs 
present in the nucleus after transfection were not associated. 
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Chapter 5 
 
   
 
Studying pegylated DNA-complexes by dual 
color FFS 
 
Parts of this chapter have been published in Macromolecules. 37: 3832-3840 (2004) 
 
1. Introduction 
Pharmaceutical carriers bearing hydrophilic segments (such as polyethyleneglycol, 
pEG) were developed to stabilize and prolong the circulation lifetime of nucleic acid 
containing particles, and to improve targeting strategies [1]. These ‘pegylated carriers’ result 
in DNA-complexes consisting of a more or less hydrophobic core of partially neutralized 
polyion strands, surrounded by a shell of hydrophilic chains. Figure 1 represents a schematic 
view of oligonucleotides complexed to a cationic homopolymer and a cationic block-
copolymer, respectively resulting in a “non-structured” DNA-complex and a more ordered 
“core-shell” DNA-complex. Non-structured DNA-complexes require a substantial excess of 
cationic carrier over ONs to prevent spontaneous aggregation of the DNA-complexes. 
However, such positively charged particles are prone to nonspecific interactions with plasma 
proteins and negatively charged cell surfaces. This can result in aggregation or dissociation of 
the DNA-complexes, activation of the complement system, rapid clearance of the DNA-
particles by phagocytes and aspecific binding with non-target cells. The shell of 
electroneutral, hydrophilic chains of core-shell DNA-particles can avoid these problems by 
reducing the interactions with biological macromolecules and cell surfaces. 
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oligonucleotide
+
oligonucleotide
+
polycationic homopolymer
pEG-segment
block-copolymer (consisting 
of a polycationic segment 
and a pEG-segment)  
Figure 1.  Schematic representation of the formation of “non-structured” DNA-complexes (A) and of 
DNA-complexes with a ‘core-shell’ architecture (B). 
 
Our former FFS work focused on the complexation of ONs with cationic 
homopolymers (e.g. poly-Lysine), resulting in non-structured polyplexes [2-5]. Especially, we 
showed that both single and dual color FFS allow studying the association and dissociation of 
polymer/oligonucleotide complexes in buffer (Chapter 3) and in cells (Chapter 4). In this 
chapter we investigate whether dual color FFS also allows evaluating the 
association/dissociation behavior of pegylated DNA-complexes in buffer. Two distinct types 
of pegylated polycations were investigated: a diblock copolymer and a multiblock copolymer 
(Figure 2), equal in chemical formula but of different molecular weight and degree of 
pegylation. Two distinct approaches were used to fluorescent label these copolymers: the 
fluorophore was either attached to the cationic segment or to the distal end of the pEG-strand 
of the copolymer. 
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1
pEI (2 kD) pEG (10 kD) pEI (25 kD) pEG (8 kD)
11
diblock pEG-pEI multiblock pEG-pEI
pEG
branched pEI
pEG
branched pEI
pEG branched pEI
 
Figure 2.  Schematic representation of diblock and multiblock pEG-pEI. The diblock pEG-pEI (batch 
PI20100, MW 12kD) consists of one branched pEI segment (2 kD) and one pEG-segment (10 kDa). 
The multiblock pEG-pEI (batch PI25080, MW 113 kDa) consists of one branched pEI segment (25 
kD) onto which 11 pEG segments (8 kD each) are coupled. 
 
2. Materials and Methods 
2.1. Oligonucleotides  
The 20-mer phosphodiester ONs (5’-CCC-CCA-CCA-CTT-CCC-CTC-TC-3’) (molar 
mass 5830 g/mol), 25-mer phosphodiester ONs (5’-TCT-GGG-TCA-TCT-TTT-CAC-GGT-
TGG-C-3’) (molar mass 8183 g/mol) and labeled analogues (using rhodamine green (Rh) or 
Cy5 as fluorescent marker) were synthesized by Eurogentec (Seraing, Belgium). The 
fluorescent labeling occurred at the 5’ end of the ONs: each oligonucleotide contained one 
label (Rh or Cy5). The ONs were used as described in Chapter 3.  
 
2.2. Polymers  
The diblock and multiblock polyethyleneglycol-polyethylenimine (pEG-pEI) 
copolymers (Figure 2) were synthesized by Prof. Dr. S. Vinogradov (University of Nebraska) 
[6]. The weight average molecular weight (MW), as determined from static light scattering, 
was respectively 12 kDa (for the diblock, batch PI20100) and 113 kDa (for the multiblock, 
batch PI25080). The total content of nitrogen was respectively 3.75 µmol/mg polymer and 
4.92 µmol/mg polymer [6]. pEG-pEI stock solutions were prepared in Hepes buffer. 
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Branched pEI (non-pegylated) was purchased from Sigma (St Louis, USA). The 
molecular weight of the two batches was respectively 2 kDa and 25 kDa. Prior to use, the 
polymer was desalted over a Sephadex-G25 column (∅10 x 100 mm) in Hepes buffer. The 
polymer concentration was determined finding the amine concentration using the method of 
Snyder and Sobocinski [7]. 
 
FITC-pEG-N-hydroxysuccinimide (FITC-pEG-NHS, MW 5kDa) was purchased from 
Shearwater Corporation (Huntsville, AL, USA). Purification over a Sephadex-G25 column 
(∅10 x 100 mm) showed that no excess of free FITC could be detected by the absorbance 
detector (Waters 486, Millipore corp. Milford, MA). 
 
2.3. Fluorescent labeling of the pEI segment in diblock and multiblock pEG-pEI 
As outlined in the introduction, two types of fluorescent pEG-pEI were investigated. 
While in the first type the pEI-segment was fluorescent-labeled, in the second type a 
fluorophore was attached to the distal end of the pEG-segment (see 2.4.). 
The pEI segment of both diblock and multiblock pEG-pEI was labeled using a 
succinimidyl-ester-activated Cy5-dye (Cy5-SE) (FluoroLinkTMCy5 monofunctional dye, 
Amersham Pharmacia, Piscataway, NJ), following the manufacturer’s procedure. The 
resulting fluorescent polymers were termed respectively diblock and multiblock pEG-pEI-
Cy5. The diblock pEG-pEI-Cy5 was purified on a Sephadex-G25 column (∅10 x 100 mm), 
which was previously equilibrated with Hepes buffer. The fractions containing fluorescent 
pEG-pEI-Cy5 were collected. From the determination of both the amine concentration (using 
the method of Snyder and Sobocinski17) and the absorbance of the label, the average number 
of labels attached to the polymer was obtained. It could be calculated that, on the average, the 
pEG-pEI-Cy5 chains bore one Cy5-label. The multiblock pEG-pEI-Cy5 was purified via 
dialysis (molecular weight cut off 12-14 kDa; Medicell International Ltd.). On the average, 1 
fluorophore per copolymer was detected. 
 
2.4. Preparation of FITC-pEG-pEI 
To obtain a diblock pEG-pEI which is fluorescent-labeled with FITC at the pEG-
segment (diblock FITC-pEG-pEI), equal volumes of pEI (MW 2Da) and FITC-pEG-NHS 
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(MW 5 kDa) stock solutions (in 0.2 M NaHCO3 at pH 9.3) were mixed yielding equal molar 
concentrations in the reaction mixture. After incubation for 1 hour, unreacted pEI was 
removed using a Sephadex-G50 column (∅10 x 300 mm) and 20 mM Hepes buffer (pH 7.4) 
as mobile phase. Non-conjugated FITC-pEG was removed by means of cation exchange 
chromatography using a carboxymethyl-Sephadex column (∅10 x 40 mm, loading buffer: 20 
mM Hepes pH 7.4, elution buffer: 20 mM Tris pH 9 with 0.7 M NaCl), followed by desalting 
over a Sephadex-G50 column (∅10 x 100 mm) in Hepes buffer. Finding the amine 
concentration using the method of Snyder and Sobocinski17 and measurement of the 
absorbance of the label allowed the determination of the average number of FITC-pEG chains 
conjugated to one pEI chain. It could be calculated that one pEI-chain was complexed to one 
FITC-pEG strand. The resulting diblock FITC-pEG-pEI copolymer (7 kDa) served as a 
labeled model for the diblock pEG-pEI copolymer (12 kDa, batch PI20100). 
To create a labeled equivalent of the multiblock pEG-pEI (113 kDa, batch PI25080), a 
solution of the multiblock pEG-pEI was mixed with an equal molar amount of FITC-pEG-
NHS (as described above for the fluorescent labeling of the diblock pEG-pEI) and further 
purified via dialysis (molecular weight cut off 12-14 kDa; Medicell International Ltd.). 
 
2.5. Preparation of polyplexes 
The N/P ratio of the polyplexes is defined as the molar ratio of the total number of 
nitrogen atoms of the polymer to the number of DNA phosphates. The polymer/ONs 
complexes (varying in N/P ratio) were prepared by adding (in one step) different volumes of 
the polymer stock solution to a fixed volume of the ONs stock solution, followed by vortexing 
for 10 seconds. To obtain the final ONs concentration of 10 µg/mL, the samples were further 
diluted with Hepes buffer. The polyplexes were allowed to equilibrate for 30 min at room 
temperature prior to use.  
For FFS measurements on the polymer/ONs complexes, 100 µL of the sample was 
prepared as described above, however, the final ONs concentration equaled 0.2 µg/mL. After 
preparation, 50 µL of the sample was immediately transferred into a 96-well plate (Grainer 
Bio-one, Frickenhausen, Germany) to begin the FFS measurements.  
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2.6. Agarose Gel Electrophoresis  
Thirty minutes after the preparation of the polyplex samples, 30 µL of these samples 
(containing 20 µg/mL Rh-labeled ONs) was mixed with 5 µL of a 50% sucrose solution in 
distilled water and placed in the wells of a 1.1 % agarose gel. A TBE buffer was used 
containing 10.8 g/L Tris base, 5.5 g/L boric acid and 0.58 g/L EDTA. A potential of 100V 
was applied for 60 min. The oligonucleotides in the gel were detected based upon the 
fluorescence of their Rh-label. 
 
2.7. Spectrofluorimetry 
The fluorescence of polymer/Rh-ONs complexes was measured on an SLM-Aminco 
Bowman spectrofluorimeter (SLM-Aminco Bowman; λex = 488 nm, λem = 510 nm), 30 
minutes after their preparation. The fluorescence of each sample was measured three times.  
 
2.8. Particle Size and Zeta-Potential Measurements 
Dynamic light scattering (DLS) and zeta-potential (ζ) measurements on the polyplexes 
were performed as described in Chapter 3.  
 
2.9. Fluorescence Fluctuation Spectroscopy (FFS) 
Dual color FFS experiments were performed on a home made dual color FFS setup as 
described in Chapter 3. 
 
 
3. Results & Discussion  
 
The electrostatic interactions between the anionic ONs and the cationic pEI-segment 
in pEG-pEI are responsible for the complex formation. The hydrophilic pEG-strands are 
neutrally charged and indifferent to these interactions. The spontaneously formed complexes 
consist of a more or less hydrophobic core of partially neutralized polyion strands, surrounded 
by a shell of neutral, hydrophilic pEG-chains. Indeed, because of this pEG-shell, the zeta-
potential of the complexes equaled zero (data not shown). Even at higher N/P ratios (N/P >> 
8) the zeta-potential remained zero, both when the diblock and the multiblock pEG-pEI were 
used. Dynamic light scattering showed that the hydrodynamic size of the complexes was 
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around 200 nm (data not shown) [4]. Even at N/P ratios approaching electroneutrality, the size 
did not change, indicating that the pEG-shell prevents aggregation of the neutral DNA-
complexes. 
Figure 3A shows that upon complexation of Rh-ONs with pEG-pEI the fluorescence 
decreases, presumably because of (self-)quenching of the fluorophores since the local 
concentration of labeled ONs in the complex is much larger than for Rh-ONs free in solution. 
However, although both diblock and multiblock pEG-pEI form core-shell type polyplexes, the 
quenching of the Rh-ONs is different. At higher N/P ratios, the fluorescence remains 
quenched for Rh-ONs complexed to the diblock pEG-pEI whereas there is a partial recovery 
of the fluorescence in cases concerning the multiblock pEG-pEI. Gel electrophoresis shows 
that for both types of polyplexes no free 25-mer Rh-ONs are present in the sample at N/P ratio 
higher than 8, which would also increase the fluorescence (data not shown). Therefore, the 
recovery of the fluorescence intensity for multiblock pEG-pEI at higher N/P ratio has to be 
related to less (self-)quenching between the Rh-labels, due to an altered distribution of the 
Rh-ONs in the complexes [3;4]. The discrepancy between both types of pEG-pEI is not due to 
their different degree of pegylation, but to the differences in their cationic segments since the 
same discrepancy is observed for Rh-ONs complexed to the (non-pegylated) pEI 
homopolymer of respectively 2 kDa and 25 kDa (Figure 3B). 
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Figure 3. Fluorescence of polymer/ONs complexes (differing in N/P ratios) as measured with a 
conventional fluorimeter. (A) Rh-ONs (25-mer) complexed to pEG-pEI (diblock z and multiblock ) 
and (B) Rh-ONs (25-mer) complexed to (non-pegylated) pEI (2 kDa z and 25 kda ). Each sample 
was measured three times. 
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Gel electrophoresis experiments revealed another difference in complexation behavior 
of diblock and multiblock pEG-pEI. Figure 4 shows that diblock pEG-pEI is not able to fully 
complex 20-mer Rh-ONs as a smear can be observed in lanes 2 to 4. It indicates that a major 
part of the Rh-ONs are still free which enables them to migrate towards the anode. However, 
multiblock pEG-pEI is able to complex the 20-mer Rh-ONs completely (lanes 5 to 7). On the 
other hand, both diblock and multiblock pEG-pEI are able to fully complex 25-mer Rh-ONs 
(lanes 9 to 11 and lanes 12 to 14). As for (non-pegylated) pEI carriers, both 2 kDa pEI and 25 
kDa pEI are able to fully complex both the 25-mer and the 20-mer Rh-ONs (data not shown). 
Gel electrophoresis experiments on diblock and multiblock FITC-pEG-pEI analogues (data 
not shown) revealed a complexation behavior identical to the unlabeled pEG-pEI shown in 
Figure 4. 
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Figure 4.  Gel electrophoresis on free Rh-ONs (lane 1 and 8), diblock-pEG-pEI/Rh-ONs complexes 
(lane 2 to 4 and 9 to 11) and multiblock-pEG-pEI/Rh-ONs complexes (lanes 5 to 7 and 12 to 14) in 
various media (Hepes buffer, Dulbecco’s Modified Eagle Medium without serum (DMEM) and with 
serum (CM)). Lane 1 to 7 show 20-mer Rh-ONs, lane 8 to 14 show 25-mer Rh-ONs. The Rh-ONs 
concentration in all the samples was 20 µg/mL, N/P equaled 15.  
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Figures 5C and 5D show the fluorescence fluctuations of a diblock FITC-pEG-
pEI/Cy5-ONs sample measured at the same time by the red (5C) and green (5D) detector of 
the FFS setup. Compared with the fluorescence fluctuations of free Cy5-ONs (Figure 5A) and 
free diblock FITC-pEG-pEI copolymer (Figure 5B), three major observations are made. First, 
highly intense fluorescence peaks appear in the fluorescence fluctuation profile. This can be 
explained as follows. When a complex exists of many fluorescent-labeled molecules, its 
fluorescence becomes much higher than that of a free molecule. Consequently, when such a 
complex comes into the focal volume, a highly intense fluorescence peak appears in the 
fluorescence fluctuation profile. Second, the average background fluorescence intensity, 
representing the average number of fluorescent molecules in the focal volume, significantly 
decreases upon complexation (compare Figure 5C and 5D with respectively 5A and 5B). As 
the Cy5-ONs and diblock FITC-pEG-pEI molecules organize into multimolecular complexes, 
the number of free Cy5-ONs and free FITC-pEG-pEI strands in the focal volume is lowered, 
which is reflected in the FFS curves. Third, highly intense fluorescence peaks are observed in 
the two detectors at the same time. The simultaneous appearance of the red and green peaks 
indicates that a complex bearing many red-labeled as well as many green-labeled components 
is passing through the focal volume. It proves that the pEG-pEI/ONs complexes are indeed 
multimolecular. Others have also reported the multimolecular nature of this class of 
polyplexes. Vinogradov et al. determined the molecular weight (by static light scattering) of 
similar pEG-pEI/ONs complexes and calculated that they consist of 23 polymer strands and 
24 oligonucleotides [8]. Harada et al. calculated for similar core-shell type pEG-pLL/ONs 
complexes, a composition of 162 (20-mer) or 248 (15-mer) ONs and hundreds of polymer 
chains [9]. Simultaneously appearing peaks of high fluorescence intensity could be observed 
for both 20-mer and 25-mer Cy5-ONs, when complexed to diblock FITC-pEG-pEI. Though 
gel electrophoresis showed that diblock FITC-pEG-pEI is not able to fully complex 20-mer 
Cy5-ONs (Figure 4, lane 2 to 4), FFS showed that at least part of the Cy5-ONs are organized 
in multimolecular polyplexes.  
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Figure 5.  The fluorescence fluctuation profiles of a solution of free Cy5-ONs (A) and free diblock 
FITC-pEG-pEI (B) as registered by respectively the red and green detector. Fluorescence fluctuation 
profiles of a diblock FITC-pEG-pEI/Cy5-ONs sample (N/P = 15; 0.2 µg/mL 20-mer Cy5-ONs) as 
simultaneously registered by the FFS 'red detector' (C) and 'green detector' (D). Fluorescence 
fluctuation profiles of the diblock FITC-pEG-pEI/Cy5-ONs sample after addition of NaCl (final 
concentration 0.5M), as simultaneously registered by the FFS 'red detector' (E) and 'green detector' (F). 
When applicable, threshold fluorescence intensity values are indicated as dotted lines, discriminating 
the highly intense fluorescence peaks (which occur as a multimolecular complex diffuses through the 
focal volume) from the average background fluorescence intensity.  
 
Excessive addition of NaCl clearly influences the fluorescence fluctuation profiles 
(Figures 5E and 5F). The average background fluorescence intensity almost completely 
restores to the values of free Cy5-ONs (Figure 5A) and free FITC-pEG-pEI (Figure 5B). 
Moreover, highly intense fluorescence peaks completely disappear. Both phenomena indicate 
the dissociation of the diblock FITC-pEG-pEI/Cy5-ONs complexes. Lane 4 in Figure 7 indeed 
shows that adding NaCl to the diblock FITC-pEG-pEI/Cy5-ONs complexes prior to loading 
them on gel results in the release of a significant amount of Rh-ONs, which can migrate freely 
through the gel. Addition of dextran sulfate to the diblock FITC-pEG-pEI/Cy5-ONs 
complexes also resulted in the complete disappearance of highly intense fluorescence peaks in 
the FFS curves (data not shown). No threshold value could be calculated anymore in the 
fluorescence fluctuation profile of the labeled ONs, while autocorrelation analysis indeed was 
able to determine a diffusion coefficient equal to that of the free labeled ONs. Dextran sulfate 
is an anionic polymer, which competes with the Cy5-ONs for binding to the pEG-pEI chains, 
and dissociates the diblock FITC-pEG-pEI/Cy5-ONs complexes as revealed from lane 5 in 
Figure 7. 
When complexing Cy5-ONs (both 20-mer and 25-mer) with multiblock FITC-pEG-
pEI, peaks of high fluorescence intensity were recorded simultaneously by both detectors 
(Figures 6C and 6D) and also the average background fluorescence intensity significantly 
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decreased. Upon adding NaCl, this average background fluorescence intensity only partly 
restored (compare Figures 8E and 8F with respectively 6A and 6B). Also a few highly intense 
fluorescence peaks remained. It indicates that adding NaCl only partly dissociates the 
multiblock FITC-pEG-pEI/Cy5-ONs complexes. Indeed, lane 10 in Figure 7 shows that only a 
minor amount of the Rh-ONs is able to migrate freely through the gel. Addition of dextran 
sulfate to the multiblock FITC-pEG-pEI/Cy5-ONs complexes resulted in the complete 
disappearance of highly intense fluorescence peaks in the FFS curves (data not shown). Also, 
gel electrophoresis shows that dextran sulfate is able to completely release the ONs from the 
multiblock pEG-pEI/ONs complexes (lane 11 in Figure 7). 
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Figure 6.  The fluorescence fluctuation profiles of a solution of free Cy5-ONs (A) and free multiblock 
FITC-pEG-pEI (B) as registered by respectively the red and green detector. Fluorescence fluctuation 
profiles of a multiblock FITC-pEG-pEI/Cy5-ONs sample (N/P = 15; 0.2 µg/mL 20-mer Cy5-ONs) as 
simultaneously registered by the FFS 'red detector' (C) and 'green detector' (D). Fluorescence 
fluctuation profiles of the multiblock FITC-pEG-pEI/Cy5-ONs sample after addition of NaCl (final 
concentration 0.5M), as simultaneously registered by the FFS 'red detector' (E) and 'green detector' (F). 
When applicable, threshold fluorescence intensity values are indicated as dotted lines. 
 
In the FFS experiments described above, the fluorescent marker (FITC) was attached 
to the pEG-strand of pEG-pEI, thus residing at the surface of the core-shell polyplexes. In the 
following experiments, the fluorescent label (Cy5) was bound to the cationic pEI-segment of 
pEG-pEI, which takes part in the electrostatic interactions between the ONs and the polymer.  
Dual color FFS measurements on the diblock pEG-pEI-Cy5/Rh-ONs samples did not 
reveal the simultaneous appearance of highly intense fluorescence peaks in the red and green 
detector or any significant changes in the average background fluorescence intensity of the 
FFS-curves (data not shown), indicating that multimolecular complexes did not exist. Gel 
electrophoresis experiments indeed confirmed these results: as revealed from lane 6 in Figure 
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7, the diblock pEG-pEI-Cy5 was not able to complex the Rh-ONs anymore, in contrast with 
the unlabeled polymer (compare lane 6 with lane 3 in Figure 7). The fluorophore on the 
cationic segment of the diblock pEG-pEI clearly hinders the complexation of this polymer 
with Rh-ONs.  
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Figure 7.  Gel electrophoresis on free 20-mer Rh-ONs (lane 1 and 2), diblock pEG-pEI/Rh-ONs 
complexes (lane 3 to 5), diblock pEG-pEI-Cy5/Rh-ONs complexes (lanes 6 to 8), multiblock-pEG-
pEI/Rh-ONs complexes (lanes 9 to 11) and multiblock pEG-pEI-Cy5/Rh-ONs complexes (lanes 12 to 
14). The Rh-ONs concentration in all the samples was 20 µg/mL, N/P equaled 15. Addition of salt 
(NaCl) or dextran sulfate (DS) to the complexes (prior to loading them on gel) clearly destabilizes (i.e. 
dissociates) the complexes. 
 
The gel electrophoresis experiments show that multiblock pEG-pEI-Cy5, like the non-
labeled copolymer, does complex with the Rh-ONs (compare lane 12 with lane 9 in Figure 7). 
Indeed, FFS-measurements reveal a significant decrease of the average background 
fluorescence intensity, indicating that the amount of non-complexed Rh-ONs and pEG-pEI-
Cy5 molecules has decreased (compare Figures 8C and 8D with respectively 8A and 8B). 
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However, highly intense fluorescence peaks did not appear at all in the red and green 
fluorescence fluctuation profiles. A plausible explanation could be a strong quenching, as the 
Rh-labels on the ONs and the Cy5-labels on the pEI-segment of the polymer are in each 
other’s proximity in the core of the polyplexes. On the contrary, for FITC-pEG-pEI/Cy5-ONs 
complexes, the FITC-label of the polymer is located at the surface of the pEG-shell, distinct 
from the Cy5-labeled ONs in the core of the complex. Apparently the quenching effect 
overrules the increase in fluorescence intensity due to the high number of fluorophores in one 
complex. Upon addition of NaCl, the average background fluorescence intensity only partly 
restored (Figure 8E and 8F), indicating that only part of the Rh-ONs is released from the 
polyplexes. This could also be observed from gel electrophoresis measurements: Figure 7 
(lane 10 and 13) shows that both non-labeled multiblock pEG-pEI and multiblock pEG-pEI-
Cy5 remain able to complex a major part of the Rh-ONs after addition of NaCl. 
Upon adding dextran sulfate to multiblock pEG-pEI/Rh-ONs complexes prior to 
loading them on gel, the Rh-ONs were completely released from the complexes as they 
migrate freely through the gel (lanes 11 and 14 in Figure 7). In FFS-measurements, adding 
dextran sulfate to a sample of multiblock pEG-pEI-Cy5/Rh-ONs complexes indeed resulted in 
the recovery of the average background fluorescence intensity (data not shown).  
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Figure 8.  The fluorescence fluctuation profiles of a solution of free Rh-ONs (A) and free multiblock 
pEG-pEI-Cy5 (B) as registered by respectively the red and green detector. Fluorescence fluctuation 
profiles of a multiblock pEG-pEI-Cy5/Rh-ONs sample (N/P = 15; 0.2 µg/mL 20-mer Cy5-ONs) as 
simultaneously registered by the FFS 'green detector' (C) and 'red detector' (D). Fluorescence 
fluctuation profiles of the same multiblock pEG-pEI-Cy5/Rh-ONs sample after addition of NaCl (final 
concentration 0.5M), as simultaneously registered by the FFS 'green detector' (E) and 'red detector' (F).  
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4. Summary and conclusions 
For both diblock and multiblock pEG-pEI, the complexation with oligonucleotides 
resulted in the formation of pegylated DNA-complexes with a core-shell structure, as 
evidenced by zeta-potential measurements. However, differences in complexation behavior 
between the two types of pEG-pEI were observed. Gel electrophoresis demonstrated that the 
diblock pEG-pEI showed better complexation behavior for 25-mer Rh-ONs than for 20-mer 
Rh-ONs, whereas multiblock pEG-pEI was able to fully complex both types of Rh-ONs. In 
addition, conventional fluorimetry revealed that the fluorescence of Rh-labeled ONs was 
differently quenched upon complexation with diblock and multiblock pEG-pEI.  
Dual color FFS measurements were performed on pEG-pEI/ONs complexes, the ONs 
and pEG-pEI chains being labeled with spectrally different fluorophores. In cases where the 
fluorescent label (FITC) was attached to the free end of the pEG-segment of pEG-pEI, dual 
color FFS measurements on FITC-pEG-pEI/Cy5-ONs (for diblock as well as multiblock pEG-
pEI) showed that both detectors simultaneously registered highly intense fluorescence signals. 
This indicates that a group of oligonucleotides and polymer-chains migrates together through 
the detection volume and therefore proves that complexes are formed, which are composed of 
many oligonucleotide and polymer strands. These observations prove the formation of 
multimolecular polyplexes, which is in agreement with the gel electrophoresis results and 
observations in literature. When the pEG-pEI polymers were fluorescent-labeled at their 
cationic pEI-segment, however, FFS did not detect multimolecular polyplexes. In the case of 
diblock pEG-pEI-Cy5, the absence of peaks of high fluorescence intensity was indeed due to 
the fact that no multimolecular polyplexes could be formed, as was shown by gel 
electrophoresis. However, gel electrophoresis showed that multiblock pEG-pEI-Cy5 did 
complex Rh-ONs. The absence of highly intense fluorescence peaks in FFS was due to the 
mutual quenching of both the Cy5- and Rh-labels that were in close proximity in the core of 
the core-shell complex. From these results, it could be concluded that dual color FFS allows 
studying the association and dissociation of pEG-pEI/ONs provided that the fluorescent label 
of the polymer is attached to the distal end of the pEG-chain. 
FFS is a very sensitive technique. Experiments can be done on small sample volumes 
in the nanomolar concentration range. Compare 50 µL of 0.2 µg/mL ONs for FFS-
measurements with 30 µL of 20 µg/mL ONs for gel electrophoresis and 1 mL of 10 µg/mL 
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ONs for dynamic light scattering, zeta-potential and conventional fluorimeter experiments. 
The very low concentrations used are a major advantage when studying scarce DNA- and 
polymer-material. The small sample volume required makes the technique suitable for 
measurements in rare media (e.g. cytoplasmic lysates) and in living cells. As a microscopy-
based technique, FFS shows potential to study the biophysical behavior of DNA-complexes in 
living cells. Since gel electrophoresis can tell us whether Rh-ONs are free (migrating towards 
the anode) or complexed (remaining in the slots), so might dual color FFS be able to 
determine in the cytoplasm of a living cell whether the Rh-ONs are still complexed to their 
carrier or not. All this indicated by the presence or absence of simultaneous peaks in both the 
red and green detector channel. However, the sample material has to be analyzed with care: 
we have demonstrated the possibility of introducing artefacts as the fluorescent label may 
alter the physicochemical behavior of the polymer. Diblock pEG-pEI-Cy5 did not complex 
the Rh-ONs anymore, possibly due to steric hindrance of the fluorophore. Also unforeseen 
quenching phenomena can result in the absence of dual color peaks while the Rh-ONs are 
complexed to their carrier (as observed for multiblock pEG-pEI-Cy5/Rh-ONs complexes). 
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Chapter 6 
 
 
 
Towards a better understanding of the 
dissociation behavior of liposome-oligonucleotide 
complexes in the cytoplasm of cells 
 
Parts of this chapter have been published in Journal of Controlled Release 103: 435-450 (2005). 
 
1. Introduction 
Cationic liposomes have been successfully used as non-viral carriers for ONs, both in 
cell cultures [1;2] and in animals [3;4]. It has been proved that the liposome/ONs complexes 
are taken up by cells via endocytosis and not through fusing with the plasma membrane [5]. 
The cellular mechanisms that govern the location and extent of intracellular dissociation of 
liposome/ONs complexes remain unclear. Dual color fluorescence microscopy studies have 
shown that cationic liposome/ONs complexes probably dissociate during endosomal escape 
and that the oligonucleotides accumulate in the nucleus whereas the lipids remain in the 
cytoplasm [6;7]. Szoka and colleagues have proposed a model in which the cationic lipids in 
the endocytosed liposome/ONs complexes interact with the anionic lipids in the inner leaflet 
of the endosomal membrane and flip-flop into the outer leaflet [8]. It is assumed that during 
these events the oligonucleotides dissociate from their carrier and escape from the endosome 
into the cytoplasm while the cationic lipids remain in the outer leaflet of the endosomal 
membrane. However, the endosomal pathway is maybe not the only way to obtain 
intracellular dissociation of the lipoplexes. Among others, Sanders et al. have shown that 
biological polyelectrolytes in the extracellular matrix are able to induce structural alterations 
of pDNA-containing lipoplexes, hereby releasing DNA [9]. Cytoplasmic soluble proteins are 
reported to induce DNA release from DNA/carrier complexes in buffer [10]. Additionally, it 
has been reported that lipoplexes that have been released from artificially ruptured endosomes 
are able to dissociate at the nuclear membranes [11]. Also, incubating lipoplexes with isolated 
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nuclei in buffer results in the nuclear accumulation of free ONs whereas the cationic lipids 
partly fuse with the nuclear membranes [12]. 
In our former work, we have proved that in buffer the complexation between 
oligonucleotides and cationic polymers can be monitored by FFS. When associating, the 
amount of detected free ONs decreases and highly fluorescent complexes appear, which are 
clearly detected by FFS. These self-assembling polymer/ONs complexes are ‘multimolecular’ 
(i.e. exist out of several ONs and several polymer strands). When dissociating, the amount of 
free ONs increases and the multimolecular complexes disappear [13-17].  
To the best of our knowledge, only two reports in literature deal with FFS on 
lipoplexes. Jurkiewicz et al. studied by single color FFS the association of ONs to liposomes 
in buffer: the binding of the ONs to the (non-labeled) liposomes decreased the diffusion 
coefficient of the ONs and reduced the number of free ONs detected in the excitation volume 
[18]. Merkle et al. determined by dual color FFS the maximum number of 40 bp double-
stranded DNA able to bind to a single liposome vesicle [19]. Giving that ONs have to be 
released from the lipoplexes in order to be biologically active, the intracellular dissociation of 
the lipoplexes is a crucial issue in the optimization of cationic liposomes for DNA-delivery. 
Therefore, the current chapter aims to investigate whether dual color FFS allows evaluating 
the complexation behavior (being association and dissociation) of liposome/ONs complexes 
in respectively buffer, cell lysate and the cytoplasm of living cells. 
 
 
2. Materials and methods 
 
2.1. Oligonucleotides  
The 25-mer phosphodiester ONs (5’-TCT-GGG-TCA-TCT-TTT-CAC-GGT-TGG-C-
3’) and labeled analogues (using rhodamine (Rh) or Cy5 as fluorescent marker) were used as 
described in Chapter 5.  
 
2.2. Polymers, lipids, detergents and polystyrene nanoparticles 
Dextran sulfate (DS) was used as described in Chapter 3. 
Sodium dodecyl sulfate (SDS) was purchased from Sigma (St Louis, USA). The 
phospholipids DOTAP (N-(1-(2,3-dioleoyloxy)propyl)-N,N,N-trimethyl-ammoniumchloride), 
DOPE (dioleoylfosfatidylethanolamine) and FITC-DOPE (i.e. DOPE being labeled at the 
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polar group with fluorescein-isothiocyanate) were purchased from Avanti® Polar Lipids 
(Alabaster, AL, USA).  
TetraspeckTM beads, of respectively 90 nm diameter and 500 nm diameter, were used as 
described in Chapter 4.  
 
2.3. Preparation of cationic liposomes 
The cationic liposomes studied contained DOTAP and DOPE in a 1:1 molar ratio with 
or without 0.2 mol % FITC-DOPE. The lipids were dissolved in a 1:1 (volume) mixture of 
chloroform:methanol. Subsequently, the solution of lipids was placed in a round-bottomed 
flask and the solvents were evaporated under vacuum at 30°C. The resulting lipid film was 
further dried under a flow of nitrogen for 1h. The lipids were then resuspended in Hepes 
buffer (20 mM at pH 7.4) at a final concentration of 5 mM DOTAP and rehydrated overnight 
at 4 °C to allow liposome formation. The resulting liposomes were extruded at room 
temperature through a polycarbonate membrane, with a pore size of 0.1 µm, using the Avanti 
Polar Lipids Mini-extruder. The hydrodynamic size and zeta potential (ζ) of the resulting 
cationic liposomes were routinely checked by respectively dynamic light scattering (DLS, 
Malvern 4700, Malvern, Worcestershire, UK) and electrophoretic mobility measurements 
(Zetasizer 2000, Malvern, Worcestershire, UK), as previously described in Chapter 3. The 
hydrodynamic diameter and ζ of the liposomes equaled respectively 140 nm ± 11 and +49 
mV ± 4.  
 
2.4. Preparation of liposome/ONs complexes 
Liposome/ONs complexes with varying +/- charge ratio were prepared. The +/- charge 
ratio of the liposome/ONs complexes (i.e. the ratio of the number of positive charges 
(originating from DOTAP) to the number of negative charges (originating from the ONs)) 
was calculated assuming that 1 µg of ONs contains 3.43 nmol negative charges.  
The liposome/ONs complexes varying in +/- charge ratio were prepared by mixing 
equal volumes of a liposome sample (with increasing concentrations) and an ONs solution 
(10µM). After addition of the liposome sample to the ONs solution, the resulting sample was 
mixed during 10 seconds and further diluted until an ONs concentration of 10 µg/mL 
(1.2µM). The liposome/ONs complexes were allowed to equilibrate for 30 min at room 
temperature prior to use. 
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2.5. Dissociation of liposome/ONs complexes in NaCl solutions and cell lysate 
To a liposome/ONs sample (the ONs concentration being 20 µg/mL (2.4µM)) an equal 
volume of NaCl (in varying concentrations) was added and mixed during 10 seconds. The 
mixture was allowed to equilibrate for 10 minutes prior to use. Dissociation experiments using 
dextran sulfate, SDS or cell lysate were performed in a similar way. For the experiments with 
cell lysate, the cell lysate (prepared as described below) was three times diluted with Hepes 
buffer (20 mM at pH 7.4). 
 
2.6. Agarose gel electrophoresis experiments 
30 µL of the FITC-liposome/Rh-ONs samples (containing 1.2 µM ONs) was mixed 
with 5 µL sucrose solution (50g sucrose/100mL distilled water) and placed in the wells of a 
1.1 % agarose gel prepared in TBE buffer (10.8 g/L Tris base, 5.5 g/L boric acid and 0.58 g/L 
EDTA). Electrophoresis was performed by applying 100 V during 1h over the gel, which was 
submerged in TBE. After this time span the gel was illuminated with ultraviolet light. The Rh-
ONs and the FITC-liposomes in the gel were detected based upon the fluorescence of their 
label. In the gel electrophoresis experiments Rh-ONs were used instead of Cy5-ONs as the 
Rh-fluorescence but not the Cy5-fluorescence could be excited by the UV-lamp. 
 
2.7. Spectrofluorimetry 
The fluorescence of respectively liposome/Cy5-ONs samples and FITC-liposome/ONs 
samples was measured on an SLM-Aminco Bowman spectrofluorimeter.  
The +/- charge ratio of the liposome/Cy5-ONs complexes was varied by keeping the Cy5-
ONs concentration constant at 10 µg/mL and varying the concentration of non-labeled 
liposomes. The +/- charge ratio of the FITC-liposome/ONs complexes was varied by keeping 
the FITC-liposome concentration constant at 50 µM DOTAP (0.1 µM FITC-DOPE) and 
varying the concentration of non-labeled ONs. The fluorescence of each sample was measured 
three times. 
 
2.8. Cell culture and preparation of cell lysate 
Vero cells (ATCC nr.: CCL-81) were cultured as described in Chapter 4. 
Cell lysate was derived from Vero cells at 90% confluency following the Clontech 
Cytoplasmic Extraction Procedure. Briefly, cells were collected after centrifugation and 
suspended in a hypotonic lysis buffer containing protease inhibitors (10 mM Hepes at pH 7.9, 
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1.5 mM MgCl2 and 10 mM KCl + 1 µM Leupeptine, 0.5 mM Pefabloc SC, 1 mM DTT and 
0.5 mM EGTA). After 15 minutes swelling on ice, cells were centrifuged again and 
resuspended in 2 times the cell pellet volume of lysis buffer + protease inhibitors. This cell 
suspension was drawn into a narrow-gauge syringe and rapidly ejected. Lysis occurred by 
repeating the drawing and ejection procedure 10 times. The disrupted cell suspension was 
then centrifuged for 20 minutes at 11000 g and the supernatant was stored at -80 °C.  
 
2.9. Fluorescence fluctuation spectroscopy 
In this study FFS experiments were performed on a home-made dual color FFS setup 
as described in Chapter 3. The measurements on the homemade FFS apparatus were 
confirmed by conducting the same experiments on a commercial instrument (Confocor II, 
Zeiss-Evotec, Jena, Germany). 
FFS measurements in buffer and cell lysate: 
FITC-liposome/Cy5-ONs samples in Hepes buffer, NaCl or cell lysate (prepared as 
described above) were further diluted with Hepes buffer until a final ONs concentration of 0.2 
µg/mL (24 nM). After dilution, 50 µL of the sample was immediately transferred into a 96-
well plate (Grainer Bio-one, Frickenhausen, Germany) to begin the FFS measurements. 
Diffusion coefficients were calculated using the average diffusion time of at least 20 
measurements. Each FITC-liposome/Cy5-ONs sample was independently prepared three 
times and each preparation was measured at least 10 times. The fluorescence fluctuation 
profiles shown in the figures were representative for the measurements done on the respective 
FITC-liposome/Cy5-ONs samples. 
FFS measurements in cells: 
Microinjection experiments were performed on Vero cells grown to 70% confluency 
on glass-bottomed cover slips (Part No. PG-1.5-14-F, Glass bottom No. 1.5, MatTek 
Corporation, Ashland, MA, USA) submerged in imaging medium (DMEM with FBS and 10 
mM Hepes). A Femtojet® microinjector and an Injectman® NI 2 micromanipulator 
(Eppendorf) were used. All injections were performed in the cytoplasm of the cells. The Vero 
cells were injected with respectively free Cy5-ONs (5µM) or FITC-liposome/Cy5-ONs (5µM 
Cy5-ONs, 1250µM DOTAP) prepared in Hepes buffer. 
FFS measurements were done at randomly selected places in cytoplasm or nucleus. To 
ensure measurements in viable cells, only non-rounded cells without the appearance of 
cytoplasmic blebs were selected. Confocal sections were taken every 0.5 µm to position the 
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excitation volume inside the cell. After the CLSM/FFS measurements, cell viability was 
evaluated using propidium iodide. 
 
 
3. Results and discussion 
 
3.1. Size and zeta-potential of the liposome/ONs complexes  
The cationic liposomes were mixed with the anionic ONs at different +/- charge ratios. 
Complex formation occurred due to electrostatic interactions between the anionic ONs and the 
cationic DOTAP lipids in the liposomes. At a +/- charge ratio below 1, small negatively 
charged lipoplexes were obtained (Figure 1). However, when the charge ratio approached 1, ζ 
approximated zero and large aggregates were consequently formed due to the disappearance 
of electrical repulsion between individual lipoplexes. At higher +/- charge ratios ζ became 
positive and equaled the ζ of the cationic liposomes (without ONs). This most likely indicates, 
as also observed by others, that the ONs became sandwiched between two lipid (bi)layers 
[9;20]. The positive surface charge of the lipoplexes at these high +/- charge ratios resulted in 
an electrical repulsion between the individual lipoplexes. This prevents them from 
aggregating and explains their smaller size. Similar diameters and ζ values were obtained 
when mixing pDNA (instead of ONs) with the DOTAP/DOPE liposomes [9].  
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Figure 1. The z-average hydrodynamic diameter (z) and zetapotential (c) of liposome/ONs 
complexes, as a function of the +/- charge ratio (n=3). 
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3.2. Fluorescence of liposome/ONs complexes 
Figure 2 shows that the fluorescence of Cy5-ONs significantly decreases upon 
complexation to non-labeled DOTAP/DOPE liposomes at +/- charge ratios below 1. Their 
fluorescence levels off at +/- charge ratios above 1. Similar quenching behavior was observed 
when complexing the Cy5-ONs to FITC-labeled cationic liposomes (data not shown). The 
decrease in Cy5-ONs fluorescence is due to quenching of the Cy5-ONs upon association with 
the cationic liposomes. Alternatively, self-quenching of the Cy5-ONs in the complexes might 
occur. Indeed, in the liposome/Cy5-ONs complexes, the Cy5-ONs are packed together and 
come into such close proximity of each other that they can quench the fluorescence of their 
neighbours. Similarly, Rh-ONs were quenched upon complexation to cationic polymers, as 
was previously shown for e.g. pDMAEMA (poly-2-dimethylaminoethyl-methacrylate, Figure 
2) [15]. However, in contrary to the pDMAEMA/Rh-ONs complexes, the fluorescence of the 
liposomes/Cy5-ONs samples did not restore at higher +/- charge ratio, which might indicate 
that the organization of the lipoplexes does not drastically change at higher +/- charge ratios. 
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Figure 2.  Fluorescence (as measured by a conventional fluorimeter) of liposome/Cy5-ONs complexes 
(♦), FITC-liposome/ONs complexes () and pDMAEMA/Rh-ONs complexes (S) [15], as a function 
of the +/- charge ratio. For the liposome/Cy5-ONs and pDMAEMA/Rh-ONs samples, the ONs 
concentration was kept constant (10 µg/mL) and the concentration of respectively non-labeled 
liposome and non-labeled pDMAEMA was varied. Excitation occurred at 650 nm (Cy5) or 520 nm 
(Rh), while the fluorescence was measured at 670 nm (Cy5) or 546 nm (Rh).  
For the FITC-liposome/ONs sample, the FITC-liposome concentration was kept constant (50 µM 
DOTAP, 0.1 µM FITC-DOPE) and the concentration of non-labeled ONs was varied. Excitation 
occurred at 492 nm, while the fluorescence was measured at 518 nm. 
 
 -85-
CHAPTER 6 
Figure 2 also shows that the fluorescence of the FITC-labeled liposomes was quenched 
upon complexation to non-labeled ONs. However, this quenching was less pronounced and 
independent of the +/- charge ratio.  
 
3.3. Characterizing the association of ONs to cationic liposomes in buffer  
Figure 3A shows the fluorescence fluctuation profile of free (i.e. non-complexed) Cy5-
ONs in Hepes buffer. A diffusion coefficient of 0.82 ±0.09 x 10-10 m²/s was obtained when 
fitting the experimental correlation curve to a single component autocorrelation function 
(equation 1) [15] and agrees with values reported in literature [15;21]. The fluorescence 
fluctuation profile of the cationic FITC-liposomes in Hepes buffer (Figure 3B) shows clearly 
that highly intense peaks of FITC-fluorescence (“FITC-peaks”) appear. As the concentration 
of liposomes in the sample is in the picomolar range (as estimated from the lipid 
concentration and the amount of lipids per liposome), the FITC-peaks must be due to the 
movement of individual liposomes, each liposome bearing several FITC labels, through the 
excitation volume. Although the FITC-peaks complicated the autocorrelation analysis, a 
diffusion coefficient of 3.5 ±0.5 x 10-12 m2/s could be obtained. Using the Stokes-Einstein 
equation, a diameter of 140 nm was calculated from this diffusion coefficient, which agrees 
with the hydrodynamic diameter of the FITC-liposomes measured by DLS (140 nm ± 11, data 
not shown). The low fluorescence signal between the FITC-peaks in Figure 3B (which we 
term “baseline fluorescence”) is due to the presence of subnanomolar concentrations of free 
FITC in the FITC-liposome samples. Indeed, autocorrelation analysis of the fluctuations of 
the baseline yielded a diffusion coefficient of fast diffusing molecules. 
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Figure 3.  Fluorescence fluctuation profiles of Cy5-ONs (A), FITC-liposomes (B), and FITC-
liposome/Cy5-ONs complexes (C). In C the fluorescence was simultaneously registered by the red 
(upper panel) and green (lower panel) detector. The +/- charge ratio of the FITC-liposome/Cy5-ONs 
complexes was 10. The final concentration of Cy5-ONs and FITC-liposomes equaled 0.2 µg/mL and 6 
µM DOTAP respectively. All samples were prepared in Hepes buffer. The threshold fluorescence 
intensity value is indicated as a dotted line, discriminating the high fluorescence peaks from the 
baseline fluorescence. 
 
Figure 3C shows that mixing Cy5-ONs and FITC-liposomes clearly influences the 
fluorescence fluctuation profile of both the Cy5-ONs and the FITC-liposomes. Hereby, both 
488 nm and 647 nm laser lines were simultaneously used to excite the fluorescent labels. 
Compared to free Cy5-ONs (Figure 3A), the fluorescence in the red detection volume 
decreased, i.e. the Cy5-baseline fluorescence in Figure 3C (60 kHz) is much lower than the 
baseline fluorescence in Figure 3A (700 kHz). This is due to a lower concentration of free 
Cy5-ONs in the excitation volume and is a first indication that Cy5-ONs are associated to the 
FITC-liposomes. A second observation indicating complexation of Cy5-ONs were the highly 
intense peaks of Cy5-fluorescence (“Cy5-peaks” in the upper panel) which appeared 
simultaneously with highly intense peaks of FITC-fluorescence (“FITC-peaks” in the lower 
panel). This can be explained by the fact that many Cy5-ONs and FITC-liposomes move 
together, thus associated, through the excitation volume. The FITC-peaks of the complexes in 
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Figure 3C were higher in intensity when compared to the FITC-peaks observed for the FITC-
liposomes (Figure 3B). This suggests that FITC-liposome/Cy5-ONs complexes consist out of 
more than one FITC-liposome. Additionally, the baseline fluorescence of the FITC-liposomes 
did not change upon complexation with the Cy5-ONs (compare Figure 3B with the lower 
panel of Figure 3C). This was also expected as the baseline fluorescence is due to free FITC, 
that most likely does not participate in the complexation. The distribution of the height of the 
Cy5-peaks and FITC-peaks in Figure 3C is probably related to the polydispersity of the 
lipoplexes with regard to the number of Cy5-ONs and FITC-liposomes per lipoplex, in 
combination with different degrees of mutual quenching between the labels. A closer look to 
Figure 3 reveals that after 7 seconds there is a Cy5-peak without simultaneous appearance of a 
FITC-peak, which we attribute to complete FITC-quenching in that lipoplex.  
Figure 3 shows that FFS can detect the association of Cy5-ONs to the liposomes with 
the formation of liposome/ONs complexes that bear a large number of Cy5-ONs and consist 
out of more than one FITC-liposome. The latter was also supported from DLS experiments 
which revealed an increase in the size of the liposomes (from 150nm till 250nm) upon 
association with Cy5-ONs. Unfortunately, the FITC-peaks and Cy5-peaks in Figure 3C 
completely disturbed the autocorrelation analysis of the fluorescence fluctuations. 
Consequently, the association of the Cy5-ONs to the FITC-liposomes could not be studied 
from a change in diffusion time as no reproducible diffusion coefficient could be calculated. 
 
3.4. Studying the dissociation of liposome/ONs complexes in buffer  
In further experiments we evaluated whether FFS could monitor the dissociation of the 
FITC-liposome/Cy5-ONs complexes. As shown above (Figure 3) the decrease in baseline 
fluorescence of the Cy5-ONs and the simultaneous appearance of FITC-peaks and Cy5-peaks 
(FITC/Cy5-peaks) are hallmarks of liposome/ONs complex formation. Consequently, gradual 
dissociation of FITC-liposome/Cy5-ONs complexes is expected to result in a gradual increase 
of the baseline fluorescence of the Cy5-ONs and a progressive disappearance of the Cy5-
peaks. To dissociate the lipoplexes we added increasing concentrations of NaCl to the 
lipoplexes and measured the baseline fluorescence of the (free) Cy5-ONs and the number of 
Cy5-peaks. To quantify the baseline and to identify high fluorescence peaks in the 
fluorescence fluctuation profiles, the software algorithm as reported by Van Craenenbroeck et 
al. was used [15;22]. 
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Figure 4A shows that adding NaCl at a final concentration of 0.15M increased the 
Cy5-baseline fluorescence compared to a sample of FITC-liposome/Cy5-ONs complexes in 
Hepes buffer, indicating a partial dissociation of the Cy5-ONs from the complexes. Addition 
of more NaCl further increased the baseline fluorescence of the Cy5-ONs and decreased the 
height of the Cy5-peaks. 
Figure 4B shows the percentage of dissociated Cy5-ONs after adding increasing 
amounts of NaCl. This percentage was obtained by comparing the baseline fluorescence of 
respectively free and complexed Cy5-ONs. A complete dissociation of the complexes by 
NaCl could not be obtained. Gel electrophoresis experiments showed similar results (data not 
shown). We observed that an anionic polymer (dextran sulfate) or a detergent (sodium 
dodecyl sulfate) was also not able to dissociate all Cy5-ONs from the complexes and Cy5-
peaks remained.  
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Figure 4. (A) Red fluorescence (Cy5) fluctuation profiles of free Cy5-ONs and of FITC-
liposome/Cy5-ONs complexes (prepared in Hepes buffer) before and after adding increasing amounts 
of NaCl.  
(B) Percentage of dissociated Cy5-ONs after adding increasing amounts of NaCl to the FITC-
liposome/Cy5-ONs complexes. Shown are: free Cy5-ONs in Hepes buffer and in 2 M NaCl; FITC-
liposome/Cy5-ONs complexes in Hepes buffer and in increasing amounts of NaCl (final NaCl 
concentrations 0.15 M, 0.50 M, 1.00 M and 2.00 M).  
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3.5. Monitoring the complexation of liposome/ONs complexes in cell lysates  
A major goal of our work is to evaluate to what extent FFS is suitable to study 
lipoplexes in the cytoplasm of living cells. Therefore, we first examined how FFS 
experiments on respectively free Cy5-ONs and FITC-liposome/Cy5-ONs complexes 
incubated in cell lysate look like. The results of these experiments are summarized in Figure 
5. Mixing of free Cy5-ONs with cell lysate resulted in a slight decrease of the baseline 
fluorescence (compare 650 kHz in Figure 5A with 700 kHz in Figure 3A) and in the 
appearance of a few Cy5-peaks. The Cy5-peaks are probably attributed to clustering of Cy5-
ONs with cellular components, resulting in highly fluorescent molecular aggregates. Clearly, 
a major part of the Cy5-ONs remains free (as the baseline fluorescence hardly decreased) 
while only a small amount of the Cy5-ONs binds to components present in the cell lysate. 
This agrees with observations from gel electrophoresis experiments: lane 2 in Figure 6 shows 
that after incubation with cell lysate, nearly all Rh-ONs still migrate freely through the gel.  
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Figure 5. Fluorescence fluctuation profiles of Cy5-ONs (A) and FITC-liposome/Cy5-ONs 
complexes (B) in cell lysate. The green and red curves represent the fluorescence registered by the 
green and red detector upon simultaneous excitation with 488 nm and 647 nm. The FITC/Cy5-peak 
(full line frame) originates from aggregated FITC-liposome/Cy5-ONs complexes. The Cy5-peak in B 
(dashed line frame) is either attributed to a FITC-liposome/Cy5-ONs complex in which the FITC-
fluorescence is quenched or to Cy5-ONs clustered with cellular components. The +/- charge ratio of 
the lipoplexes was 10. The final Cy5-ONs and FITC-liposome concentration equaled 0.2 µg/mL and 6 
µM DOTAP, respectively. 
 
Figure 5B shows FFS on FITC-liposome/Cy5-ONs complexes in cell lysate. Mixing 
lipoplexes with the cell lysate resulted in a nearly complete disappearance of the FITC-
fluorescence. Also, both small as well as huge Cy5-peaks appeared. Only the huge Cy5-peaks 
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were accompanied by very weak FITC-peaks. The huge Cy5-peaks indicate the presence of 
very slowly diffusing, gigantic aggregates containing many Cy5-ONs and probably arrive 
from aggregated FITC-liposome/Cy5-ONs complexes. The small Cy5-peaks (not 
accompanied by a FITC-peak) can either be attributed to intact FITC-liposome/Cy5-ONs 
complexes with completely quenched FITC-fluorescence (similar to one peak in Figure 3C) or 
to Cy5-ONs clustered with cellular components (as demonstrated in Figure 5A). The red 
baseline fluorescence of the complexes in cell lysate is around 200 kHz (Figure 5B). This is 
higher than the red baseline fluorescence of the complexes in Hepes buffer (60 kHz, Figure 
3C) and much lower than the value of free Cy5-ONs in Hepes buffer (700 kHz in Figure 3A). 
This indicates that only a small portion of Cy5-ONs dissociated from the complexes in cell 
lysate. This could also be confirmed by gel electrophoresis. Lane 4 in Figure 6 shows the 
result of gel electrophoresis on FITC-liposomes/Rh-ONs incubated in cell lysate. Only a small 
amount of freely migrating Rh-ONs can be detected, while the majority of the Cy5-ONs 
remains in the slots, either complexed to the original liposome carrier or aggregated with 
cellular components. From the small amount of released Cy5-ONs, a minor part might be 
associated with components present in the cell lysate (as concluded from the control 
experiment in Figure 5A and 6B in combination with lanes 1 and 2 in Figure 6). Therefore, 
one can conclude that the major part of the ONs remaining in the slots is still associated to the 
FITC-liposomes. 
 1 2 3 4
 
Figure 6. Gel after electrophoresis on Rh-ONs and FITC-liposome/Rh-ONs complexes (+/- charge 
ratio = 10). Lane 1 and 2 contain 0.3 µg free Rh-ONs in Hepes buffer respectively without (lane 1) and 
with (lane 2) addition of cell lysate. Lane 3 and 4 contain FITC-liposome/Rh-ONs complexes in Hepes 
buffer respectively without (lane 3) and with (lane 4) addition of cell lysate. (Note that Rh-ONs 
instead of Cy5-ONs were used in all gel electrophoresis experiments. The reason is that the UV-lamp 
used can visualize Rh-fluorescence but not Cy5-fluorescence). 
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3.6. Monitoring the complexation of liposome/ONs complexes in cells 
As a control experiment dual color FFS measurements were first performed in the 
cytoplasm and nucleus of ‘blanc’ cells (i.e. cells which were not loaded with free Cy5-ONs or 
FITC-liposome/Cy5-ONs complexes). Generally, the fluorescence registered by the two 
detectors was very low while from time to time extremely small and negligible peaks 
appeared.  
Microinjection of free Cy5-ONs in the cytoplasm resulted in nuclear accumulation of 
the Cy5-ONs within minutes (Figure 8C). This rapid nuclear accumulation has also been 
reported in literature [23-27]. Accordingly, the Cy5-fluorescence (as measured by FFS) was 
significantly higher in the nucleus than in the cytoplasm. In the nucleus, Cy5-peaks could not 
be observed by FFS, indicating that only free Cy5-ONs diffuse through the excitation volume. 
However, following autocorrelation analysis of the fluorescence fluctuations (using either 1-
component (eq. 1) or 2-component (eq. 3) fits), a large amount of the Cy5-ONs seemed to be 
significantly retarded (data not shown). In the cytoplasm, however, Cy5-peaks were 
frequently observed, indicating interactions between Cy5-ONs and cellular components 
(Figure 7A) and in agreement with the FFS measurements on free Cy5-ONs in cell lysate 
(Figure 5A).  
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Figure 7.  Fluorescence fluctuation profiles as measured by the green and red detector in the cytoplasm 
of a Vero-cell, after cytoplasmic injection of free Cy5-ONs (A) and a FITC-liposome/Cy5-ONs 
sample (B). 
 
Microinjecting FITC-liposome/Cy5-ONs in the cytoplasm of Vero cells resulted 
within minutes in a higher Cy5-fluorescence (as measured by FFS) in the nucleus compared to 
the cytoplasm. This could be attributed to the small fraction of free Cy5-ONs in the lipoplex 
sample. However, we observed that the Cy5-fluorescence in the nucleus further gradually 
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increased with time (hours), suggesting that (at least part of) the Cy5-ONs were released from 
the complexes. The release of Cy5-Ons could be confirmed by CLSM imaging: Figures 8E 
and 8F show that the green fluorescence of the FITC-liposomes remains located in the 
cytoplasm, whereas the red fluorescence is also present in the nucleus. After microinjecting 
FITC-liposomes/Cy5-Ons complexes, Cy5-peaks could be regularly observed by FFS in the 
cytoplasm, however, they were never accompanied by simultaneous occurring FITC-peaks 
(Figure 7B). Again, these small Cy5-peaks can either be attributed to intact FITC-
liposome/Cy5-Ons complexes with completely quenched FITC-fluorescence or to Cy5-Ons 
clustered with cellular components. Simultaneously occurring FITC/Cy5-peaks, attributed to 
aggregated lipoplexes and as seen in cell lysate (Figure 5B) were, however, not observed in 
the cytoplasm. 
 
D E F
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Figure 8.  Transmission image (A) and green (B) and red (C) CLSM image of Vero-cells 10 minutes 
after cytoplasmic injection of a Cy5-ONs solution. Transmission image (D) and green (E) and red (F) 
CLSM image of a Vero-cell 30 minutes after cytoplasmic injection of a FITC-liposome/Cy5-ONs 
sample. A circle is drawn around the nucleus. 
 
3.7. Why does FFS not detect simultaneous FITC/Cy5-peaks in the cytoplasm? 
All experiments on the FITC-liposome/Cy5-Ons complexes injected in Vero cells so 
far indicate that a part of the Cy5-Ons is released as Cy5-Ons are detected in the nuclei. The 
other part seems to remain bound as Cy5-peaks frequently appear in the cytoplasm (Figure 
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7B). As the Cy5-peaks were not accompanied by simultaneous FITC-peaks we could have 
concluded that the Cy5-peaks would be due to a clustering of Cy5-Ons with cellular 
components and would not be due to Cy5-Ons still complexed to FITC-liposomes. However, 
the considerations below learn us that we cannot make this conclusion. 
As the (large) FITC/Cy5-peaks (in cell lysate; Figure 5B) were attributed to 
aggregated lipoplexes, we first reasoned that simultaneous FITC/Cy5-peaks were not detected 
in the cytoplasm as the aggregates are too large to migrate through the cytoplasm crowded 
with cell organelles and thus cannot move through the excitation volume. To test this 
hypothesis we performed FFS measurements on respectively ‘small’ (90 nm) and ‘large’ (500 
nm) dual labeled polystyrene beads. Microinjecting 90 nm beads in the cytoplasm of Vero 
cells resulted in the simultaneous appearance of FITC/Cy5- peaks (Figure 9), proving that 
these spheres are mobile in the cytoplasm. However, microinjected 500 nm beads seemed to 
be immobile in the cytoplasm as we did not observe simultaneous FITC/Cy5-peaks (which we 
did see for these beads in buffer; data not shown). Considering the hydrodynamic diameter of 
the lipoplexes to be around 250 nm (Figure 1), one can expect that the size of aggregated 
lipoplexes largely exceeds 500 nm. These observations suggest that simultaneous FITC/Cy5-
peaks in the cytoplasm could not be observed by FFS as the aggregated (and possibly also non 
aggregated) lipoplexes were sterically entrapped.  
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Figure 9.  Fluorescence fluctuation profile as registered by the green and red detector in the cytoplasm 
of a Vero-cell, after cytoplasmic injection of dual labeled polystyrene spheres (90 nm diameter). 
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A second reason for the lack of simultaneous FITC/Cy5-peaks in the cytoplasm may 
be related to the quenching of the FITC-fluorescence in the FITC-liposome/Cy5-Ons 
complexes. Indeed, we observed that the extent of FITC-quenching is dependent on the 
solvent composition of the sample. E.g. we saw that the buffer in which the FITC-
liposome/Cy5-Ons complexes were prepared had a major effect on the fluorescence 
fluctuation profiles: when using PBS (Dulbecco’s phosphate buffered saline), instead of 20 
mM Hepes buffer, simultaneous FITC/Cy5-peaks did also not appear and only Cy5-peaks 
were observed (compare Figure 10A with Figure 3C). The complete disappearance of the 
FITC fluorescence in PBS is probably due to excessive quenching of the FITC-molecules by 
the Cy5-molecules. This hypothesis was supported by the fact that partial release of the Cy5-
Ons from the lipoplexes in PBS, upon increasing the NaCl concentration, did result in the 
appearance of simultaneous occurring FITC/Cy5-peaks (Figure 10B). 
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Figure 10.  The fluorescence fluctuation profiles of a FITC-liposome/Cy5-ONs sample (charge ratio = 
10; 0.2 µg/mL Cy5-ONs) in PBS before (A) and after (B) induced dissociation in 0.2M NaCl as 
simultaneously registered by the FFS green and red detector. 
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4. Conclusions 
In a first setup, we studied the complexation behavior of Cy5-ONs to cationic FITC-
liposomes in buffer. We observed that upon binding Cy5-ONs to FITC-liposomes significant 
fluorescence quenching (of both FITC and Cy5) occurs. This was attributed to 
(self)quenching of the labels in the complexes. We demonstrated that in Hepes buffer dual 
color FFS is able to monitor the binding of Cy5-ONs to the FITC-liposomes. Mixing Cy5-
ONs with FITC-liposomes resulted in multimolecular complexes, which consist out of many 
Cy5-ONs and FITC-liposomes. These lipoplexes are highly fluorescent and, consequently, 
they are clearly detected. Also, upon mixing the Cy5-ONs with FITC-liposomes the 'baseline 
Cy5-fluorescence' of the fluorescence fluctuations as registered by the FFS instrument was 
drastically lowered. This decrease in baseline Cy5-fluorescence is caused by the decreased 
amount of free Cy5-ONs in the detection volume. Dissociation of the FITC-liposome/Cy5-
ONs complexes, upon adding NaCl, could be clearly observed by FFS as the 'baseline Cy5-
fluorescence' increased. The FFS results on the complexation behavior of the lipoplexes were 
confirmed by gel electrophoresis measurements.  
FFS measurements on free Cy5-ONs in (diluted) cell lysate of Vero cells revealed that 
the major part of the Cy5-ONs remained free, however, a minor part of the Cy5-ONs seemed 
to cluster with cellular components. FFS measurements on FITC-liposome/Cy5-ONs 
complexes in (diluted) cell lysate indicated that most, however not all, of the Cy5-ONs 
remained complexed. We also observed that aggregation of FITC-liposome/Cy5-ONs 
complexes occurred. 
FFS measurements on free Cy5-ONs injected in the cytoplasm of Vero cells revealed 
that (part) of the Cy5-ONs clustered with cellular components in the cytoplasm (in agreement 
with the observations in cell lysate) whereas a major part of the Cy5-ONs accumulated in the 
nucleus. Micro-injection of FITC-liposome/Cy5-ONs complexes revealed that part of the 
Cy5-ONs were clearly released from the lipoplexes as free Cy5-ONs were detected in the 
nucleus.  
Finally, this study indicates that FFS shows potential to evaluate the biophysical 
properties of (sometimes rare) nanomaterials in complex biological media. As gel 
electrophoresis can tell us whether ONs are free or complexed, so does dual color FFS allow 
us to determine in the cytoplasm of a living cell whether the Cy5-ONs are migrating freely or 
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complexed, providing additional information to observations with CSLM. Also, experiments 
can be done on small sample volumes in the nanomolar concentration range: compare 50 µL 
of 0.2 µg/mL ONs for FFS-measurements with the 30 µL of a 20 µg/mL ONs solution needed 
for gel electrophoresis and the 1 mL of a 10 µg/mL ONs solution we used for the dynamic 
light scattering, zeta-potential and conventional fluorimeter experiments. However, to resolve 
in the cytoplasm whether the Cy5-ONs are still complexed to their carrier (showing 
simultaneous FITC/Cy5-peaks) or have dissociated and subsequently have underwent 
interactions with cellular components (showing only Cy5-peaks), the unforeseen quenching of 
FITC-fluorescence described in this chapter should be overcome. This is part of further 
research. 
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In antisense therapy, single stranded oligonucleotides (ONs) are applied to inhibit the 
production of an unwanted protein in a living cell. At present, most antisense applications are 
in fundamental research, however, a growing interest remains in developing drugs based upon 
the antisense mechanism, mainly aimed at interfering with viral infections and cancer. The 
biological efficacy of administered antisense ONs is restrained by their inefficient cellular 
uptake and their sensitivity to degradation. Consequently, therapeutic ONs are strongly 
dependent on carriers to maintain their physicochemical properties in the extracellular matrix, 
to cross cellular membranes and to escape from the endosomes. Several laboratories have 
been encouraged to look for appropriate pharmaceutical carrier systems for ONs. One current 
strategy is screening a high number of pharmaceutical carriers for ONs delivery. While much 
effort is oriented towards the synthesis of new carriers, the optimization of the 
physicochemical and pharmaceutical features of the complexes is frequently neglected. We 
believe that rational design of improved vectors requires a better knowledge of the multistage 
process by which pharmaceutical vectors deliver ONs into cells. An important step, which has 
to occur once the complexes have arrived in the cytoplasm, is the release of the ONs from 
their carrier. To obtain further breakthroughs in understanding the complex matter of 
intracellular delivery of DNA complexes there is an urgent need for tools which allow 
studying the dissociation of DNA complexes in cells. In Chapter 1 we described how several 
advanced light microscopy techniques show potential for this purpose. To study the 
intracellular dissociation of two components (DNA and its carrier), the simultaneous 
observation of both components ensures a higher signal specificity. This can be obtained by 
labelling both components with spectrally different fluorophores (e.g. red and green) and 
detecting their emission light separately by two detectors simultaneously monitoring the same 
detection volume. 
In confocal imaging, average intensities of fluorescence are directly measured as a 
function of space to monitor the distribution of the labeled components throughout the cells. 
The colocalization of the fluorescent markers may indicate that the DNA and its carrier are 
associated, a lack of colocalization may indicate that the DNA is released from its carrier. 
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However, due to the resolution limit of a light microscope it remains possible that the 
fluorescently labeled molecules are observed colocalized without being associated. Compared 
with the spatial analysis of the DNA and the carrier (as in dual color microscopy), the 
temporal analysis of the movement of the DNA and the carrier could be more robust to 
conclude whether the fluorescently labeled species are interacting. While dual color 
microscopy answers the question “are the DNA and the carrier located together”, dual color 
FFS may answer the question whether they really move together. With this idea in mind, we 
were interested to explore whether dual color FFS allows studying the dissociation of 
carrier/ONs complexes intracellularly. Especially because the experimental results in Chapter 
2 illustrated the need for advanced microscopy techniques to understand why some 
carrier/ONs combinations show biological activity, whereas other combinations fail.  
In the first part of Chapter 2, we studied the biological efficiency of ONs packed in 
several types of pharmaceutical carriers. We used a well-studied antisense assay in which the 
ability of the ONs to downregulate the expression of the intracellular adhesion molecule-1 
(ICAM-1) is evaluated. A biological assay answers the question whether a certain 
pharmaceutical carrier successfully delivers ONs or not. However, it does not give an answer 
on the important question why one carrier is successful while another one fails. In the second 
part of Chapter 2, we tried to find out why some carrier/ONs combinations showed biological 
activity and why others did not. We were especially interested in knowing how cellular 
methods like flow cytometry and confocal laser scanning microscopy (CLSM) could provide 
us with additional information on the cellular delivery of the carrier/ONs combinations 
studied.  
We showed that free PO-ONs and PS-ONs failed to decrease the ICAM-1 protein 
level. Using CLSM and flow cytometric measurements we showed that this was due to the 
inability of naked ONs to diffuse passively through the cellular membrane. Presumably 
because they are large, negatively charged hydrophilic molecules.  
Although flow cytometric and CLSM experiments clearly showed cellular uptake for 
PS-ONs and PO-ONs complexed with Lipofectin, Lipofectin/PO-ONs did not show a 
decrease in the ICAM-1 protein level while Lipofectin/PS-ONs showed a biological effect. 
We therefore suggested that the absence of antisense activity of Lipofectin/PO-ONs 
complexes was not attributed to an inefficient entrance of the complexes in the cells but rather 
to enzymatic degradation of the PO-ONs. Due to the backbone modification, PS-ONs are 
more stable in cells than PO-ONs, which may explain why they showed biological activity. 
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Contrary to the liposome-based Lipofectin, the polymer graft-pDMAEMA efficiently 
increased the antisense activity of both types of ONs. Noticeably, graft-pDMAEMA/PS-ONs 
had a very efficient inhibition of the ICAM-1 expression. As expected, flow cytometric and 
(dual color) CLSM experiments showed indeed cellular uptake and intracellular dissociation 
of both graft-pDMAEMA/PS-ONs and graft-pDMAEMA/PO-ONs complexes. 
The gel electrophoresis competition experiments revealed that graft-pDMAEMA 
formed more stable complexes with PS-ONs than with PO-ONs. However, as the graft-
pDMAEMA/PS-ONs complexes were more biologically active than the graft-
pDMAEMA/PO-ONs, it would be wrong to conclude from the gel electrophoresis 
experiments that the graft-pDMAEMA/PS-ONs complexes are too stable to dissociate 
intracellularly. Although in literature results from non-cellular experiments like gel 
electrophoresis are often used to predict the intracellular dissociation behavior of DNA 
complexes, our results clearly showed that measuring the dissociation behavior of DNA-
complexes intracellularly is highly recommended. 
Although flow cytometry and CLSM are useful to understand the cellular uptake and 
intracellular localization of ONs, our experiments showed that the outcome of CLSM and 
flow cytometry measurements could not explain why PO-ONs were active when complexed 
to graft-pDMAEMA while they were unactive when complexed to Lipofectin. Similarly, one 
could not explain from CLSM and flow cytometry why PS-ONs complexed to graft-
pDMAEMA better decreased the ICAM-1 protein expression than PO-ONs complexed to 
graft-pDMAEMA. As PO-ONs become susceptible to degradation by cytoplasmic DNase as 
soon as they are released from their carrier, one could argue that a better understanding of the 
time and (intracellular) place at which dissociation of the complexes occurs is crucial to 
explain these observations. Because FFS can be applied on a cellular scale, we were interested 
to explore whether it would also allow to study the dissociation of crrier/ONs complexes 
intracellularly.  
Therefore, in Chapter 3 the complexation behavior between oligonucleotides and the 
cationic polymer poly-L-Lysine (pLL) was first studied in buffer by both single and dual color 
FFS. In this Chapter we proved that dual color FFS is a straightforward method to detect the 
association and dissociation of pLL/ONs complexes. The FFS results on the dual labeled 
polymer/oligonucleotide complexes matched the observations seen in the single color FFS 
measurements. Although we have not observed controversies between the single color and 
dual color FFS results on pLL/ONs complexes, a clear disadvantage of dual color FFS is that 
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both interacting species have to be labeled, which enhances the risk of fluorophore induced 
artefacts. As explained above, a major advantage of dual color FFS over single color FFS in 
studying the complexation behavior of DNA complexes in cells is that it might yield a 
considerable improvement in signal specificity. In heterogeneous media like cells the DNA 
and the cationic polymers may interact not only with each other but also with many other 
different species.  
By two-dimensional scatter plot analysis of the dual color FFS data, we obtained a 
more detailed view on the composition of the pLL/ONs complexes in the sample. Especially, 
dual color FFS proved that a substantial number of pLL/ONs complexes consisted out of 
numerous ONs bound to numerous pLL strands. Consequently, the appearance of highly 
intense fluorescence peaks simultaneously in both red and green detector proved that the 
carrier/ONs complexes did not dissociate. Whenever highly intense fluorescence peaks 
appeared in the fluctuations profiles, correlation and photon count histogram anlysis of the 
fluorescence fluctuation profile were no longer feasible. As a consequence one could not 
study the complexation of oligonucleotides based upon a change in their mobility as 
correlation analysis is necessary to obtain the diffusion coefficient from the fluctuations. 
Searching for the presence or absence of highly intense fluorescence peaks simultaneously in 
both fluorescence fluctuation profiles seemed to be the only way of analysis one could use to 
know whether oligonucleotides were respectively complexed to/or dissociated from their 
carriers. 
In a next step, we wished to explore if dual color FFS was able to detect intact and 
dissociated polymer/ONs complexes in the cytoplasm of living cells and to what extent dual 
color FFS provided new information on the intracellular behavior of polymer/ONs complexes. 
In Chapter 4, we have shown that cationic polymers of high molar mass, like graft-
pDMAEMA of 1700 kDa, also used in Chapter 2, could not enter the nucleus upon 
microinjection in the cytoplasm. When such (red-labeled) polymers were used as a carrier for 
(green-labeled) ONs, CLSM experiments were sufficiently suited to prove whether the 
polymer/oligonucleotide complexes were able to dissociate in the cytoplasm or not: upon 
dissociation the released green-labeled ONs entered the nucleus while the red-labeled polymer 
chains remained in the cytoplasm, consequently the red and green labels did not colocalize in 
the nucleus. However, in opposite to the high molar mass cationic polymers, cationic 
polymers of lower molar mass, like pLL of 30 kD used in this study, did enter the nucleus 
upon microinjection or transfection. Consequently, when such (red-labeled) polymers were 
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used as carriers for (green-labeled) ONs, the nuclei showed both green and red fluorescence, 
regardless of whether the polyplexes were dissociated or not. Clearly, CLSM experiments 
could not reveal whether the dual colored nuclei were due to intact Cy5-pLL/RhGr-ONs 
polyplexes or to dissociated Cy5-pLL and RhGr-ONs chains. Our results showed that dual 
color FFS, which monitors the movement of the fluorescent molecules, could solve this 
question. Upon cytoplasmic microinjection or upon transfection with Cy5-pLL/RhGr-ONs 
complexes, FFS was able to detect simultaneously red and green fluorescence peaks in the 
cytoplasm. In the nucleus, however, simultaneous peaks were never observed. From these 
results we could conclude that the Cy5-pLL and RhGr-ONs present in the nucleus after 
transfection were not associated. 
As described in Chapter 5, pharmaceutical carriers bearing hydrophilic segments (such 
as polyethyleneglycol, pEG) represent an interesting type of pharmaceutical carriers, 
developed to stabilize and prolong the circulation lifetime of the drug/carrier particles, and to 
improve targeting strategies. These ‘pegylated carriers’ result in DNA-complexes consisting 
of a more or less hydrophobic core of partially neutralized polyion strands, surrounded by a 
shell of hydrophilic chains. In Chapter 5 we investigated whether dual color FFS also allowed 
evaluating the association/dissociation behavior of pegylated DNA-complexes in buffer. Two 
distinct types of pegylated polycations were investigated: a diblock copolymer and a 
multiblock copolymer, equal in chemical formula but of different molecular weight and 
degree of pegylation. Two distinct approaches were used to fluorescent label these 
copolymers: the fluorophore was either attached to the cationic segment or to the distal end of 
the pEG-strand of the copolymer. 
For both diblock and multiblock pEG-pEI, the complexation with oligonucleotides 
resulted in the formation of pegylated DNA-complexes with a core-shell structure, as 
evidenced by zeta-potential measurements. However, differences in complexation behavior 
between the two types of pEG-pEI were observed. Gel electrophoresis demonstrated that the 
diblock pEG-pEI showed better complexation behavior for 25-mer Rh-ONs than for 20-mer 
Rh-ONs, whereas multiblock pEG-pEI was able to fully complex both types of Rh-ONs. In 
addition, conventional fluorimetry revealed that the fluorescence of Rh-labeled ONs was 
differently quenched upon complexation with diblock and multiblock pEG-pEI.  
In cases where the fluorescent label (FITC) was attached to the free end of the pEG-
segment of pEG-pEI, dual color FFS measurements on FITC-pEG-pEI/Cy5-ONs (for diblock 
as well as multiblock pEG-pEI) showed that both detectors simultaneously registered highly 
-104-  
 
SUMMARY 
intense fluorescence signals. This indicated that a group of oligonucleotides and polymer-
chains migrated together through the detection volume and therefore proved that complexes 
were formed, which were composed out of many oligonucleotide and polymer strands. These 
observations proved the formation of multimolecular polyplexes, which was in agreement 
with the gel electrophoresis results and observations in literature. When the pEG-pEI 
polymers were fluorescent-labeled at their cationic pEI-segment, however, FFS did not detect 
multimolecular polyplexes. In the case of diblock pEG-pEI-Cy5, the absence of peaks of high 
fluorescence intensity was indeed due to the fact that no multimolecular polyplexes could be 
formed, as was shown by gel electrophoresis. However, gel electrophoresis showed that 
multiblock pEG-pEI-Cy5 did complex Rh-ONs. The absence of highly intense fluorescence 
peaks in FFS was due to the mutual quenching of both the Cy5- and Rh-labels that were in 
close proximity in the core of the core-shell complex. From these results, it could be 
concluded that dual color FFS alloweds studying the association and dissociation of pEG-
pEI/ONs provided that the fluorescent label of the polymer was attached to the distal end of 
the pEG-chain. 
Cationic liposomes represent a third type of pharmaceutical carriers. Most commercial 
transfection agents are liposome based. They have successfully been used as non-viral carriers 
for ONs, both in cell cultures and in animals. Giving that ONs have to be released from the 
lipoplexes in order to be biologically active, the intracellular dissociation of the lipoplexes is a 
crucial issue in the optimization of cationic liposomes for DNA-delivery. Therefore, we 
investigated in Chapter 6 whether dual color FFS allows evaluating the complexation 
behavior (being association and dissociation) of liposome/ONs complexes in respectively 
buffer, cell lysate and the cytoplasm of living cells. 
In a first setup, we studied the complexation behavior of Cy5-ONs to cationic FITC-
liposomes in buffer. We observed in conventional fluorimeter measurements that upon 
binding Cy5-ONs to FITC-liposomes significant fluorescence quenching (of both FITC and 
Cy5) occurs. This was attributed to (self)quenching of the labels in the complexes. We 
demonstrated that in Hepes buffer dual color FFS is able to monitor the binding of Cy5-ONs 
to the FITC-liposomes. Mixing Cy5-ONs with FITC-liposomes resulted in multimolecular 
complexes, which consist out of many Cy5-ONs and FITC-liposomes. These lipoplexes were 
highly fluorescent and, consequently, they were clearly detected. Also, upon mixing the Cy5-
ONs with FITC-liposomes the 'baseline Cy5-fluorescence' of the fluorescence fluctuations as 
registered by the FFS instrument was drastically lowered. This decrease in baseline Cy5-
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fluorescence was caused by the decreased amount of free Cy5-ONs in the detection volume. 
Dissociation of the FITC-liposome/Cy5-ONs complexes, upon adding NaCl, could be clearly 
observed by FFS as the 'baseline Cy5-fluorescence' increased. The FFS results on the 
complexation behavior of the lipoplexes were confirmed by gel electrophoresis 
measurements.  
FFS measurements on free Cy5-ONs in (diluted) cell lysate of Vero cells revealed that 
the major part of the Cy5-ONs remained free, however, a minor part of the Cy5-ONs seemed 
to cluster with cellular components. FFS measurements on FITC-liposome/Cy5-ONs 
complexes in (diluted) cell lysate indicated that most, however not all, of the Cy5-ONs 
remained complexed. We also observed that aggregation of FITC-liposome/Cy5-ONs 
complexes occurred. 
FFS measurements on free Cy5-ONs injected in the cytoplasm of Vero cells revealed 
that (part) of the Cy5-ONs clustered with cellular components in the cytoplasm (in agreement 
with the observations in cell lysate) whereas a major part of the Cy5-ONs accumulated in the 
nucleus. Micro-injection of FITC-liposome/Cy5-ONs complexes revealed that part of the 
Cy5-ONs were clearly released from the lipoplexes as free Cy5-ONs were detected in the 
nucleus.  
However, to resolve in the cytoplasm whether the Cy5-ONs are still complexed to 
their carrier (showing simultaneous FITC/Cy5-peaks) or have dissociated and subsequently 
have underwent interactions with cellular components (showing only Cy5-peaks), the 
unforeseen quenching of FITC-fluorescence described in Chapter 6 should be overcome. This 
is part of further research. 
Finally, this study indicates that FFS shows potential to evaluate the biophysical 
properties of (sometimes rare) nanomaterials in complex biological media. As gel 
electrophoresis can tell us whether ONs are free or complexed, so does dual color FFS allow 
us to determine in the cytoplasm of a living cell whether the Cy5-ONs are migrating freely or 
complexed, providing additional information to observations with CSLM. Furthermore, 
experiments can be done on small sample volumes in the nanomolar concentration range.  
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Bij antisense therapie worden enkelstrengige oligonucleotiden (ON) toegediend om de 
productie van een ongewenste proteïne te verhinderen. Totnogtoe kaderen de meeste antisense 
toepassingen in het fundamenteel onderzoek. Nochtans blijft er grote belangstelling voor de 
ontwikkeling van geneesmiddelen gebaseerd op het antisense mechanisme, in het bijzonder 
met betrekking tot het bestrijden van virale infecties en kanker. De biologische 
doeltreffendheid van de toegediende ON wordt beknot door hun gevoeligheid voor afbraak en 
hun inefficiënte opname door de doelcellen. Bijgevolg zijn therapeutische ON erg afhankelijk 
van farmaceutische dragers om hun fysico-chemische eigenschappen in de extracellulaire 
matrix te bewaren, om de cellulaire membranen te overbruggen en om vrijgesteld te worden 
uit de endosomen. Verschillende laboratoria trachten geschikte farmaceutische dragers te 
ontwikkelen voor ON. De huidige strategie bestaat erin een zeer groot aantal mogelijke 
dragers te screenen. Terwijl veel aandacht besteed wordt aan de synthese van nieuwe 
mogelijke dragers, wordt de optimalisatie van de fysico-chemische en farmaceutische 
kenmerken van de ON-complexen vaak verwaarloosd. We zijn ervan overtuigd dat een 
rationeel design van verbeterde dragers een betere kennis vereist van de verschillende 
hindernissen die het ON-complex moet nemen. De vrijgave van de ON uit hun drager is een 
belangrijke stap, en die dient plaats te grijpen eens de complexen het cytoplasma bereikt 
hebben. Om verdere doorbraken te verzekeren in de complexe studie van de intracellulaire 
toediening van DNA-complexen, is er een dringende nood aan technieken die toelaten het 
dissociatiegedrag van DNA-complexen in de cellen te bestuderen. In hoofdstuk 1 hebben we 
beschreven hoe verschillende geavanceerde fluorescentiemicroscopietechnieken hiervoor in 
aanmerking komen. Om de intracellulaire dissociatie van 2 componenten (DNA en drager) te 
bestuderen, verzekert het gelijktijdig observeren van beide componenten een betere kijk op 
het gebeuren. Dat gelijktijdig observeren is mogelijk door een verschillende kleurstof (bv. 
rood en groen) te koppelen aan beide componenten en hun emissielicht afzonderlijk te 
registreren met 2 detectors die tegelijkertijd hetzelfde detectievolume bekijken.  
Bij confocale beeldvorming worden gemiddelde fluorescentie-intensiteiten in functie 
van de ruimte gemeten om de distributie van de gelabelde componenten in de cel te 
achterhalen. Indien beide fluorescente kleurstoffen op dezelfde plaats worden waargenomen, 
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veronderstelt men dat DNA en drager geassocieerd zijn. Wanneer beide kleurstoffen niet op 
dezelfde plaats voorkomen, geeft dat aan dat het DNA vrijgesteld is van de farmaceutische 
drager. Door de resolutielimiet van een fluorescentiemicroscoop is het echter mogelijk dat de 
fluorescente moleculen samen gezien worden zonder dat ze geassocieerd zijn. Vergeleken met 
de ruimtelijke distributie van DNA en drager (zoals bij microscopie) is de analyse van het al 
dan niet samen bewegen van DNA en drager misschien een meer doeltreffende methode om 
vast te stellen of beide fluorescente soorten interageren. Terwijl tweekleurige microscopie een 
antwoord geeft op de vraag “Komen DNA en drager op dezelfde locatie voor?”, beantwoordt 
tweekleurige fluorescentie fluctuatie spectroscopie (FFS) de vraag of beide echt samen 
bewegen of niet. Op basis hiervan wilden we achterhalen of tweekleurige FFS toelaat om de 
dissociatie van drager/ON-complexen te bestuderen in cellen. In het bijzonder omdat de 
experimentele resultaten in hoofdstuk 2 illustreerden dat er nood is aan geavanceerde 
microscopietechnieken om te begrijpen waarom sommige drager/ON-combinaties biologische 
activiteit vertonen terwijl andere combinaties falen. 
In het eerste deel van hoofdstuk 2 bestudeerden we het biologische effect van ON 
verpakt in verschillende types farmaceutische dragers. Daarvoor werd een welgekende 
antisense-test gebruikt waarbij werd nagegaan hoezeer de ON in staat zijn om de expressie 
van de intracellulaire adhesiemolecule-1 (ICAM-1) af te zwakken. Een biologische test 
beantwoordt de vraag of een bepaalde farmaceutische drager de ON succesvol in de cel 
aflevert of niet. De antisense-test geeft echter geen antwoord op de belangrijke vraag waarom 
een bepaalde drager wel succesvol is terwijl een andere faalt. In het tweede deel van 
hoofdstuk 2 probeerden we te achterhalen waarom sommige van de gebruikte drager/ON-
combinaties wel biologische activiteit vertoonden en andere niet. We wilden meer bepaald 
weten hoe cellulaire methoden zoals flow cytometrie en Confocale Laser Scanning 
Microscopie (CLSM) bijkomende informatie kunnen verschaffen over de cellulaire toediening 
van de gebruikte drager/ON-combinaties.  
We toonden aan dat vrije fosfodiëster oligonucleotiden (PO-ON) en fosfothioaat 
oligonucleotiden (PS-ON) het ICAM-1 expressieniveau niet deden afnemen. Aan de hand van 
CLSM en flow cytometriemetingen toonden we aan dat de verklaring daarvoor ligt in het feit 
dat de vrije ON niet doorheen het celmembraan kunnen dringen. Vermoedelijk is dat zo 
omdat de vrije ON grote, negatief geladen en hydrofiele moleculen zijn. 
Zowel voor PS-ON als voor PO-ON gecomplexeerd met de commerciële 
liposoomdispersie ‘Lipofectin’ toonden flow cytometrie en CLSM-metingen een duidelijke 
cellulaire opname van de ON aan. Lipofectin/PO-ON waren niet in staat het ICAM-1 
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expressieniveau te laten afnemen terwijl Lipofectin/PS-ON wel biologisch effect vertoonden. 
We veronderstelden dat het gebrek aan antisense activiteit van Lipofectin/PO-ON niet 
veroorzaakt werd door een inefficiënte opname van de complexen door de cellen, maar eerder 
te wijten was aan enzymatische afbraak van de PO-ON. Door hun ruggengraatmodificatie zijn 
PS-ON immers stabieler in cellen dan PO-ON. Dat kan verklaren waarom zij in combinatie 
met Lipofectin wel biologisch actief waren. 
In tegenstelling tot Lipofectin, verhoogde het polymeer graft-pDMAEMA de antisense 
activiteit van beide types ON. De combinatie graft-pDMAEMA/PS-ON in het bijzonder bleek 
zeer efficiënt om de ICAM-1 expressie te verhinderen. Zoals verwacht toonden flow 
cytometrie en (tweekleurige) CLSM-experimenten inderdaad cellulaire opname en 
intracellulaire dissociatie van zowel graft-pDMAEMA/PS-ON als graft-pDMAEMA/PO-ON-
complexen. 
Bij gelelektroforese toonden competitie-experimenten aan dat graft-pDMAEMA meer 
stabiele complexen vormde met PS-ON dan met PO-ON. Bovendien waren graft-
pDMAEMA/PS-ON-complexen meer biologisch actief dan graft-pDMAEMA/PO-ON-
complexen. Op basis van de gelelektroforese-experimenten zou men verkeerdelijk kunnen 
besluiten dat graft-pDMAEMA/PS-ON-complexen te stabiel zijn om intracellulair te 
dissociëren. Nochtans worden in de literatuur vaak voorspellingen gemaakt over het 
intracellulair dissociatiegedrag van DNA-complexen op basis van niet-cellulaire experimenten 
(zoals gelektroforese). Onze resultaten gaven echter duidelijk aan dat het aan te bevelen is om 
het dissociatiegedrag van DNA-complexen in de cellen zelf te bestuderen. 
Hoewel flow cytometrie en CLSM een indicatie kunnen geven van cellulaire opname 
en intracellulaire localisatie van ON, gaven onze resultaten aan dat CLSM en flow cytometrie 
niet kunnen verklaren waarom PO-ON wel biologisch actief bleken in combinatie met graft-
pDMAEMA terwijl ze inactief waren in combinatie met Lipofectin. CLSM en flow 
cytometrie verklaarden evenmin waarom PS-ON gecomplexeerd aan graft-pDMAEMA beter 
de ICAM-1-expressie inhibeerden dan PO-ON gecomplexeerd aan graft-pDMAEMA. 
Aangezien PO-ON ook in het cytoplasma gevoelig zijn voor afbraak door DNAse (van zodra 
zij vrijgesteld worden van hun farmaceutische drager), kan men veronderstellen dat een beter 
inzicht in het tijdstip waarop en de (intracellulaire) plaats waar dissociatie van de complexen 
optreedt, cruciaal is om die waarnemingen te verklaren. Vermits FFS toegepast kan worden 
op cellulair niveau, wilden we achterhalen of die techniek toelaat om de dissociatie van 
drager/ON-complexen intracellulair te bestuderen. 
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Daartoe werd in hoofdstuk 3 eerst het complexatiegedrag tussen oligonucleotiden en 
het cationisch polymeer poly-L-Lysine (pLL) in buffer bestudeerd door zowel eenkleurige als 
tweekleurige FFS. We bewezen dat tweekleurige FFS ondubbelzinnig zowel associatie als 
dissociatie van pLL/ON-complexen kan detecteren. De FFS-resultaten van tweekleurig 
gelabelde polymeer/oligonucleotide-complexen stemden overeen met de waarnemingen van 
eenkleurige FFS-metingen. Hoewel we geen tegenstrijdigheden hebben waargenomen tussen 
de resultaten van eenkleurige en tweekleurige FFS voor de pLL/ON-complexen, blijft een 
nadeel van de tweekleurige aanpak dat beide interagerende moleculen moeten worden 
voorzien van een fluorescent label. Dat verhoogt immers het risico op de introductie van 
artefacten. Het voornaamste voordeel van tweekleurige FFS ten opzichte van eenkleurige FFS 
bij het bestuderen van het complexatiegedrag van DNA-complexen in cellen is wel dat 
tweekleurige FFS in staat is om het gedrag van beide interagerende componenten gelijktijdig 
te evalueren. In heterogene media zoals in cellen hoeven DNA en cationisch polymeer niet 
enkel te interageren met elkaar maar kunnen ze dat ook met vele andere componenten.  
Via een tweedimensionele scatteranalyse van de tweekleurige FFS-data verkregen we 
een meer gedetailleerd beeld van de samenstelling van pLL/ON-complexen. Tweekleurige 
FFS bewees dat een aanzienlijk aantal van de pLL/ON-complexen bestond uit verschillende 
ON gebonden aan verschillende pLL-strengen. Bijgevolg bewees het gelijktijdig opduiken 
van sterk intens fluorescente pieken in de groene en de rode detector dat de drager/ON-
complexen niet gedissocieerd waren. Wanneer sterk intens fluorescente pieken optreden in de 
fluorescentiefluctuatieprofielen blijken zowel correlatie-analyse als ‘photon count histogram’-
analyse van het fluorescentiefluctuatieprofiel niet langer mogelijk. Vermits correlatie-analyse 
vereist is om een diffusiecoëfficient uit de fluorescentiefluctuaties te berekenen, kan de 
complexatie van de oligonucleotiden niet bestudeerd worden aan de hand van wijzigingen in 
hun mobiliteit. Evalueren of sterk intens fluorescente pieken gelijktijdig in beide 
fluorescentiefluctuatieprofielen optreden, is bijgevolg de enige manier om te analyseren of de 
oligonucleotiden en hun dragers gecomplexeerd of gedissocieerd zijn.  
Vervolgens wilden we onderzoeken of tweekleurige FFS in staat is om intacte en 
gedissocieerde polymeer/ON-complexen te detecteren in het cytoplasma van levende cellen 
en in hoeverre tweekleurige FFS nieuwe inzichten verschaft over het intracellulair gedrag van 
polymeer/ON-complexen. In hoofdstuk 4 toonden we aan dat cationische polymeren met hoog 
molecuulgewicht, zoals graft-pDMAEMA van 1700 kDa uit hoofdstuk 2, niet in staat zijn om 
de celkern te bereiken na micro-injectie in het cytoplasma. Wanneer dergelijke (rood-
gelabelde) polymeren fungeerden als drager voor (groen-gekleurde) ON, volstonden CLSM-
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experimenten om vast te stellen of de polymeer/oligonucleotide-complexen gedissocieerd 
waren in het cytoplasma of niet: bij dissociatie migreerden de vrijgestelde groen-gelabelde 
ON naar de celkern terwijl de rood-gelabelde polymeerketens in het cytoplasma achterbleven. 
Bijgevolg kwamen rood en groen niet samen voor in de celkern.  
Cationische polymeren met een laag molecuulgewicht, zoals pLL van 30 kDa uit 
hoofdstuk 3, waren echter wel in staat om naar de celkern te migreren na micro-injectie in het 
cytoplasma of na transfectie. Wanneer dergelijke rood-gelabelde polymeren (bv. Cy5-pLL) 
als farmaceutische drager gebruikt werden voor groen-gelabelde ON (RhGr-ON), vertoonden 
de celkernen gelijktijdig groene en rode fluorescentie. Het is duidelijk dat via CLSM-
experimenten niet achterhaald kon worden of de tweekleurige celkernen veroorzaakt werden 
door intacte Cy5-pLL/RhGr-ON-polyplexen of door gedissocieerde Cy5-pLL-ketens en 
RhGr-ON. Onze resultaten toonden aan dat tweekleurige FFS hierover wel uitsluitsel kan 
geven omdat die techniek het al dan niet samen bewegen van de fluorescente moleculen 
detecteert. Na cytoplasmatische micro-injectie of transfectie met Cy5-pLL/RhGr-ON-
complexen was FFS in staat om gelijktijdig optredende groene en rode fluorescente pieken te 
detecteren in het cytoplasma. In de kern werden echter nooit gelijktijdige pieken 
geobserveerd. Daaruit konden we besluiten dat de Cy5-pLL en RhGr-ON die in de kern 
voorkomen na transfectie inderdaad niet meer geassocieerd waren. 
Zoals beschreven in hoofdstuk 5, vormen polymeren die hydrofiele segmenten (zoals 
polyethyleenglycol, pEG) bevatten een interessant type van farmaceutische dragers. Zij 
werden ontwikkeld om de gevormde geneesmiddel/drager-complexen te stabiliseren, hun 
circulatietijd in het lichaam te verlengen en doelgerichte strategieën te verbeteren. Deze 
‘gepegyleerde’ dragers vormen DNA-complexen die bestaan uit een min of meer hydrofobe 
kern van gedeeltelijk geneutraliseerde polyionstrengen die omgeven wordt door een mantel 
van hydrofiele ketens. In hoofdstuk 5 werd onderzocht of tweekleurige FFS ook in staat is het 
associatie/dissociatiegedrag van gepegyleerde drager/ON-complexen te bestuderen in buffer. 
Twee verschillende types van gepegyleerde polycationen werden onderzocht: een diblok-
copolymeer en een meervoudig blok-copolymeer, beide gelijk in scheikundige samenstelling 
maar verschillend in molecuulgewicht en graad van pegylatie. Twee verschillende strategieën 
werden toegepast om deze copolymeren fluorescent te labelen: het fluorescent label werd 
ofwel gebonden aan het cationisch segment, ofwel aan het uiteinde van de pEG-keten van het 
copolymeer. 
Zowel voor het diblok als voor het meervoudig pEGpEI leidde de complexatie met 
oligonucleotiden tot de vorming van gepegyleerde DNA-complexen met een kern-
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mantelstructuur (zoals werd bewezen met zeta-potentiaalmetingen). Nochtans werden 
verschillen in complexatiegedrag tussen de twee types pEGpEI waargenomen. 
Gelelektroforese toonde aan dat diblok pEGpEI een betere complexatie vertoonde met 25-
meer Rh-ON dan met 20-meer Rh-ON, terwijl meervoudig pEGpEI in staat was om beide 
types Rh-ON volledig te complexeren. Conventionele fluorimetrie toonde verder aan dat de 
fluorescentie van de Rh-gelabelde ON bij complexatie verschillend gequenched werd door 
diblok en meervoudig pEGpEI. 
Wanneer het uiteinde van de pEG-keten van pEGpEI fluorescent gelabeld was (met 
FITC) bewezen tweekleurige FFS-metingen op FITC-pEGpEI/Cy5-ON (zowel voor diblok 
als voor meervoudig pEGpEI) dat beide detectoren gelijktijdig sterk intense fluorescente 
pieken registreerden. Dat gaf aan dat een groep ON en polymeerstrengen samen door het 
detectievolume migreerden, wat aldus bewees dat de complexen waren opgebouwd uit 
verschillende ON gebonden aan verschillende polymeerstrengen. De waarnemingen bewezen 
de vorming van multimoleculaire complexen en bevestigden zo gelelektroforeseresultaten en 
literatuurgegevens. Wanneer echter het cationisch deel van de pEGpEI-polymeren fluorescent 
gelabeld werd, was FFS niet in staat om multimoleculaire complexen te detecteren. Bij diblok 
pEGpEI-Cy5 was het gebrek aan sterk intense fluorescente pieken inderdaad het gevolg van 
het feit dat geen multimoleculaire complexen gevormd werden, hetgeen met gelelektroforese 
gestaafd kon worden. Gelelektroforese toonde echter aan dat meervoudig pEGpEI-Cy5 wel in 
staat was de Rh-ON te complexeren. Het gebrek aan sterk intense fluorescente pieken in de 
FFS-metingen was het gevolg van wederzijdse quenching tussen de Cy5- en de Rh-labels, die 
in de kern van het kern/mantelcomplex in elkaars nabijheid zitten. Daaruit konden we 
besluiten dat tweekleurige FFS in staat is om het associatie/dissociatiegedrag van 
pEGpEI/ON-complexen te bestuderen op voorwaarde dat het fluorescente label van het 
polymeer bevestigd was aan het uiteinde van de pEG-keten. 
Cationische liposomen vertegenwoordigen een derde type van farmaceutische dragers. 
Bijna alle in de handel verkrijgbare transfectiemiddelen zijn gebaseerd op 
liposoomformuleringen. Dat type dragers is reeds succesvol aangewend als niet-virale drager 
voor ON, zowel in celkweek als in dieren. Aangezien de ON dienen vrijgesteld te worden uit 
de lipoplexen om biologisch actief te zijn, is de intracellulaire dissociatie van de 
liposoom/ON-complexen een cruciale stap in het optimalisatieproces van cationische 
liposomen voor ON-toediening. Op grond daarvan werd in hoofdstuk 6 nagegaan of 
tweekleurige FFS toelaat om het complexatiegedrag van liposoom/ON-complexen te 
bestuderen in buffer, in cellysaat en in levende cellen. 
 -112- 
 
SAMENVATTING 
Vooreerst werd het complexatiegedrag van Cy5-ON aan cationische FITC-liposomen 
in buffer bestudeerd. Conventionele fluorescentiemetingen toonden dat bij binding van Cy5-
ON aan FITC-liposomen een significante quenching van de fluorescentie optrad bij zowel 
FITC als Cy5. Die werd toegeschreven aan (zelf)quenching van de labels in de complexen. In 
buffer was tweekleurige FFS in staat om de binding van Cy5-ON aan FITC-liposomen te 
volgen. Het mengen van Cy5-ON met FITC-liposomen leidde tot multimoleculaire 
complexen die bestonden uit verschillende Cy5-ON en FITC-liposomen. Die FITC-
liposoom/Cy5-ON-complexen waren sterk fluorescent en werden daarom duidelijk 
gedetecteerd. Bovendien daalde de ‘basisruis Cy5-fluorescentie’ van de 
fluorescentiefluctuaties bij complexatie van Cy5-ON aan FITC-liposomen. Die daling in 
basisruis Cy5-fluorescentie werd veroorzaakt door een lagere hoeveelheid vrije Cy5-ON in 
het detectievolume. Door toevoeging van NaCl werden de FITC-liposoom/Cy5-ON-
complexen gedissocieerd. Door tweekleurige FFS kon dit duidelijk gevolgd worden door een 
stijging in de basisruis Cy5-fluorescentie. De FFS-resultaten stemden overeen met de 
gelelektroforese-resultaten.  
FFS-metingen op vrije Cy5-ON in (verdund) cellysaat van Vero-cellen onthulden dat 
het merendeel van de Cy5-ON vrij in oplossing bleef. Een klein deel van de Cy5-ON bleek 
echter te clusteren met cellulaire componenten, met de vorming van sterk fluorescente 
partikels tot gevolg. FFS-metingen op FITC-liposoom/Cy5-ON-complexen in (verdund) 
cellysaat gaven aan dat het merendeel van de Cy5-ON gecomplexeerd bleef. Aggregatie van 
de FITC-liposoom/Cy5-ON-complexen werd eveneens waargenomen. 
FFS-metingen op vrije Cy5-ON geïnjecteerd in het cytoplasma van Vero-cellen gaf 
aan dat een deel van de Cy5-ON clusterde met cellulaire componenten in het cytoplasma (wat 
overeenstemde met de FFS-resultaten van vrije ON in cellysaat), terwijl de meerderheid van 
de Cy5-ON in de celkern accumuleerde. Micro-injectie van FITC-liposoom/Cy5-ON-
complexen onthulde dat een deel van de Cy5-ON vrijgesteld werd uit de lipoplexen vermits 
vrije Cy5-ON gedetecteerd werden in de celkern. Om te achterhalen of de Cy5-ON in het 
cytoplasma nog gecomplexeerd zijn aan hun originele farmaceutische drager (waarbij 
gelijktijdig FITC/Cy5-pieken optreden) of reeds gedissocieerd zijn en vervolgens geclusterd 
zijn op cellulaire componenten (waarbij enkel Cy5-pieken optreden), dient het onvoorziene 
quenchingfenomeen van FITC-fluorescentie vermeden te worden. Dat maakt deel uit van 
verder onderzoek. 
Als algemeen besluit kan gesteld worden dat FFS een krachtige techniek is om 
biofysische kenmerken van (soms zeldzaam) nanomateriaal in complexe biologische media te 
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bestuderen. Zoals gelelektroforese aangeeft of ON vrij of gecomplexeerd zijn, kan 
tweekleurige FFS in het cytoplasma van een levende cel onderzoeken of de Cy5-ON vrij 
migreren of gecomplexeerd zijn. Bovendien kunnen in vitro-experimenten opgezet worden in 
kleine volumina met nanomolaire concentraties aan fluorescent materiaal.  
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